{
  "results": [
    {
      "example_idx": 0,
      "dataset_id": "1511",
      "question": "What is a lockdown?",
      "ground_truth_answer": "A lockdown is the implementation of strict restrictions and measures to limit people's movement and activities in order to control the spread of infections, such as the one mentioned in the given context.",
      "generated_response": "<think>\nOkay, the user is asking, \"What is a lockdown?\" and the context provided seems to be about estimating infections and the impact of non-lockdown measures. Wait, the titles and passages are a bit confusing. Let me look again.\n\nThe context has four entries. The first three are just the title \"Estimating the number of infections and the impact of non-\" followed by \"Passage: Lockdown\". The fourth entry has the same title but the passage is \"banned Implemented with lockdown.57 24/3/2020\". Hmm, maybe there's some formatting issues here. The user might have intended to provide a paper or article about lockdowns and their impact on infections.\n\nSo, the question is about defining a lockdown. The answer should be a general definition. The context mentions lockdowns in the context of public health, probably related to a pandemic like COVID-19. The passage \"banned Implemented with lockdown.57 24/3/2020\" might be a typo or a fragment. Maybe \"banned\" should be \"ban\" or part of a larger sentence. The date 24/3/2020 is March 24, 2020, which is when many countries started lockdowns.\n\nSince the context is about estimating infections and the impact of non-lockdown measures, the answer should connect lockdowns to public health measures. A lockdown typically refers to strict restrictions on movement and activities to prevent the spread of a disease. The answer should mention that it's a public health measure, enforced by authorities, requiring people to stay home except for essential reasons, closing non-essential businesses, schools, etc., to reduce transmission.\n\nI need to make sure the answer is accurate and not just copying from the context, which seems incomplete. The user might be expecting a standard definition based on common knowledge, even if the provided context is fragmented. So, the answer should define a lockdown in the context of public health, mention its purpose, and maybe reference the example from the context like the date 24/3/2020 if relevant. But since the context is unclear, it's safer to stick to the general definition.\n</think>\n\nA **lockdown** is a public health measure implemented by authorities to restrict movement and gatherings of people in order to control the spread of a contagious disease, such as during a pandemic. It typically involves strict limitations on",
      "retrieved_chunks": [
        "Title: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: banned Implemented with lockdown.57 24/3/2020"
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 0.0,
      "binary_pred": 0,
      "binary_gt": 0,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 1,
      "dataset_id": "1085",
      "question": "What complications are associated with CHIKV?",
      "ground_truth_answer": "Complications associated with CHIKV include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about the complications associated with CHIKV, which is the Chikungunya virus. I need to look through the provided context to find all the mentioned complications.\n\nFirst, the first passage lists several complications from most common to least. Let me check that again. It says: respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure. So those are the main ones mentioned there.\n\nThen, looking at the second part of the passage, there's mention of neonates. It says that mothers can transmit CHIKV during the perinatal period, leading to high morbidity. The neonates showed symptoms by day 4, and six had meningoencephalitis. Another part mentions nineteen cases of neonatal infection leading to encephalitis due to vertical transmission. So encephalitis is a complication here, specifically in neonates.\n\nWait, the first passage already listed meningoencephalitis as a complication. So in the neonatal cases, they mention encephalitis again. Are these the same? Meningoencephalitis is inflammation of both the brain and meninges, while encephalitis is just the brain. But in the context, they might be considered under central nervous system problems. However, the second part specifically mentions encephalitis in neonates, so I should include that as a separate point or note that it's a specific case in neonates.\n\nAlso, the first passage mentions \"other central nervous system problems,\" so maybe encephalitis is part of that. But since the neonatal cases are highlighted separately, it's worth noting that vertical transmission can lead to encephalitis in newborns.\n\nSo compiling all the complications: respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other CNS issues, kidney failure, and neonatal encephalitis from vertical transmission. Also, the high morbidity in neonates due to perinatal transmission.\n\nI need to present these in a clear list, making sure to include both the general complications and the specific neonatal ones. The answer should list all the complications mentioned in the context without adding any external information. Let me check again to make sure I didn't miss anything. The first passage lists the complications",
      "retrieved_chunks": [
        "Passage: More than 50% of patients who suffer from severe CHIKF are over 65 y old, and more than 33% of them die. Most adults who suffer from severe CHIKF have underlying medical conditions . The other group that is disproportionately affected by severe CHIKV is children. Other complications associated with CHIKV, from most common to least common, include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure .",
        "discovered that mothers could transmit CHIKV to their progeny during the perinatal period , and it is associated with a high degree of morbidity. By mean Day 4 of life, all of the neonates were symptomatic for CHIKV, exhibiting common CHIKF symptoms. Six neonates were confirmed to have contracted CHIKV and developed mengoencephalitis.",
        "Passage: and complications.",
        "reported nineteen cases of neonatal infection associated with intrapartum maternal viremia that progressed to develop encephalitis owing to vertical transmission from infected mothers .",
        "Title: Chikungunya: A Potentially Emerging Epidemic?"
      ],
      "computed_relevance": 0.2,
      "computed_utilization": 0.2,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 2,
      "dataset_id": "1248",
      "question": "What does Clade A contain?",
      "ground_truth_answer": "Clade A contains 1,889 viruses from 34 countries collected from 2010 to the present.",
      "generated_response": "<think>\nOkay, let's try to figure out what Clade A contains based on the provided context. The user is asking about Clade A, but looking through the passages, I notice mentions of clades like 1B.1, 1B.2, 1C.2, 1A.1, and 1A.1.1. However, there's no direct mention of \"Clade A\" in the given text. The titles and passages refer to different lineages such as 1B human seasonal lineage, 1C swine lineage, and their subdivisions.\n\nThe first passage talks about exceptions in clades like 1B.1 and 1B.2. The second passage mentions exceptions for 1A.1 and 1A.1.1. The third passage discusses the 1C lineage with clades in China and South Korea. Nowhere in the context is there a \"Clade A\" mentioned. Instead, the clades are numbered with a numerical system starting with 1B, 1C, etc. \n\nSince the question is about Clade A, but the provided information doesn't reference Clade A at all, it's possible that there's a misunderstanding or a typo. The answer would need to state that there's no information provided about Clade A in the given context. Alternatively, if \"Clade A\" refers to one of the mentioned clades like 1A.1, but the user might have mislabeled it. However, based strictly on the provided text, there's no Clade A. Therefore, the answer should indicate that the context doesn't mention Clade A.\n</think>\n\nThe provided context does not mention or describe \"Clade A.\" The text references clades such as **1B.1**, **1B.2**, **1C.2**, **1A.1**, and **1A.1.1**, but there is no explicit information about a \"Clade A\" in the given passages. The nomenclature used in the context appears to follow a numerical/letter system (e.g., 1B, 1C) rather than a standalone \"Clade A.\" If \"Clade A\" refers to a broader lineage or a misinterpretation of the numbered clades (e.g., 1A.1), further clarification would be needed. Based on the provided text, **Clade A is",
      "retrieved_chunks": [
        "For the most part, each clade had an APD of \u03fe7% from other clades and an APD of \u03fd7% within the clade.",
        "For the most part, each clade had an APD of \u03fe7% from other clades and almost all had an APD of \u03fd7% within the clade. The within-clade exceptions were the 1B.1 and 1B.2 clades . The 1B.1 second-order clade had too few representative sequences to calculate genetic distance, and 1B.2 represented multiple monophyletic clades that individually did not meet our criteria for further division. Similarly, the extensive 1B.1.1 clade did not meet criteria for further splitting.",
        "Each clade had an APD of \u03fe7% from other clades and an APD of \u03fd7% within the clade, although some minor exceptions were made when all other clade-defining criteria were met and mitigating circumstances supported the exception.",
        "The one within-clade exception in this lineage was 1C.2 , which had multiple monophyletic\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: The 1B human seasonal lineage within-and between-clade APDs are presented in Table 3 .",
        "Within-clade exceptions were made for the first-order 1A.1 and the extensive 1A.1.1 second-order clade\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: Clade designations for 1C swine lineage. The 1C lineage consisted of 315 viruses from 14 countries collected from 2010 to the present in China and South Korea. Avian H1 HA sequences were generally restricted to two monophyletic clades distinct from, but sister to, the 1C swine viruses: these HA sequences were defined as \"Other-Avian.\" The within-and between-clade APDs are presented in Table 4 ."
      ],
      "computed_relevance": 0.5,
      "computed_utilization": 0.5,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 1.0,
      "gt_utilization": 0.041666666666666664,
      "gt_completeness": 0.041666666666666664,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 3,
      "dataset_id": "1696",
      "question": "How do the S1 subunits compare with that of SARS-likeCOV and human SARS-COV?",
      "ground_truth_answer": "The S1 subunit of 2019-nCoV shares around 70% identity with those of two bat SARS-like CoVs and human SARS-CoV.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how the S1 subunits of 2019-nCoV compare to those of SARS-like CoVs and human SARS-CoV. \n\nFirst, I need to look at the provided context. The passage mentions that the S1 subunit of 2019-nCoV shares around 70% identity with the two bat SARS-like CoVs and human SARS-CoV. Also, it notes that the core domain of the RBD (receptor binding domain) is highly conserved. \n\nWait, the context starts by saying that most bat SARS-related CoVs have deletions in the spike receptor binding domain compared to human SARS-CoV. But then it contrasts 2019-nCoV with those bat viruses. The S1 subunit's identity is 70%, which is lower than the S2's 99% identity. The RBD core is conserved, though.\n\nSo the answer should mention the 70% identity for the S1 subunit and note the conserved RBD core. Also, maybe mention that unlike some bat CoVs, 2019-nCoV doesn't have those deletions in the RBD? Wait, the first sentence says that most bat SARSr-CoVs have deletions in the RBD compared to human SARS-CoV. But 2019-nCoV's RBD is conserved. So maybe that's why it's more similar to human SARS-CoV in that region despite lower overall S1 identity.\n\nPutting it all together: The S1 subunit of 2019-nCoV has about 70% identity with bat SARS-like CoVs and human SARS-CoV. The RBD core is highly conserved. Also, unlike most bat SARSr-CoVs, 2019-nCoV doesn't have deletions in the RBD. But the question specifically asks about the S1 subunit comparison. So focus on the 70% identity and the conserved RBD core domain.\n</think>\n\nThe S1 subunit of 2019-nCoV shares approximately **70% identity** with the S1 subunits of bat SARS-like CoVs (e.g., ZC45) and human SARS-CoV. However, the **core",
      "retrieved_chunks": [
        "Unlike 2019-nCoV and human SARS-CoV, most known bat SARSr-CoVs have two stretches of deletions in the spike receptor binding domain when compared with that of human SARS-CoV.",
        "The SL1, SL2, SL3, SL4, S5, SL5A, SL5B, and SL5C structures were similar among the 2019-nCoV, human SARS-CoV and the bat SARS-related ZC45. In the 2019-nCoV, part of the S5 found was inside Figure 7 Continued the orf1a/b , which was similar to SARS-CoV. In bat SARS-related CoV ZC45, the S5 was not found inside orf1a/b.",
        "We found that the S2 subunit of 2019-nCoV is highly conserved and shares 99% identity with those of the two bat SARS-like CoVs and human SARS-CoV .",
        "Though the S1\n\nTitle: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: subunit of 2019-nCoV shares around 70% identity to that of the two bat SARS-like CoVs and human SARS-CoV ), the core domain of RBD are highly conserved ).",
        "Title: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: Spike glycoprotein comprised of S1 and S2 subunits."
      ],
      "computed_relevance": 0.2857142857142857,
      "computed_utilization": 0.8571428571428571,
      "computed_completeness": 0.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.12,
      "gt_utilization": 0.04,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 4,
      "dataset_id": "669",
      "question": "What is Bacillus subtilis?",
      "ground_truth_answer": "Bacillus subtilis is a species of bacteria that has been shown to be effective in the prevention and/or treatment of intestinal diseases such as diarrhea, colitis, irritable bowel syndrome, irritable bowel disease, and colorectal cancer. It is also a part of the normal intestinal microbiome and has been found in the healthy human gastrointestinal tract. Bacillus subtilis produces surfactins, fengycins, and iturins, which have antimicrobial and antiviral properties.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What is Bacillus subtilis?\" and they provided some context from two passages.\n\nFirst, I need to look through the given context to find relevant information. The first passage mentions that Bacillus species, including subtilis, are found in traditional fermented foods and are used in probiotics like Biosubtyl and others. It also says they're used in food industry as starter cultures. The second passage goes into more detail about Bacillus subtilis specifically. It says that unlike Lactobacillus, Bacillus wasn't considered part of the normal intestinal microbiome. However, B. subtilis produces surfactins, fengycins, and iturins in a certain ratio. It also helps restore gut microflora by increasing beneficial bacteria and decreasing harmful ones. Additionally, it maintains gut barrier integrity, reduces endotoxins, and decreases inflammation.\n\nSo putting this together, Bacillus subtilis is a species of Bacillus that's used as a probiotic. It's found in fermented foods and has beneficial effects on the gut, such as balancing the microbiome and reducing inflammation. The answer should mention its role in probiotics, the specific benefits it provides to the gut, and maybe the compounds it produces. I need to make sure the answer is concise but covers all the key points from the context provided. Also, avoid any information not in the context. Let me check if there's anything else. The first passage lists some commercial probiotics that include Bacillus species, so mentioning that it's used in those products would be good. Also, note that it wasn't traditionally considered part of the intestinal microbiome but is now recognized for its benefits. Alright, that should cover it.\n</think>\n\nBacillus subtilis is a species of the Bacillus genus historically found in traditional fermented foods and widely used as a probiotic. It is recognized for its beneficial effects on intestinal health, including restoring gut microflora balance by increasing beneficial bacteria (e.g., Bifidobacterium, Lactobacillus) and reducing harmful species (e.g., Acinetobacter, Clostridium). It produces bioactive compounds like surfactins, fengycins, and iturins, which help maintain gut barrier integrity, lower endotoxin levels, and reduce inflammation. Though not traditionally classified as part of the normal intestinal microbiome",
      "retrieved_chunks": [
        "Bacillus spp.",
        "subtilis plays a\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: Historically, species of Lactobacillus and Bacillus are found in the traditional fermented food products possessing beneficial properties for the intestinal function and are widely used as components of commercially available probiotics: DE111 , Enterogermina , Biosubtyl , Biosporin , BioSpora , Blicheni and Zhengchangsheng , GanedenBC 30 , Lactobacterin , HOWARU or DR20 , Yakult , PCC . In food industry, lactobacilli are applied as starter cultures in the production of fermented milk products, cheese, sausages, bread, kimchi, pickles, and yogurts, the latter accounting for the largest share of sales . The administration of probiotics has been shown to favorably\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: For a long time, the representatives of Bacillus genus, unlike the species of Lactobacillus, were not considered as a part of the normal intestinal microbiome. Being isolated from feces, Bacillus spp.",
        "subtilis produces surfactins, fengycins and iturins in a ratio of 6:37:57 .",
        "subtilis restored balance in gut microflora: beneficial species of Bifidobacterium, Lactobacillus, and Butyricicoccus spp. were increased, while gut damage-promoting species of Acinetobacter sp., Ruminococcus sp., Clostridium spp., and Veillonella sp.",
        "subtilis also retained gut barrier integrity, decreased the endotoxin concentration and reduced gut inflammation Bene et al., 2017) ."
      ],
      "computed_relevance": 0.5555555555555556,
      "computed_utilization": 0.5555555555555556,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.4090909090909091,
      "gt_utilization": 0.18181818181818182,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 0.0,
      "binary_pred": 1,
      "binary_gt": 0,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 5,
      "dataset_id": "81",
      "question": "What past research has been done on severe, single-wave pandemics?",
      "ground_truth_answer": "The given passages do not specifically mention past research on severe, single-wave pandemics. However, they do reference research on pandemic strains, influenza spread, and pandemic severity categories, as well as the origins and circulation of specific pandemic influenza strains.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about past research on severe, single-wave pandemics. I need to look through the provided contexts to find relevant information.\n\nFirst, looking at the first context titled \"The origins of the great pandemic,\" it mentions the 1889 pandemic with three major waves from 1889 to 1892, specifically noting the 1892 wave as the most intense. The passage also speculates about herald waves of the 1918 pandemic possibly starting as early as 1915. However, the 1889 example isn't a single wave but multiple. The 1918 pandemic is usually known for multiple waves too, so maybe this isn't the best example here.\n\nNext, the second context is about the 2009 H1N1 pandemic in Hong Kong. It discusses research on epidemiology, impact, and control, considering five pandemic severity categories and various interventions. The study extended previous work by considering different severity levels and intervention combinations. However, the 2009 pandemic had multiple waves in some regions, so not sure if it's single-wave.\n\nThe third context from Taiwan talks about the 2009 pH1N1 pandemic and uses a Richards model variation to analyze multi-wave epidemics. They mention distinguishing between two types of turning points in multi-wave scenarios. This seems to focus on multi-wave rather than single-wave, but maybe the methods developed here could be applied to single-wave studies.\n\nThe fourth context is an economic analysis of mitigation strategies for five pandemic severity categories. It references studies using individual-based simulation models combined with costing models. The focus here is on strategies for different severities, not specifically on single-wave pandemics.\n\nPutting this together, the contexts don't directly mention severe, single-wave pandemics. However, the 1889 pandemic is mentioned as having three waves, but the 1892 wave was the most intense. The 1918 pandemic's herald waves are speculated. The 2009 pandemic had multiple waves in some areas but might have been single-wave in others. The research methods from the Taiwan study on multi-wave could be adapted. The economic analysis looked at different severities but not wave counts. \n\nSince the question is about past research on severe, single-wave pandemics, the answer might need to infer that while the mentioned pandemics",
      "retrieved_chunks": [
        "Title: The origins of the great pandemic\nPassage: Because the 1889 pandemic unfolded with three major waves worldwide from 1889 to 1892 , with the 1892 wave being the most intense, at least on the East Coast of the USA, it seems worth considering whether so-called herald waves of the 1918 pandemic might have stretched back all the way to 1915. Viruses with identical or nearly identical genome sequences to those in the fall wave were circulating in early 1918 , at a time prior to the recognition of a new pandemic. It is perhaps not so great a leap to imagine that these viruses were related to\n\nTitle: The epidemiological and public health research response to 2009 pandemic influenza A(H1N1): experiences from Hong Kong\nPassage: of convalescent plasma to treat severe infections was shown to be feasible in a pandemic 57 and evidence of its effectiveness albeit from a small study should justify further studies.",
        "56 While we focused on research into the epidemiology, impact, and control of pH1N1, much important research on pH1N1 has been carried out in other areas outside the scope of our review.",
        "The current study extends upon the scope of these studies in several ways: five gradations of pandemic severity are considered, more combinations of interventions are considered, social distancing interventions of varying durations are considered, and probabilities of severe health outcomes for each severity category are based on fatality, hospitalization and ICU usage data as observed from the 2009 pandemic.",
        "Also in contrast with those models,\n\nTitle: On Temporal Patterns and Circulation of Influenza Virus Strains in Taiwan, 2008-2014: Implications of 2009 pH1N1 Pandemic\nPassage: When there is more than one wave of infections, as in our current study, a variation of the Richards model can be utilized, which makes the distinction between two types of turning points ; one type which occurs at the peak incidence, and a second type which occurs in a multi-wave epidemic when the growth rate of the cumulative case number begins to increase again, indicating the beginning of the next wave.",
        "To give two specific examples, local researchers confirmed the origins of the 2009 pandemic strain by comparison with a detailed local swine influenza surveillance program, 65 and performed important basic studies on pathogenesis. 66 Two sets of studies\n\nTitle: Economic analysis of pandemic influenza mitigation strategies for five pandemic severity categories\nPassage: Several related studies which also used individualbased simulation models of influenza spread coupled with costing models are those of those of Sander et al., Perlroth et al., Brown et al., and Andradottir et al."
      ],
      "computed_relevance": 0.25,
      "computed_utilization": 0.25,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.26666666666666666,
      "gt_utilization": 0.26666666666666666,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 6,
      "dataset_id": "1564",
      "question": "How many reported viral pneumonia?",
      "ground_truth_answer": "The passage does not provide a specific number of reported viral pneumonia cases overall. However, it mentions 2744 confirmed cases of pneumonia with 2019-nCoV infection in China, and it also mentions 77 fatal cases of pandemic H1N1v 2009 infection.",
      "generated_response": "<think>\nOkay, let's see. The user is asking how many reported viral pneumonia cases there are based on the provided context. Let me go through each of the passages to find any numbers mentioned.\n\nFirst, the first passage talks about pneumonia in adults with influenza in the US from 2005\u20132008. It mentions that patients with pneumonia were more likely to receive antiviral therapy, but it doesn't give specific numbers of cases. So probably not here.\n\nNext, the second passage is about bacterial co-infection in the 2009 H1N1 pandemic. It says 29% of 77 fatal cases had bacterial pneumonia. But again, that's about co-infection rates, not total viral pneumonia cases.\n\nThird passage is about the 2019-nCoV (COVID-19) pneumonia. It states that as of January 26, 2020, there were 2744 confirmed cases of pneumonia with 2019-nCoV infection. This seems like a direct number related to viral pneumonia. The question is about \"reported viral pneumonia,\" and this is a specific number from China. \n\nThe fourth passage again mentions the 2009 H1N1 outbreak in La Gloria, giving attack rates but not total numbers. Then there's a line: \"A total of 51 cases have been cured and discharged. At present, 5794 suspected cases were recorded...\" Wait, this seems to be part of the same context. But which virus? The title mentions the 2019-nCoV guideline. However, the 51 cases cured and 5794 suspected might be part of the same data as the 2744 confirmed. But the 2744 is the confirmed cases. The user is asking for reported viral pneumonia. The 2744 is confirmed cases of pneumonia with 2019-nCoV, which is viral. The other numbers like 5794 suspected cases are not confirmed, so the answer should be 2744. \n\nWait, but the user's question is \"How many reported viral pneumonia?\" So the answer is the 2744 confirmed cases from the third passage. The other numbers like 51 discharged or 5794 suspected are not the total reported viral pneumonia cases. The 274",
      "retrieved_chunks": [
        "Title: Pneumonia among adults hospitalized with laboratory-confirmed seasonal influenza virus infection\u2014United States, 2005\u20132008\nPassage: Patients with pneumonia ] were significantly more likely to receive influenza antiviral therapy than patients without pneumonia ; P <0.01].",
        "A total of confirmed cases were reported from Hong Kong, Macao and Taiwan of China:\n\nTitle: Clinical review: Primary influenza viral pneumonia\nPassage: Bacterial co-infection, though uncommonly reported in the early stages of the 2009 H1N1 pandemic, may be more prevalent than initially thought. A recent analysis of lung specimens from 77 fatal cases of pandemic H1N1v 2009 infection found a prevalence of concurrent bacterial pneumonia in 29% of these patients .",
        "Title: A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)\nPassage: At 24:00 on 26 January 2020, the National Health Commission of the People's Republic of China has recorded a total of 2744 confirmed cases of pneumonia with 2019-nCoV infection from 30 provinces , including 461 severe cases and 80 deaths.",
        "Title: Clinical review: Primary influenza viral pneumonia\nPassage: age versus 6% to 9% of the adults 18 to 64 years of age and none of the children . Influenza attack rates during seasonal epidemics vary between 10% and 20% but can be much higher during pandemics. For example, an analysis of the pandemic 2009 H1N1 influenza A outbreak in La Gloria, Veracruz, found clinical attack rates of 29% in adults older than 15 years and 61% in children younger than 15 years of age .",
        "A total of 51 cases have been cured and discharged. At present, 5794 suspected cases were recorded, 32,799 with close contacts to the confirmed patients have been tracked, 583 people were released from medical observation that day, and 30,453 people were still undergoing medical observation."
      ],
      "computed_relevance": 0.1111111111111111,
      "computed_utilization": 0.3333333333333333,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.125,
      "gt_utilization": 0.125,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 7,
      "dataset_id": "1247",
      "question": "How has most of the analysis of MERS-CoV genetics  been performed?",
      "ground_truth_answer": "Most of the analysis of MERS-CoV genetics has been performed using high throughput or \"deep\" sequencing methods for complete genome deduction.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how most of the analysis of MERS-CoV genetics has been performed. I need to look through the provided context to find the answer.\n\nLooking at the first passage, the first sentence says, \"Most of the analysis of MERS-CoV genetics has been performed using high throughput or 'deep' sequencing methods for complete genome deduction.\" That seems like the direct answer. The key terms here are \"high throughput\" and \"deep sequencing methods.\" \n\nI should check the other passages to make sure there's no conflicting information. The second passage mentions genetic recombination studies but doesn't talk about the primary method. The third passage discusses genome analyses and specific regions like the spike protein, but again, the method isn't mentioned there. The fourth passage talks about vigilance and data sharing but not the analysis method. \n\nSo the first passage clearly states that high throughput or deep sequencing is the main method. The answer should be that most analysis has been done using high throughput or deep sequencing methods for complete genome deduction. I need to present this in a concise way without adding extra details from other parts.\n</think>\n\nMost of the analysis of MERS-CoV genetics has been performed using **high throughput or \"deep\" sequencing methods for complete genome deduction**. This approach was highlighted as the first widespread use of deep sequencing to study an emerging viral outbreak with global reach.",
      "retrieved_chunks": [
        "Title: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Most of the analysis of MERS-CoV genetics has been performed using high throughput or \"deep\" sequencing methods for complete genome deduction . MERS-CoV was the first subject of such widespread use of deep sequencing to study an emerging viral outbreak with global reach.",
        "Whole genome sequencing has been used extensively to study MERS-CoV travel and variation and although it remains a tool for experts, it appears\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Two studies during 2015, one looking at Jeddah-2014 MERS-CoV variants and another looking at a variant exported from South Korea to China, have now identified signs of genetic recombination among MERS-CoV variants.",
        "Despite assays having been published early on, subgenomic sequencing, once the mainstay of viral outbreak studies, has less often been published during MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Analyses of MERS-CoV genomes have shown that most single nucleotide differences among variants were located in the last third of the genome , which encodes the spike protein and accessory proteins . At least nine MERS-CoV genomes contained amino acid substitutions in the receptor binding domain of the spike protein and codons 158 , 460 , 1020 , 1202 and 1208 bear investigation as markers of adaptive change . The spike protein had not changed in the recombinant MERS-CoV genome identified in China in 2015 but was reported to have varied at a higher rate than that for complete MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Vigilance remains important for containment since MERS-CoV is a virus with a genetic makeup that has been observed for only three years and is not stable.",
        "Continued laboratory testing, sequencing, analysis, timely data sharing and clear communication are essential for such vigilance to be effective.",
        "The technique can produce genomic ."
      ],
      "computed_relevance": 0.125,
      "computed_utilization": 0.125,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2857142857142857,
      "gt_utilization": 0.047619047619047616,
      "gt_completeness": 0.16666666666666666,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 8,
      "dataset_id": "1129",
      "question": "How were  the spread of GFP-expressing virus-infected cells tracked?",
      "ground_truth_answer": "The spread of GFP-expressing virus-infected cells was tracked using immunofluorescence microscopy, whole-organ imaging with IVIS, flow cytometry, and inverted fluorescence microscopy.",
      "generated_response": "<think>\nOkay, let's see. The question is asking how the spread of GFP-expressing virus-infected cells was tracked. I need to look through the provided context and passages to find the method they used.\n\nFirst, the context mentions that images were produced showing GFP-expressing cells in white and non-GFP in black. That's probably part of the tracking method. Then, in the first passage, they talk about generating single-cell clones with GFP. But the key part might be in the passage under the title about accelerated viral dynamics. The passage says, \"After application of the overlay, plates were monitored periodically using an inverted fluorescence microscope until the first signs of GFP expression were witnessed.\" So they used a fluorescence microscope to monitor the cells over time. \n\nAnother part mentions using a split-GFP-tagged viral protein in the enterovirus study. Split-GFP systems can be used to visualize replication sites. But the main tracking method here seems to be the fluorescence microscope. They probably observed the cells under the microscope periodically to track how the infection spread as GFP expression became visible. The overlay application might be part of the cell culture technique to allow monitoring without interference. \n\nSo putting it together, the answer is that they used an inverted fluorescence microscope to monitor the cells periodically, looking for GFP expression as an indicator of infected cells. The mention of the split-GFP in another study might be a different method, but the specific answer here is the fluorescence microscope monitoring.\n</think>\n\nThe spread of GFP-expressing virus-infected cells was tracked by **monitoring plates periodically using an inverted fluorescence microscope**. This allowed the researchers to observe the first signs of GFP expression, which indicated viral infection and replication in real time. The GFP fluorescence (white in the images) distinguished infected cells from non-infected ones (black), enabling visualization of the spatial and temporal dynamics of viral spread. \n\n**Answer:**  \nThe spread was tracked by periodic monitoring with an inverted fluorescence microscope to detect GFP expression in infected cells.",
      "retrieved_chunks": [
        "One color channel was imaged, such that images produced show GFP-expressing cells in white and non-GFP-expressing cells in black .",
        "For the generation of single-cell clones stably expressing GFP, BGM and HeLa cells were transduced and grown in the presence of puromycin to generate pools of GFP-expressing cells, which were subsequently used to prepare single-cell clones by limiting dilution.",
        "The authors found that using a 10 6 PFU intranasal inoculation, 10% of dendritic cells were observed to express GFP and 2%-3% of macrophages and neutrophils were also GFP+ at 48 h post-infection .",
        "Title: Accelerated viral dynamics in bat cell lines, with implications for zoonotic emergence\nPassage: After application of the overlay, plates were monitored periodically using an inverted fluorescence microscope until the first signs of GFP expression were witnessed .",
        "Title: Illuminating the Sites of Enterovirus Replication in Living Cells by Using a Split-GFP-Tagged Viral Protein\nPassage: transduction, the MLV particles were 5 to 10 times concentrated using a 100-kDa concentrator ."
      ],
      "computed_relevance": 0.2,
      "computed_utilization": 0.4,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.21052631578947367,
      "gt_utilization": 0.21052631578947367,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 9,
      "dataset_id": "1261",
      "question": "What's the recommended procedure to disinfect at CT scanner after a COVID-19 exposure?",
      "ground_truth_answer": "The recommended procedure to disinfect a CT scanner after a COVID-19 exposure involves sterilization procedures, noncontaminated CT disinfection procedures, and immediate disinfection of the imaging equipment after the examination.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about the recommended procedure to disinfect a CT scanner after a COVID-19 exposure. The context provided has several passages with similar titles and mentions of CT disinfection procedures. \n\nFirst, I need to parse the context. The titles all mention emergency management related to COVID-19. The passages talk about noncontaminated CT disinfection procedures after examining suspected cases, fever-CT disinfection, and preparing to disinfect imaging equipment immediately after examination.\n\nThe key points here are that after a suspected COVID-19 case is examined using a CT scanner, there's a need to disinfect it. The passages mention \"noncontaminated CT disinfection procedures\" and \"immediately after the examination\" steps. The repetition of \"fever-CTs\" might be a typo or a specific term, but since the main focus is on CT scanners, I should focus on the general disinfection steps.\n\nThe answer should probably include steps like using appropriate disinfectants, following specific protocols, and ensuring that the equipment is properly sterilized. The context doesn't provide detailed steps, but it does emphasize immediate disinfection after the examination. So the answer should highlight that the recommended procedure involves disinfecting the CT scanner immediately after the examination using established sterilization protocols to prevent contamination.\n</think>\n\nThe recommended procedure to disinfect a CT scanner after a COVID-19 exposure involves **immediately disinfecting the imaging equipment** following the examination of a suspected or confirmed case. This includes adhering to established sterilization protocols, such as using appropriate disinfectants and ensuring thorough cleaning of all surfaces and components of the CT scanner to prevent cross-contamination. The process emphasizes prompt action post-examination to mitigate the risk of viral transmission.",
      "retrieved_chunks": [
        "Title: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Noncontaminated CT disinfection procedures after suspected COVID-19 case examination\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Fever-CT disinfection procedures after examination\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: fever-CTs) after these sterilization procedures. Title: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: equipment and prepares to disinfect the imaging equipment immediately after the examination."
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.5,
      "gt_utilization": 0.5,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 10,
      "dataset_id": "790",
      "question": "What can RNA sequencing be used to monitor?",
      "ground_truth_answer": "RNA sequencing can be used to monitor transcripts that may not be in the existing genomic annotation, allowing the search for novel transcripts, and even identification of SNPs and other variants, as well as for transcriptome profiling in cancers such as breast cancer, gastrointestinal tumors, and prostate cancer.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking what RNA sequencing can be used to monitor. I need to base my answer on the provided context.\n\nFirst, I'll look through the context again. The first passage mentions that RNA-Seq provides higher coverage, precision, and sensitivity compared to alternatives like qRT-PCR and microarrays. It also says RNA-Seq maps transcriptomic fragments to the reference genome, allowing for the discovery of novel transcripts, SNPs, and variants. \n\nThe second passage talks about using RNAseq in influenza virus-infected cells to reveal molecular pathways related to tissue injury. It also notes that RNAseq can discern the magnitude of RNA changes and mark them as canonical responses. Plus, since it's not limited by probes, it's better at detecting novel interactions during infections.\n\nSo, putting this together, RNA sequencing can monitor various things. The key points from the context are: detecting RNA changes (magnitude), identifying novel transcripts, SNPs, variants, and molecular pathways. Also, it's useful for studying responses like innate immune responses in infections. The fact that it's not probe-dependent makes it good for finding new interactions. \n\nThe answer should list these points. Let me check if there's anything else. The first passage mentions quantitation and reproducibility. The second passage specifically mentions influenza infection studies. So maybe include monitoring gene expression changes, novel transcripts, SNPs, and pathways, especially in disease contexts like infections. Also, the ability to detect low-abundance transcripts since microarrays have issues with that. \n\nWait, the question is about what RNAseq can monitor. So the answer should be things like gene expression levels, novel transcripts, SNPs, molecular pathways, and maybe absolute RNA levels using spike-ins. Also, the context mentions that RNAseq can detect changes in RNA magnitude, which relates to gene expression monitoring. \n\nI need to make sure I don't include things not in the context. For example, the context doesn't mention all possible applications, just what's in the passages. So stick to what's given. The answer should be concise, listing the main points from the context.\n</think>\n\nRNA sequencing (RNA-Seq) can be used to monitor **gene expression levels**, **novel transcripts**, **single nucleotide polymorphisms (SNPs)**, and **molecular pathways** associated with biological processes or diseases (e.g., tissue injury and complications in influenza infections). It provides high-resolution quant",
      "retrieved_chunks": [
        "Alternatives to RNA sequencing are qRT-PCR and microarrays. The former is laborious and has a limited number of targets, while microarrays demand previously established transcriptomic probes and might have some background noise interfering on low abundant transcripts .",
        "Title: Personal genomes, quantitative dynamic omics and personalized medicine\nPassage: The development of RNA sequencing brought higher coverage, better precision and quantitation, and higher resolution and sensitivity, bringing RNA-Seq technology and transcriptomics on par with genomic sequencing . RNA-Seq considers reads that correspond to millions of transcriptomic fragments that are mapped to the reference genome, to provide information on transcripts that may not be in the existing genomic annotation, allowing the search for novel transcripts, and even identification of SNPs and other variants, while showing remarkable reproducibility .",
        "Spike-in controls can be used as quality control and also to estimate the absolute levels of RNA expression since in scRNA-seq the exact number of cells\n\nTitle: RNA Sequencing of H3N2 Influenza Virus-Infected Human Nasal Epithelial Cells from Multiple Subjects Reveals Molecular Pathways Associated with Tissue Injury and Complications\nPassage: changes to serve as potential reference markers of the innate responses of influenza infection.",
        "Given that RNAseq functions by reading virtually all the RNAs present in the samples tested, we can also discern the magnitude of each RNA change and mark them as the canonical responses. In addition, as RNAseq is not constrained by probe usage as in microarrays, they are therefore more reliable in detecting novel interactions during influenza infections of hNECs. Hence, RNAseq analysis will further augment the transcriptomic data established previously by microarray analysis.",
        "Once sequencing reads are obtained, low-quality bases, adaptors, and barcodes need to be trimmed before alignment."
      ],
      "computed_relevance": 0.5555555555555556,
      "computed_utilization": 0.5555555555555556,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.38095238095238093,
      "gt_utilization": 0.09523809523809523,
      "gt_completeness": 0.25,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 11,
      "dataset_id": "480",
      "question": "In what direction does the Vesicular stomatitis virus spread through the nervous system?",
      "ground_truth_answer": "The Vesicular stomatitis virus spreads in a retrograde direction through the nervous system.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking in which direction the Vesicular stomatitis virus (VSV) spreads through the nervous system based on the provided context.\n\nFirst, I need to look at the context given. The titles and passages mention \"retrograde transsynaptic transport.\" The term \"retrograde\" usually refers to movement against the usual direction, so in the nervous system, that would mean from the synapse back towards the cell body. \n\nLooking at the first passage: \"These data show that rVSV can spread in a retrograde direction from the injection site...\" So they directly state that the virus spreads retrograde. The second part talks about injections into M1 and CP, and how if the virus only spreads retrograde, certain areas shouldn't be labeled. The results at 2 dpi (days post injection) support that the labeling is restricted, which aligns with retrograde spread. \n\nAnother part says, \"Labeling remained well-restricted... suggesting that viral spread becomes less efficient after crossing one or two connections...\" This implies that the virus moves across synapses in a specific direction, which is retrograde. Also, the mention of \"consistent with injections into V1\" might be another example of the same retrograde spread.\n\nSo putting it all together, the key term is \"retrograde direction\" mentioned explicitly in the first passage. The other parts support this by showing that the virus doesn't spread in the anterograde direction (which would be from cell body to synapse) because the labeling stays in expected areas when injected into certain regions. Therefore, the answer should be that the virus spreads in a retrograde direction.\n</think>\n\nThe Vesicular stomatitis virus (VSV) spreads through the nervous system in a **retrograde direction**. The context explicitly states that the virus \"can spread in a retrograde direction from the injection site\" and that its transsynaptic transport is restricted to retrograde pathways, as evidenced by labeling patterns in neural circuits. This retrograde spread is further supported by observations that viral spread becomes less efficient after crossing one or two synaptic connections, consistent with movement against the typical direction of neural signaling (from synapse to cell body).",
      "retrieved_chunks": [
        "Title: Vesicular stomatitis virus with the rabies virus glycoprotein directs retrograde transsynaptic transport among neurons in vivo\nPassage: These data show that rVSV can spread in a retrograde direction from the injection site, but do not address whether the virus can spread exclusively in the retrograde direction.",
        "Injections of rVSV into M1 should not label neurons in the CP if the virus can only label cells across synapses in the retrograde direction. Indeed, at 2 dpi, areas directly\n\nTitle: Vesicular stomatitis virus with the rabies virus glycoprotein directs retrograde transsynaptic transport among neurons in vivo\nPassage: These data show that rVSV can spread in a retrograde direction from the injection site, but do not address whether the virus can spread exclusively in the retrograde direction.",
        "Injections of rVSV into M1 should not label neurons in the CP if the virus can only label cells across synapses in the retrograde direction. Indeed, at 2 dpi, areas directly\n\nTitle: Vesicular stomatitis virus with the rabies virus glycoprotein directs retrograde transsynaptic transport among neurons in vivo\nPassage: dpi, as previously observed . Labeling remained well-restricted to the expected corticostriatal circuits at 5 dpi, suggesting that viral spread becomes less efficient after crossing one or two connections, consistent with injections into V1 .",
        "Title: Vesicular stomatitis virus with the rabies virus glycoprotein directs retrograde transsynaptic transport among neurons in vivo\nPassage: dpi, as previously observed .",
        "Labeling remained well-restricted to the expected corticostriatal circuits at 5 dpi, suggesting that viral spread becomes less efficient after crossing one or two connections, consistent with injections into V1 ."
      ],
      "computed_relevance": 0.25,
      "computed_utilization": 0.625,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 12,
      "dataset_id": "1585",
      "question": "How do these exact processes ultimately restrict viral infectivity?",
      "ground_truth_answer": "These processes ultimately restrict viral infectivity by triggering a legion of cellular defense and antiviral systems, inducing inflammatory factors and activating innate and adaptive immunity. Additionally, these mechanisms include the activation of direct antiviral activity against the replicative stages of viruses, targeting common pathways or structures that are essential for viral replication. This evolutionary arms race between countermeasures and species-specific factors ultimately prevent effective viral envelope clustering, decrease fluidity and imposes rigidity, and induce an outward membrane curvature that opposes the forces exerted by viral fusion machinery, ultimately inhibiting the ins and outs of HIV replication and restricting viral infectivity.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how the exact processes mentioned in the context restrict viral infectivity. First, I need to go through the provided passages and identify the key mechanisms described.\n\nLooking at the first context about TBFV, it mentions that mammalian cells trigger general defense and antiviral systems when infected. These systems are designed to limit virus reproduction. So, that's a general antiviral response.\n\nThe second context is about HIV and cell-intrinsic antiretroviral restrictions at the plasma membrane. The passage talks about processes common to all enveloped viruses. It mentions unavoidable processes, which suggests that these are essential steps viruses must go through, and the host has mechanisms to block them.\n\nThe third passage goes into more detail. It says that IFITM multiplexes form a meshwork in the membrane, decreasing fluidity and inducing curvature that opposes viral fusion machinery. This affects enveloped viruses like IAV and even non-enveloped ones like reoviruses by disrupting endosomal membranes. The text also mentions that these mechanisms are regulated by type 1 interferons and pattern recognition responses, linking them to the broader immune response.\n\nThe answer should tie together these points. The processes include physical barriers like the meshwork reducing membrane fluidity and altering curvature, which hinders viral entry (fusion for enveloped viruses, endosomal disruption for non-enveloped). Also, restriction factors target essential viral pathways that can't be easily mutated away. For lentiviruses, accessory proteins counteract these factors, but the host's mechanisms are part of an evolutionary arms race. The involvement of interferons and immune responses adds another layer by coordinating these defenses.\n\nSo, the exact processes restrict infectivity by physically blocking viral entry steps, targeting critical replication pathways, and being regulated by the immune system to broadly inhibit various viruses. The answer should mention these points concisely.\n</think>\n\nThe processes described in the context restrict viral infectivity through multiple mechanisms:  \n1. **Physical Barriers**: Antiviral factors like IFITM proteins form a \"meshwork\" in the plasma membrane, reducing membrane fluidity and inducing curvature that opposes viral fusion machinery (e.g., for enveloped viruses like IAV). This also disrupts endosomal membrane interactions required for non-enveloped viruses (e.g., reoviruses).  \n2. **Targeting Essential Pathways**: Restriction factors inhibit conserved viral replication steps (",
      "retrieved_chunks": [
        "Title: The role of viral persistence in flavivirus biology\nPassage: When mammalian cell cultures are acutely infected with TBFV, a legion of general cellular defense and antiviral systems are triggered, as are specific factors designed to limit or restrict virus reproduction.",
        "Title: Inhibiting the Ins and Outs of HIV Replication: Cell-Intrinsic Antiretroviral Restrictions at the Plasma Membrane\nPassage: These unavoidable processes are common to all enveloped viruses.",
        "The evolutionary arms race between these countermeasures and species-specific\n\nTitle: Inhibiting the Ins and Outs of HIV Replication: Cell-Intrinsic Antiretroviral Restrictions at the Plasma Membrane\nPassage: may prevent the effective viral envelope clustering that is required particularly for IAV fusion and the IFITM multiplexes could also form a \"meshwork\" within the outer leaflet of the membrane that not only decreases fluidity and imposes rigidity but induces an outward membrane curvature that opposes the forces exerted by the viral fusion machinery. These general mechanisms may account for the diversity of viruses inhibited, including nonenveloped viruses, such as reoviruses, that do not require fusion, but do need to disrupt the endosomal membrane to enter the cell .",
        "It is perhaps unsurprising that the mammalian host has evolved multiple antiviral mechanisms whose role is to inhibit viral replicative processes that are associated with entry and exit , necessitating either the evolution of directly encoded countermeasures by the virus, or other mechanisms of resistance or avoidance. Furthermore, these mechanisms are often regulated by type 1 interferons and pattern recognition responses, linking these factors to the wider antiviral immune response.",
        "These antiviral factors, sometimes called restriction factors, often target common pathways or structures that are essential for viral replication, and which cannot be simply mutated around. In the case of lentiviruses, several restriction factors have been identified that are targets of virally encoded accessory proteins , for example tetherin and Vpu described below."
      ],
      "computed_relevance": 0.25,
      "computed_utilization": 0.375,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.38095238095238093,
      "gt_utilization": 0.38095238095238093,
      "gt_completeness": 1.0,
      "gt_adherence": 0.0,
      "binary_pred": 1,
      "binary_gt": 0,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 13,
      "dataset_id": "378",
      "question": "What is the 5-year survival rate for colorectal cancer patients?",
      "ground_truth_answer": "The provided context does not contain information about the 5-year survival rate for colorectal cancer patients. Therefore, it is not possible to answer the question based on the given passages.",
      "generated_response": "<think>\nOkay, let's see. The user is asking about the 5-year survival rate for colorectal cancer patients. But looking at the provided context, I need to check if there's any information related to that.\n\nFirst, the context mentions colectomy rate and short-term mortality rate as 7.7% and 0.8% respectively. Wait, the mortality rate here is short-term, not 5-year. The colectomy rate is 7.7%, which is lower than some other studies. There's also a mention of no cases of rectal dysplasia or cancer after a 3-year follow-up. But the question is about 5-year survival for colorectal cancer. \n\nHmm, the context doesn't mention survival rates at all. The mortality rate given is 0.8%, but that's short-term, probably within a year or so. The 5-year survival rate isn't discussed here. The passages are about colectomy rates, research in China on severe ulcerative colitis, and some surgical procedures like proctocolectomy. There's no data on colorectal cancer survival rates. \n\nSo the answer should be that the information isn't provided in the context. The user might be confusing ulcerative colitis with colorectal cancer. The context is about SUC (severe ulcerative colitis) patients, not colorectal cancer. Therefore, the 5-year survival rate for colorectal cancer isn't addressed here.\n</think>\n\nThe provided context does not mention the 5-year survival rate for colorectal cancer patients. The information given pertains to colectomy rates (7.7%), short-term mortality rates (0.8%), and outcomes related to severe ulcerative colitis (SUC) research in China. There is no data on colorectal cancer survival rates in the context. \n\nAnswer: The 5-year survival rate for colorectal cancer patients is not provided in the given context.",
      "retrieved_chunks": [
        "The colectomy rate and short-term mortality rate were 7.7% and 0.8% respectively.",
        "Title: Chinese research into severe ulcerative colitis has increased in quantity and complexity\nPassage: no cases of rectal dysplasia and/or cancer was reported after a median 3-year follow-up.",
        "Title: Chinese research into severe ulcerative colitis has increased in quantity and complexity\nPassage: The colectomy rate in our study was found to be 7.7%, while the colectomy rate in hospitalized SUC patients reported by the West China Hospital is 17.9%, both are lower than the 20%-40% reported in United Kingdom . Title: Chinese research into severe ulcerative colitis has increased in quantity and complexity\nPassage: significantly increased.",
        "Title: Chinese research into severe ulcerative colitis has increased in quantity and complexity\nPassage: mortality rate were 7.7% and 0.8% respectively.",
        "Total proctocolectomy with ileal pouch-anal anastomosis was the most commonly employed operation."
      ],
      "computed_relevance": 0.3333333333333333,
      "computed_utilization": 0.3333333333333333,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.0,
      "gt_utilization": 0.0,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 14,
      "dataset_id": "25",
      "question": "Which Human Coronavirus showed species specific clinical characteristics of its infection?",
      "ground_truth_answer": "HCoV\u2010HKU1 is the Human Coronavirus that showed species-specific clinical characteristics of its infection, specifically with a higher severity of gastrointestinal symptoms on the fourth day of illness.",
      "generated_response": "<think>\nOkay, let's see. The question is asking which human coronavirus showed species-specific clinical characteristics in the study mentioned. The context provided is from an abstract of a study titled \"Species-specific clinical characteristics of human coronavirus infection among otherwise healthy adolescents and adults.\"\n\nFirst, I need to recall the key points from the abstract. The passage mentions that the authors looked at four species: HCoV-OC43, HCoV-229E, HCoV-NL63, and HCoV-HKU1. The main finding was that there were no species-specific differences in clinical characteristics except for HCoV-HKU1. For that one, there was a trend towards higher severity of gastrointestinal symptoms on the fourth day of illness.\n\nSo the answer should be HCoV-HKU1. The question is straightforward once I parse the abstract correctly. The key sentence is: \"We did not observe species-specific differences in the clinical characteristics of HCoV infection, with the exception of HCoV-HKU1...\" That directly answers the question.\n</think>\n\nThe Human Coronavirus that showed species-specific clinical characteristics of its infection is **HCoV-HKU1**. The study found that, unlike the other species (HCoV-OC43, HCoV-229E, and HCoV-NL63), HCoV-HKU1 exhibited a trend toward higher severity of gastrointestinal symptoms on the fourth day of illness. \n\n**Answer:** HCoV-HKU1.",
      "retrieved_chunks": [
        "Title: Species\u2010specific clinical characteristics of human coronavirus infection among otherwise healthy adolescents and adults\nPassage: Authors: Bouvier, Monique; Chen, Wei\u2010Ju; Arnold, John C.; Fairchok, Mary P.; Danaher, Patrick J.; Lalani, Tahaniyat; Malone, Leslie; Mor, Deepika; Ridor\u00e9, Michelande; Burgess, Timothy H.; Millar, Eugene V. Title: Species\u2010specific clinical characteristics of human coronavirus infection among otherwise healthy adolescents and adults\nPassage: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5820427/\n\nTitle: Species\u2010specific clinical characteristics of human coronavirus infection among otherwise healthy adolescents and adults\nPassage: DOI: 10.1111/irv.12538",
        "Title: Species\u2010specific clinical characteristics of human coronavirus infection among otherwise healthy adolescents and adults\nPassage: Abstract: Human coronavirus is a known cause of influenza\u2010like illness .",
        "The distribution of species was as follows: HCoV\u2010OC43 , HCoV\u2010229E , HCoV\u2010NL63 , and HCoV\u2010HKU1 . We did not observe species\u2010specific differences in the clinical characteristics of HCoV infection, with the exception of HCoV\u2010HKU1, for which the severity of gastrointestinal symptoms trended higher on the fourth day of illness.",
        "In a multisite, observational, longitudinal study of ILI among otherwise healthy adolescents and adults, 12% of subjects were PCR\u2010positive for HCoV."
      ],
      "computed_relevance": 0.16666666666666666,
      "computed_utilization": 0.16666666666666666,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.4,
      "gt_utilization": 0.1,
      "gt_completeness": 0.25,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 15,
      "dataset_id": "1741",
      "question": "What has been demonstrated to  be  effective for prevention?",
      "ground_truth_answer": "Vaccines have been demonstrated to be effective for prevention, as well as household-based quarantine and isolation. Additionally, the use of face masks and hand hygiene has shown potential efficacy in reducing disease spread.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking what has been demonstrated to be effective for prevention based on the provided context. Let me go through the context step by step.\n\nFirst, the context mentions the eradication of smallpox through vaccines, as Edward Jenner's work led to that. So vaccines are definitely a point here. Then there are several passages about non-pharmaceutical interventions for influenza. The first passage talks about measures like social distancing, school closures, travel restrictions, and household quarantine. It says these are likely somewhat effective but hard to implement long-term. Then there's a study on face masks and hand hygiene. The study had a control group with education on diet and lifestyle, another group with masks plus education, and they distributed masks and taught proper use. The study's title mentions assessing the efficacy of masks and hand hygiene for influenza control. Another part says there's uncertainty about the efficacy of face masks and hand hygiene. However, the study compared three interventions, which might include masks and hand hygiene. \n\nSo putting it all together, the effective prevention methods mentioned are vaccines (as in smallpox eradication) and non-pharmaceutical interventions like social distancing, quarantine, and possibly masks and hand hygiene, though the latter's efficacy is uncertain. The answer should include vaccines and the non-pharmaceutical measures that were found effective in the studies mentioned. Wait, the question is about what has been demonstrated. The smallpox eradication is a clear example of vaccines working. The non-pharmaceutical interventions like social distancing and quarantine are said to be \"likely to be somewhat effective.\" The study on masks and hand hygiene is part of the proposed study, but the preliminary findings might show their effectiveness. However, the passage says there's uncertainty about their efficacy. Hmm. The study compared three interventions, but the results aren't fully detailed here. The answer should focus on what was demonstrated. Since the smallpox example is clear, vaccines are effective. The non-pharmaceutical measures like social distancing, closures, and quarantine are mentioned as somewhat effective. The study on masks and hand hygiene is part of the research, but the answer might need to mention that the study is assessing their efficacy, but maybe not yet demonstrated. Wait, the question is \"What has been demonstrated to be effective?\" So the smallpox example shows vaccines. The other parts mention that non-pharmaceutical interventions are likely somewhat effective but with uncertainty. The study is preliminary",
      "retrieved_chunks": [
        "In fact, their effectiveness in the prevention of infectious diseases could be clearly observed in the eradication of smallpox, declared officially in 1976 by WHO, just two centuries after Edward Jenner showed the prevention of smallpox infection by inoculating cowpox into a person .",
        "Title: Preliminary Findings of a Randomized Trial of Non-Pharmaceutical Interventions to Prevent Influenza Transmission in Households\nPassage: and targeted antiviral prophylaxis, other population-level social distancing measures such as school and workplace closures and travel restrictions are likely to be somewhat effective in reducing influenza transmission in the community , but implementation on a prolonged basis and with repeated waves of the pandemic could be difficult. Household-based quarantine and isolation will likely be effective in mitigating the impact of a pandemic .",
        "In the control arm, households received education about the importance of a healthy diet and lifestyle, both in terms of illness prevention and symptom alleviation . Households in the face mask arm received the control intervention plus education about the potential efficacy of masks in reducing disease spread to household contacts if all parties wear masks, distribution of a box of 50 surgical masks for each household member , and demonstration of proper face-mask wearing and hygienic disposal. Index subjects and all household contacts were taught to wear masks as often as possible at home\n\nTitle: Preliminary Findings of a Randomized Trial of Non-Pharmaceutical Interventions to Prevent Influenza Transmission in Households\nPassage: through intensive counselling, and demonstration of proper wearing of masks or hand washing.",
        "Title: Recent Progress towards Novel EV71 Anti-Therapeutics and Vaccines\nPassage: Vaccines have always been considered as one of the most effective preventions against various types of infections, ranging from bacterial to viral infections.",
        "There is however considerable uncertainty about the efficacy of some non-pharmaceutical interventions at the personal level including face masks and hand hygiene. Our proposed study, to assess the efficacy of masks and hand-hygiene for influenza control,\n\nTitle: Preliminary Findings of a Randomized Trial of Non-Pharmaceutical Interventions to Prevent Influenza Transmission in Households\nPassage: Our study compared three interventions."
      ],
      "computed_relevance": 0.3333333333333333,
      "computed_utilization": 0.6666666666666666,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.5333333333333333,
      "gt_utilization": 0.4666666666666667,
      "gt_completeness": 0.875,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 16,
      "dataset_id": "944",
      "question": "What does LAIV rely on?",
      "ground_truth_answer": "LAIV relies on antigenic match and the HA and NA antigens are replaced on the same schedule as the TIV.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What does LAIV rely on?\" based on the provided context. Let me go through the information given step by step.\n\nFirst, looking at the context, there's a mention in the first passage: \"While LAIV relies on antigenic match and the HA and NA antigens are replaced on the same schedule as the TIV...\" So here, it directly states that LAIV relies on antigenic match. The HA and NA antigens are the hemagglutinin and neuraminidase, which are key surface proteins of the influenza virus. The antigenic match refers to how well the vaccine's strains match the circulating strains in a given season. \n\nAdditionally, the passage mentions that the HA and NA antigens are replaced on the same schedule as the TIV (trivalent inactivated vaccine). This suggests that LAIV, like other influenza vaccines, depends on updating its components annually to match the predicted circulating strains. \n\nI should check if there are other parts of the context that mention what LAIV relies on. The other passages talk about mucosal immunity, administration as a nasal spray, and safety concerns, but the key part here is the antigenic match. The question is specifically about what LAIV relies on, and the answer is directly stated in the first passage. \n\nSo the answer should be that LAIV relies on antigenic match, specifically regarding the HA and NA antigens. The user might be looking for that specific term. Let me make sure there's no other possible answer. The passage also mentions that LAIV induces mucosal immunity, but the question is about what it relies on for efficacy, not the type of immunity it induces. Therefore, the correct answer is antigenic match.\n</think>\n\nLAIV relies on **antigenic match**, specifically the alignment of its hemagglutinin (HA) and neuraminidase (NA) antigens with circulating influenza strains. The context explicitly states that LAIV \"relies on antigenic match\" and that these antigens are updated on the same schedule as inactivated vaccines (TIV) to ensure efficacy. This dependency on matching circulating strains is critical for its protective effectiveness. \n\n**Answer:** Antigenic match.",
      "retrieved_chunks": [
        "For this reason, LAIV has shown some superiority over the IIV in terms of the induction of mucosal immunity via secreted immunoglobulin A . Use of the LAIV has proven to be safe in children and immunocompromised persons . The most spelt-out advantage is the \"non-invasive\" capacity of the attenuated viruses and this had made it suitable to use for all categories of vaccines, although LAIVs are not recommended for people with underlying chronic medical conditions .",
        "LAIV is not recommended for all populations; however, it is generally considered to be as effective as inactivated vaccines and may be more efficacious in children . While LAIV relies on antigenic match and the HA and NA antigens are replaced on the same schedule as the TIV , there is some suggestion that LAIV may\n\nTitle: Efficacy and synergy of live-attenuated and inactivated influenza vaccines in young chickens\nPassage: decade and it has been reported to protect young individuals better than IIV . Importantly, recent studies showed that LAIV can pre-sensitize the population and, subsequently, synergistically boost the efficacy of IIV . It should be noted that the use of LAIV in poultry requires strict safety standards due to concerns about the possibility that wild type strains may circulate in domestic poultry without apparent clinical symptoms, undergo genetic reassortment with the vaccine virus, and produce novel virulent strains . An ideal poultry LAIV should not be able to revert to wild type virus or undergo reassortment with field strains.",
        "LAIV is administered as a nasal spray and contains the same three or four influenza virus strains as inactivated vaccines but on an attenuated vaccine backbone . LAIV are temperature-sensitive and cold-adapted so they do not replicate effectively at core body temperature, but replicate in the mucosa of the nasopharynx . LAIV immunization induces serum antibody responses, mucosal antibody responses , and T cell responses. While robust serum antibody and nasal wash antibody responses are associated with protection from infection, other immune responses, such as",
        "Title: Current and Novel Approaches in Influenza Management\nPassage: LAIV viruses in the nasopharynx elicit immune response that epitomizes a natural influenza infection.",
        "A typical setback to the use of the LAIV\n\nTitle: Virus-Vectored Influenza Virus Vaccines\nPassage: February and then manufacturers begin production, taking at least six months to produce the millions of vaccine doses required for the fall ."
      ],
      "computed_relevance": 0.14285714285714285,
      "computed_utilization": 0.14285714285714285,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.13043478260869565,
      "gt_utilization": 0.043478260869565216,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 17,
      "dataset_id": "1009",
      "question": "What have the studies on NP shown for the protection against influenza challege?",
      "ground_truth_answer": "The studies on NP have shown that NP-specific CD8 T-cell responses may be directly correlated to protection against homologous influenza virus infection, and that mucosal vaccination with rAd/NP can confer complete protection against lethal homologous virus challenge. Additionally, protection against heterosubtypic influenza virus infection may also be correlated to NP-specific CTL response.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking what studies on NP (nucleoprotein) have shown regarding protection against influenza challenge. I need to look through the provided context to find relevant information.\n\nFirst, the context includes several passages. The first one mentions that NP-specific CTL (cytotoxic T lymphocyte) response may be directly correlated with protection against homologous influenza virus infection. Also, protection against heterosubtypic infection might be linked to NP-specific CD8 T cells since their levels increased in surviving mice. \n\nThen there's a study titled \"Mucosal Vaccination...\" which shows that rAd/NP immunization increases NP-specific CD8 T cells in the lungs. They tested cross-protection with heterologous H1N1 and H3N2 challenges. They found that the protection might correlate with the magnitude of NP-specific CD8 T-cell responses because NP has a conserved epitope. However, they also noted that virus titers in the lungs didn't differ between groups, implying that protection isn't necessarily tied to virus titers detected there.\n\nAnother part mentions that in some cases, protection against lethal challenge correlates with NP-specific CD8 T cells, even when virus titers are similar. So, the key points are the role of NP-specific CD8 T cells in both homologous and heterosubtypic protection, and that this protection isn't always linked to lower virus titers in the lungs.\n\nI need to synthesize this into a concise answer. Make sure to mention both homologous and heterosubtypic protection, the role of NP-specific CD8 T cells, and the note about virus titers not correlating with protection. Also, reference the studies mentioned, like the rAd/NP vaccination study.\n</think>\n\nStudies on influenza nucleoprotein (NP) have demonstrated that NP-specific CD8 T-cell responses play a critical role in protection against both **homologous** and **heterosubtypic influenza virus challenges**. Key findings include:  \n\n1. **Homologous Protection**: NP-specific cytotoxic T lymphocyte (CTL) responses are directly correlated with protection against infection by viruses of the same subtype.  \n2. **Heterosubtypic Protection**: Surviving mice challenged with a lethal dose of a heterosubtypic influenza virus showed elevated NP-specific CD8 T-cell levels, suggesting these responses contribute to cross-protection.  \n3",
      "retrieved_chunks": [
        "route, indicating that NP-specific CTL response may be directly correlated to protection against homologous influenza virus infection. Moreover, protection against heterosubtypic influenza virus infection may also be correlated to NP-specific CTL response as NP-specific blood CD8 T lymphocyte levels considerably increased in mice that survived the lethal challenge with heterosubtypic\n\nTitle: Surveillance Study of Influenza Occurrence and Immunity in a Wisconsin Cohort During the 2009 Pandemic\nPassage: detect similar correlations of T-cell reactivity with outcomes was that we had too few infected donors. Protective mechanisms in animal models include antibodies to influenza NP and M2. Although NP is highly conserved, occasional antibodies recognize pH1N1 NP but not NP from seasonal viruses .",
        "route\n\nTitle: Mucosal Vaccination with Recombinant Adenovirus Encoding Nucleoprotein Provides Potent Protection against Influenza Virus Infection\nPassage: In our present study, we demonstrated that rAd/NP immunization increases the frequency of NP-specific CD8 T cells recruited to the lungs of i.n.",
        "Title: Mucosal Vaccination with Recombinant Adenovirus Encoding Nucleoprotein Provides Potent Protection against Influenza Virus Infection\nPassage: Complete protection offered by i.n. immunization of rAd/NP during heterologous H1N1 or heterosubtypic H3N2 virus challenge rendered us to investigate whether the observed cross-protection correlates with the magnitude NP-specific CD8 T-cell responses, given that influenza NP contains a conserved immunodominant CD8 T-cell epitope as indicated previously. In order to determine the possible presence of such correlation, blood lymphocytes of mice challenged with 10 LD 50 dose of influenza A/Philippines were analyzed by K d /NP 147-155 -tetramer staining from day 0 to day 12 post-challenge.",
        "Title: Mucosal Vaccination with Recombinant Adenovirus Encoding Nucleoprotein Provides Potent Protection against Influenza Virus Infection\nPassage: virus titers at day 5 post-challenge were detected at similar levels in all immunization groups .",
        "As a result, the protection may not necessarily correlate with virus titers detected in the lungs upon lethal challenge."
      ],
      "computed_relevance": 0.4,
      "computed_utilization": 0.5,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.30434782608695654,
      "gt_utilization": 0.21739130434782608,
      "gt_completeness": 0.7142857142857143,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 18,
      "dataset_id": "640",
      "question": "What do ANDV-infected hamsters fitted with physiologic monitoring devices exhibit?",
      "ground_truth_answer": "Diminished pulse pressures, tachycardia, and hypotension that closely mimic the shock experienced by patients who succumb to HCPS.",
      "generated_response": "<think>\nOkay, let's see. The question is asking what ANDV-infected hamsters with physiologic monitoring devices exhibit. I need to look through the provided context to find the answer.\n\nFirst, I'll check the first passage mentioned. The title is \"Hantaviruses in the Americas...\" and the passage says that these hamsters show diminished pulse pressures, tachycardia, and hypotension, which mimic the shock seen in HCPS patients. That seems directly relevant. \n\nOther passages talk about things like high viral titers in tissues, issues with alveolar macrophages, and lung tissue findings, but the question specifically mentions physiologic monitoring devices. The first passage's answer points to the physiological parameters like pulse pressure, heart rate, and blood pressure. \n\nI should make sure there's no other mention of physiologic monitoring in other sections. The other titles and passages discuss pathogenesis and immune responses but don't mention the specific physiologic parameters monitored. So the answer is likely the diminished pulse pressures, tachycardia, and hypotension from the first context.\n</think>\n\nANDV-infected hamsters fitted with physiologic monitoring devices exhibit **diminished pulse pressures, tachycardia, and hypotension**, which closely mimic the shock associated with hantavirus cardiopulmonary syndrome (HCPS) in humans.",
      "retrieved_chunks": [
        "ANDV-infected hamsters fitted with physiologic monitoring devices exhibited diminished pulse pressures, tachycardia, and hypotension that appear to closely mimic the shock that is believed to be the proximate cause of demise in patients who succumb to HCPS . Title: Hantaviruses in the Americas and Their Role as Emerging Pathogens\nPassage: Compared to the human disease, ANDV-infected hamsters exhibit exceptionally high titers of live ANDV in their tissues, with much of the viral replication occurring in hepatocytes, which are spared in the human disease. Titers of live ANDV in some cases exceed 10 8 /g, whereas hantavirus isolates from human tissues have been notoriously difficult to obtain.",
        "Title: Depletion of Alveolar Macrophages Does Not Prevent Hantavirus Disease Pathogenesis in Golden Syrian Hamsters\nPassage: Serial sections of lung tissue from these groups further revealed the presence of ANDV antigen colocalized to CD31-positive endothelial cells in both capillaries and larger vessels . Regardless of treatment, no differences were observed in the pathogenesis of HPS-like disease in ANDV-infected hamsters. Hamsters in all groups exhibited signs of mild to moderate inflam- mation, interstitial pneumonia, alveolar fibrin deposition, and edema characteristic of ANDV infection.",
        "Title: Depletion of Alveolar Macrophages Does Not Prevent Hantavirus Disease Pathogenesis in Golden Syrian Hamsters\nPassage: progresses. At later times after infection, similar levels of viral genome and/or infectious virus were found in the lung of all hamsters, supporting the argument that AM contribute more substantially to the immune response against ANDV early after infection but less so at later times once ANDV is primarily replicating in endothelial cells.",
        "Despite the universal occurrence of mildly-elevated hepatic enzymes in patients with HCPS, hepatic enzymes do not appear to be present at elevated levels in the blood of diseased hamsters even immediately before death .",
        "Title: Hantaviruses in the Americas and Their Role as Emerging Pathogens\nPassage: abundantly in the microvascular endothelium."
      ],
      "computed_relevance": 0.1,
      "computed_utilization": 0.1,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.07142857142857142,
      "gt_utilization": 0.07142857142857142,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 19,
      "dataset_id": "1629",
      "question": "Why is the Spanish Influenza virus the Mother of the modern influenza viruses?",
      "ground_truth_answer": "The Spanish Influenza virus is considered the Mother of all modern influenza viruses due to its initial genetic characterization, the origin and evolution of its hemagglutinin gene, characterization of its neuraminidase gene, and characterization of its matrix gene. This extensive research and understanding of the genetic makeup of the virus has provided crucial insights into the development and evolution of influenza viruses, making it a significant and influential virus in the history of influenza pandemics.",
      "generated_response": "<think>\nOkay, let's see. The user is asking why the Spanish Influenza virus is called the Mother of all modern influenza viruses. The context provided includes several passages about the 1918 Spanish flu, focusing on the characterization of different genes like hemagglutinin, neuraminidase, matrix, and initial genetic studies. The references mention a paper from 2000 in the Proceedings of the National Academy of Sciences by Reid et al.\n\nFirst, I need to recall what I know about the 1918 Spanish flu. It was a pandemic that killed millions. The term \"Mother of all pandemics\" might refer to its significant impact or its genetic influence on later flu strains. The context here talks about the genetic characterization of the virus. So, maybe the answer lies in how the 1918 virus's genes have contributed to subsequent influenza viruses.\n\nThe passages mention the hemagglutinin (HA) and neuraminidase (NA) genes. HA is important for the virus to attach to host cells, and NA helps in releasing new virus particles. The matrix gene is structural. The initial genetic characterization study from 2000 probably compared the 1918 virus to others. If the 1918 virus's genes are found in modern strains, that would explain why it's considered the mother. Also, the 1918 virus might have contributed to the genetic makeup of later pandemics, like the 1957 or 1968 ones through antigenic shifts. Antigenic shift occurs when different flu strains exchange genes, leading to new viruses. If the 1918 virus's genes were part of such shifts, it would be a progenitor.\n\nThe answer should tie together the genetic legacy of the 1918 virus in modern flu strains. The provided context doesn't give explicit details beyond the characterization, so I need to infer based on general knowledge. The 1918 virus's HA gene is part of the H1N1 subtype, which is still circulating today. The 2009 swine flu was also an H1N1, which might have genetic components from the 1918 strain. Therefore, the 1918 virus's genes have persisted and evolved, contributing to modern influenza viruses through genetic reassortment. Hence, it's called the mother because its genetic material",
      "retrieved_chunks": [
        "Origin and evolution of the 1918 \u201cSpanish\u201d influenza virus hemagglutinin gene. Title: 1918 Influenza: the Mother of All Pandemics\nPassage: Characterization of the 1918 \u201cSpanish\u201d influenza virus neuraminidase gene.",
        "Title: 1918 Influenza: the Mother of All Pandemics\nPassage: Characterization of the 1918 \u201cSpanish\u201d influenza virus matrix gene",
        "Title: 1918 Influenza: the Mother of All Pandemics\nPassage: Initial genetic characterization of the 1918 \u201cSpanish\u201d influenza virus. Title: 1918 Influenza: the Mother of All Pandemics\nPassage: 12.",
        "Proc Natl Acad Sci U S A 2000;97:6785\u201390.",
        "Reid AH, Fanning TG, Hultin JV, Taubenberger JK."
      ],
      "computed_relevance": 0.2857142857142857,
      "computed_utilization": 0.8571428571428571,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.4,
      "gt_utilization": 0.4,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 20,
      "dataset_id": "962",
      "question": "What is  the result of rAd5 trials?",
      "ground_truth_answer": "The provided context does not contain the specific result of rAd5 trials. The information given pertains to methods used in the study, such as statistical analysis, luciferase activity assays, PCR methods for creating recombinant constructs, transfection of cells, and verification of expressed target proteins. It does not mention the specific results of rAd5 trials.",
      "generated_response": "<think>\nOkay, let's see. The user is asking about the result of rAd5 trials based on the provided context. First, I need to check the context given. The context mentions that a P value less than 0.05 is considered statistically significant. The assays were repeated three times independently. The statistical methods used include unpaired two-tailed t-tests for two groups and ANOVA or Mann-Whitney tests for more than two groups.\n\nLooking at the titles and passages, the study is about the anti-radiation effect of polyethylenimine as a TLR5 agonist. The data are presented as mean \u00b1 SD, and relative luciferase activity is calculated by dividing the stimulated cells' activity by the mock cells'. \n\nHowever, the question specifically asks about \"rAd5 trials.\" The term rAd5 isn't mentioned in the provided context. The context talks about polyethylenimine and TLR5, but not rAd5. Maybe rAd5 is a typo or a term used in a different part of the study not included here. Since the user's provided context doesn't mention rAd5 trials, there's no information to answer the question. Therefore, the answer should state that the context doesn't provide results for rAd5 trials.\n</think>\n\nThe provided context does not mention any results related to \"rAd5 trials.\" The study focuses on the anti-radiation effects of polyethylenimine as a TLR5 agonist, with statistical analyses and luciferase activity measurements described, but there is no reference to rAd5 in the given passages or titles.",
      "retrieved_chunks": [
        "A value of P < 0.05 was considered statistically significant.",
        "The assays were repeated three times independently.",
        "Title: Anti-radiation damage effect of polyethylenimine as a toll-like receptor 5 targeted agonist\nPassage: Data are expressed as mean \u00b1 SD .",
        "Title: Anti-radiation damage effect of polyethylenimine as a toll-like receptor 5 targeted agonist\nPassage: relative luciferase activity of the stimulated cells divided by the relative luciferase activity of the mock cells.",
        "Statistical difference between groups was determined using the unpaired two-tailed t test. When there were more than two groups, differences were analyzed using analysis of variance if the variances were equal, and the Mann-Whitney nonparametric test if variances were unequal ."
      ],
      "computed_relevance": 0.6666666666666666,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.0,
      "gt_utilization": 0.42857142857142855,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 21,
      "dataset_id": "152",
      "question": "What is the structure of the CD40 Ligand?",
      "ground_truth_answer": "The CD40 Ligand is a type II membrane glycoprotein with a sandwiched extracellular structure composed of a \u03b2-sheet, \u03b1-helix loop, and a \u03b2-sheet, allowing for trimerization. It is a member of the TNF superfamily and can form hetero-trimeric complexes.",
      "generated_response": "<think>\nOkay, let's tackle this question about the structure of the CD40 Ligand. The user wants to know what the structure is, based on the provided context. Let me go through the passages again to make sure I don't miss any key details.\n\nFirst, the context mentions that CD40L is a type II membrane glycoprotein with a molecular weight of 32-39 kDa. It's part of the TNF superfamily. The structure is described as a \"sandwiched extracellular structure composed of a \u03b2-sheet, \u03b1-helix loop, and a \u03b2-sheet.\" That sounds like a specific arrangement of secondary structural elements. Also, it allows for trimerization, which is a common feature in the TNF family. \n\nAnother part of the context talks about trimerization being important for receptor binding. The ligand forms hetero-trimeric complexes and binds to the receptor along three clefts formed by neighboring monomers in the trimer. So, the trimerization is crucial for its function. Additionally, there are seven conserved residues at the trimer interface and six conserved receptor binding sites in the TNF domain, which are mapped in the crCD40L sequence. \n\nPutting this together, the structure involves a trimeric arrangement with specific secondary structures (\u03b2-sheets and \u03b1-helix loops) and conserved residues that facilitate both trimerization and receptor interaction. The key points are the type II membrane glycoprotein classification, the TNF superfamily membership, the sandwiched structure with \u03b2-sheets and \u03b1-helix loops, and the trimeric form necessary for receptor binding.\n</think>\n\nThe CD40 Ligand (CD40L) has a structure characterized as a **type II membrane glycoprotein** with a molecular weight of 32\u201339 kDa. It belongs to the **TNF superfamily** and features an extracellular \"sandwiched\" structure composed of **\u03b2-sheets and \u03b1-helix loops**. A critical aspect of its structure is **trimerization**, where three monomers assemble into a hetero-trimeric complex. This trimeric form creates three clefts between neighboring monomers, each binding an elongated receptor molecule (CD40). The trimerization is essential for receptor interaction, facilitated by **seven conserved residues at the trimer interface** and **six conserved receptor-binding sites**",
      "retrieved_chunks": [
        "Title: Identification and characterisation of the CD40-ligand of Sigmodon hispidus\nPassage: CD40L plays a critical role in orchestrating immune responses against pathogens. Depending on the post-translational modification, the murine CD40L is a 32-39 kDa type II membrane glycoprotein that was initially identified as a surface marker exclusive to activated CD4 + T cells . It is a member of the TNF superfamily consisting of a sandwiched extracellular structure composed of a \u03b2-sheet, \u03b1-helix loop, and a \u03b2-sheet, allowing for the trimerization of CD40L, an additional feature of the TNF family of ligands . Since its initial discovery, CD40L has been shown to be not only expressed on CD4+ T cells, but\n\nTitle: Identification and characterisation of the CD40-ligand of Sigmodon hispidus\nPassage: CD40L plays a critical role in orchestrating immune responses against pathogens. Depending on the post-translational modification, the murine CD40L is a 32-39 kDa type II membrane glycoprotein that was initially identified as a surface marker exclusive to activated CD4 + T cells . It is a member of the TNF superfamily consisting of a sandwiched extracellular structure composed of a \u03b2-sheet, \u03b1-helix loop, and a \u03b2-sheet, allowing for the trimerization of CD40L, an additional feature of the TNF family of ligands . Since its initial discovery, CD40L has been shown to be not only expressed on CD4+ T cells, but\n\nTitle: Identification and characterisation of the CD40-ligand of Sigmodon hispidus\nPassage: hetero-trimeric complexes and bind one elongated receptor molecule along each of three clefts formed by neighboring monomers of the trimer and ligand trimerization is for receptor binding .",
        "Title: Identification and characterisation of the CD40-ligand of Sigmodon hispidus\nPassage: hetero-trimeric complexes and bind one elongated receptor molecule along each of three clefts formed by neighboring monomers of the trimer and ligand trimerization is for receptor binding .",
        "All seven known conserved residues that constitute the trimer interface on the conserved TNF domain , were mapped to the putative crCD40L protein sequence. Additionally, all six known conserved receptor binding sites on the conserved TNF domain , were mapped to the crCD40L protein sequence.",
        "All seven known conserved residues that constitute the trimer interface on the conserved TNF domain , were mapped to the putative crCD40L protein sequence. Additionally, all six known conserved receptor binding sites on the conserved TNF domain , were mapped to the crCD40L protein sequence."
      ],
      "computed_relevance": 0.3333333333333333,
      "computed_utilization": 0.6666666666666666,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.3333333333333333,
      "gt_utilization": 0.16666666666666666,
      "gt_completeness": 0.5,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 22,
      "dataset_id": "1241",
      "question": "What is the basic reproduction number (R 0)?",
      "ground_truth_answer": "The basic reproduction number (R 0) is a widely used epidemiological measurement that represents the average number of secondary infections generated by a single primary case in a fully susceptible population. If R 0 > 1, then the disease can invade an otherwise susceptible population and persist, whereas if R 0 < 1, the disease cannot successfully invade and will die out. It is used to measure the transmission potential of a given population and is important for assessing the effectiveness of different intervention strategies in controlling the spread of diseases.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking for the definition of the basic reproduction number, R0. I need to look through the provided contexts to gather the necessary information.\n\nFirst, in the first context, it says R0 is the most widely used measure of transmission potential. It's defined as the number of secondary infections from a primary case in a fully susceptible population. Also, it mentions that if R0 is greater than 1, the disease can spread, and if less than 1, it dies out.\n\nThe second context reiterates that R0 is the average number of infections each case causes. It also emphasizes the importance of estimating R0 for intervention strategies.\n\nThird context adds that R0 is used to determine the minimum immunization coverage needed. The threshold condition for preventing an outbreak is related to R0.\n\nFourth context clarifies that R0 assumes a fully susceptible population with no control measures. It also differentiates R0 from the effective reproduction number R, which includes control measures.\n\nPutting this all together, the answer should define R0 as the average number of secondary cases from one infected individual in a completely susceptible population. It should mention the threshold of 1 for spread vs. dying out, and note that it's used for public health strategies. Also, clarify that R0 doesn't account for control measures or immunity.\n</think>\n\nThe basic reproduction number (R\u2080) is a key epidemiological metric that represents the **average number of secondary infections** generated by a single infected individual in a **fully susceptible population** with no control measures in place. It quantifies the transmission potential of an infectious disease:  \n- If **R\u2080 > 1**, the disease can spread and persist in the population.  \n- If **R\u2080 < 1**, the disease will eventually die out.  \n\nR\u2080 is critical for designing public health interventions, such as determining vaccination coverage thresholds, and understanding the dynamics of disease spread. It differs from the *effective reproduction number* (R), which accounts for the impact of control measures and changes in population immunity over time.",
      "retrieved_chunks": [
        "Title: The Failure of R (0)\nPassage: The basic reproductive ratio-also known as the basic reproductive number, the basic reproduction number, the control reproduction number, or R 0 -is one of the foremost concepts in epidemiology . R 0 is the most widely used epidemiological measurement of the transmission potential in a given population . It is a measure of initial disease spread, such that if R 0 > 1, then the disease can invade an otherwise susceptible population and hence persist, whereas if R 0 < 1, the disease cannot successfully invade and will die out. The concept is defined as the number of secondary infections\n\nTitle: Preparation for Possible Sustained Transmission of 2019 Novel Coronavirus\nPassage: Secondly, the R0, the basic reproduction number, is correctly described as the average number of infections each case causes.",
        "For this reason, estimating the basic reproduction number is paramount for assessing the effectiveness of different intervention strategies.",
        "Title: Correcting the Actual Reproduction Number: A Simple Method to Estimate R(0) from Early Epidemic Growth Data\nPassage: The basic reproduction number, R 0 , of an infectious disease is the average number of secondary cases generated by a single primary case in a fully susceptible population . R 0 is the most widely used epidemiological measurement of the transmission potential in a given population. Statistical estimation of R 0 has been performed for various infectious diseases , aiming towards understanding the dynamics of transmission and evolution, and designing effective public health OPEN ACCESS intervention strategies. In particular, R 0 has been used for determining the minimum coverage of immunization, because the threshold condition to prevent a major\n\nTitle: Early real-time estimation of the basic reproduction number of emerging or reemerging infectious diseases in a community with heterogeneous contact pattern: Using data from Hong Kong 2009 H1N1 Pandemic Influenza as an illustrative example\nPassage: totally susceptible population . When R 0 is greater than one, there is a likelihood that the infection will to continue to spread; however if R 0 is less than one, then the infection will eventually die out.",
        "R is the effectiive number and can include the impact of control measures.",
        "But it lacks two key ideas: 1) the 0 after the R implies the native state, which is a fully susceptible population and without any control measures."
      ],
      "computed_relevance": 0.8333333333333334,
      "computed_utilization": 0.75,
      "computed_completeness": 0.9,
      "computed_adherence": 1.0,
      "gt_relevance": 0.5,
      "gt_utilization": 0.4444444444444444,
      "gt_completeness": 0.8888888888888888,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 23,
      "dataset_id": "1533",
      "question": "What is a Hantavirus?",
      "ground_truth_answer": "A Hantavirus is a virus that is primarily transmitted by rodents through their urine, feces, and saliva, as well as the aerosols produced by them. It can cause severe pathologies in humans, such as hemorrhagic fever with renal syndrome and hantavirus cardiopulmonary syndrome.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What is a Hantavirus?\" I need to base my answer on the provided context.\n\nFirst, I'll go through each passage to gather relevant information. The first context mentions that Hantavirus is transmitted mainly by rodents through urine, feces, saliva, and aerosols. It also notes that it's not a new disease in Germany but has increased in China and Europe. \n\nThe second passage says that Hantaviruses are part of the Bunyaviridae family and are directly transmitted via aerosols from small mammals' excreta without arthropod vectors. It also mentions that while found in insectivores and bats, only rodent-borne ones cause human disease. They have a tri-segmented RNA genome.\n\nAnother passage talks about outbreaks being linked to striped field mouse population cycles and climate change. The Americas context states that humans get infected via aerosols from rodent excreta. In Asia, Hantavirus causes hemorrhagic fever with renal syndrome, specifically from Hantan and Seoul viruses. \n\nAnother part mentions that Hantaviruses are zoonotic pathogens worldwide except Antarctica and can cause two severe diseases: HFRS and HCPS. There's also a note about the recent increase in illnesses despite humans coexisting with rodents for a long time.\n\nPutting this together, Hantavirus is a virus transmitted by rodents, spreads through aerosols, belongs to Bunyaviridae, has a tri-segmented RNA genome, causes severe diseases like HFRS and HCPS, and is found globally except Antarctica. The answer should include transmission methods, hosts, diseases caused, and maybe the genome structure. I need to make sure to mention that while they're found in various animals, only rodent-borne ones affect humans. Also, note the two main syndromes they cause. Avoid including too much detail about specific regions unless necessary. Keep it concise but comprehensive based on the context provided.\n</think>\n\nHantavirus is a zoonotic virus primarily transmitted to humans through exposure to aerosols contaminated with excreta (urine, feces, saliva) of infected rodents, though rare cases may involve bites. It belongs to the Bunyaviridae family and has a tri-segmented RNA genome. Found worldwide except Antarctica, hantaviruses are carried by small mammals like rodents, insectivores, and bats",
      "retrieved_chunks": [
        "Title: Vaccines and Therapeutics Against Hantaviruses\nPassage: Hantavirus is a virus transmitted mainly by rodent animals, mainly through urine, feces, and saliva and the aerosols produced by them, but rarely by the bites of infected animals . In recent years, the infection rate of hantavirus has increased in China and Europe . Hantavirus disease has turned out to be a newly identified but not a \"new\" disease in Germany .",
        "Viruses of the genus Hantavirus are exceptions within the Bunyaviridae family, in being directly transmitted via aerosols ofsmall mammals excreta with no role for arthropod vectors . Although a growing diversity of hantaviruses has been discovered over the last decade in insectivores and bats , up to now, only rodent-borne hantaviruses have been shown at the origin of human diseases. Hantaviruses are small, enveloped viruses, possessing a tri-segmented RNA genome of\n\nTitle: Vaccines and Therapeutics Against Hantaviruses\nPassage: In recent years, the repeated outbreak of hantavirus disease has caused a serious threat to human health. The spread of hantavirus from natural hosts to humans is a natural ecological process; however, the outbreak of hantavirus is driven by striped field mouse population cycle dynamics and seasonal climate change . Title: Hantaviruses in the Americas and Their Role as Emerging Pathogens\nPassage: The main mechanism by which humans acquire hantavirus infection is by exposure to aerosols of contaminated rodent feces, urine, and saliva .",
        "In Asia, hantavirus infection by Hantan virus and Seoul virus targets mainly the human kidney and causes hemorrhagic fever with renal syndrome . In\n\nTitle: Complete Genome and Phylogeny of Puumala Hantavirus Isolates Circulating in France\nPassage: Hantaviruses are emerging zoonotic pathogens distributed worldwide except in Antarctica .",
        "There is a long history of human co-existence with rodents, raising questions about the apparent recent increases in hantavirus-related illnesses, especially HCPS.",
        "They may cause two severe pathologies in humans: hemorrhagic fever with renal syndrome and hantavirus cardiopulmonary syndrome ."
      ],
      "computed_relevance": 0.25,
      "computed_utilization": 0.25,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.65,
      "gt_utilization": 0.25,
      "gt_completeness": 0.38461538461538464,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 24,
      "dataset_id": "1031",
      "question": "How long is the protein Alpha-tubulin?",
      "ground_truth_answer": "The provided context doesn't contain information specifically about the length of the protein Alpha-tubulin. Therefore, it is not possible to determine the length of the protein Alpha-tubulin from the given passages.",
      "generated_response": "<think>\nOkay, let's try to figure out how long the Alpha-tubulin protein is based on the given context. The question is asking for the length of the protein, so I need to look through the provided information for any mention of length or related terms.\n\nLooking at the first context paragraph, it mentions variations in the length and mass of protein ranging between approximately 25% and 4.62 fold. But that seems to refer to variations, not the actual length. The rest of the context talks about experimental procedures like incubation, lysis buffer components, centrifugation speeds, and temperatures. There's a mention of a tubulin polymerization assay, but no specific length given.\n\nThe titles and passages from other studies don't mention Alpha-tubulin's length either. The titles are about different proteins (Tollip, Alpha-COPI, SGTA, phosphoproteomics) and their respective experiments. The passages describe PCR conditions, centrifugation speeds, etc., but nothing about the length of Alpha-tubulin.\n\nSince the context provided doesn't include any numerical data on the length of Alpha-tubulin, I can't derive the answer from the given information. The user might be expecting an answer based on general knowledge, but according to the instructions, I should only use the provided context. Therefore, the answer isn't present in the given context.\n</think>\n\nThe provided context does not specify the length of the Alpha-tubulin protein. The information given includes experimental procedures (e.g., incubation conditions, centrifugation parameters) and variations in protein length/mass (25% to 4.62-fold), but no numerical value for the actual length of Alpha-tubulin is stated. Additional data or external references would be required to answer this question. \n\nAnswer: The length of Alpha-tubulin is not explicitly provided in the given context.",
      "retrieved_chunks": [
        "These findings suggest a tendency of recurrent duplications and/ or insertions, as well as deletions evidenced by variations in the length and mass of protein ranging between approximately 25% and 4.62 fold, respectively.",
        "To separate polymerized from soluble tubulin, the cells were all incubated at 37uC for 5 min in the dark in hypotonic lysis buffer containing 5 mM paclitaxel, 10 mM Trichostatin-A , 1 mM MgCl2, 2 mM EGTA, 0.5% Nonidet P-40, 2 mM phenylmethylsulfonyl fluoride, 200 units/ml aprotinin, 100 mg/ml soybean trypsin inhibitor, 5.0 mM e-amino caproic acid, 1 mM benzamidine, and 20 mM Tris-HCl, pH 6.8, vortexed vigorously and centrifuged at ,15,000 g at 22uC for\n\nTitle: Tollip or Not Tollip: What Are the Evolving Questions behind It?",
        "Title: Alpha-COPI Coatomer Protein Is Required for Rough Endoplasmic Reticulum Whorl Formation in Mosquito Midgut Epithelial Cells\nPassage: at 10000 rpm for 10 min at 4uC.",
        "Title: Small Glutamine-Rich Tetratricopeptide Repeat-Containing Protein Alpha (SGTA) Ablation Limits Offspring Viability and Growth in Mice\nPassage: of 92 \u00b0C for 1 min, 58 \u00b0C for 1 min and 72 \u00b0C for 2 min; followed by final elongation at 72 \u00b0C for 10 min.",
        "Title: Quantitative Phosphoproteomics of Proteasome Inhibition in Multiple Myeloma Cells\nPassage: Tubulin polymerization assay was performed essentially as previously described ."
      ],
      "computed_relevance": 0.4,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.0,
      "gt_utilization": 0.0,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 25,
      "dataset_id": "721",
      "question": "What is the most common cause of viral gastroenteritis in children?",
      "ground_truth_answer": "The most common cause of viral gastroenteritis in children is rotavirus infection.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking for the most common cause of viral gastroenteritis in children. I need to look through the provided context to find the answer.\n\nFirst, looking at the first context titled \"Viruses Causing Gastroenteritis: The Known, The New and Those Beyond,\" the passage says, \"Rotavirus infection is the most common cause of viral gastroenteritis among children...\" That seems like a direct answer. But I should check the other contexts to make sure there's no conflicting information.\n\nThe second context mentions caliciviruses, specifically noroviruses, as the most important cause of epidemic non-bacterial gastroenteritis worldwide, affecting both adults and children. However, the question is specifically about children. The first context clearly states rotavirus as the most common in children. The third part of the same context also mentions astrovirus being important in young children and elderly, but the prevalence study in the UK found antibodies in 70% of five-year-olds. However, the key point here is that rotavirus is stated as the most common, while astrovirus accounts for about 10% of cases. \n\nAnother part of the context says that viral gastroenteritis is a major cause of mortality, especially in children in developing countries. The first passage directly answers the question by naming rotavirus. The other viruses mentioned (norovirus, astrovirus) are significant but not the most common. \n\nSo, putting it all together, the answer should be rotavirus.\n</think>\n\nThe most common cause of viral gastroenteritis in children is **rotavirus**. The context explicitly states that \"Rotavirus infection is the most common cause of viral gastroenteritis among children,\" while other viruses like norovirus and astrovirus are noted as significant contributors but not the primary cause in this demographic.",
      "retrieved_chunks": [
        "Title: Viruses Causing Gastroenteritis: The Known, The New and Those Beyond\nPassage: Rotavirus infection is the most common cause of viral gastroenteritis among children; however, parents of infected children also often become ill and as a result rotavirus is the second most common cause of gastroenteritis in adults . Studies in human volunteers have shown that infection with rotavirus causes diarrhea, results in shedding of the virus and a rise in antibody anti-virus titer after infection . Additionally, astroviruses infections are common, accounting for about 10% of all sporadic diarrhea cases . Astrovirus has been isolated from diseased people, filtrated and administered to healthy individuals after which in some of the volunteers\n\nTitle: Incubation periods of viral gastroenteritis: a systematic review\nPassage: Caliciviruses, in particular noroviruses, are the most important cause of epidemic, non-bacterial gastroenteritis worldwide, affect both adults and children, and account for 40 to 50% of all foodborne gastroenteritis in the United States . Title: Incubation periods of viral gastroenteritis: a systematic review\nPassage: Acute viral gastroenteritis is an important and often unappreciated cause of morbidity and mortality worldwide.",
        "Astrovirus has been found by several studies to be an important cause of acute gastroenteritis in young children; a prevalence study in the United Kingdom found that over 70% of five year-olds had antibodies to the virus . Astrovirus has also been cited as an important cause of gastroenteritis in elderly populations . Title: Viruses Causing Gastroenteritis: The Known, The New and Those Beyond\nPassage: Text: The gastrointestinal tract is a vulnerable organ for infections as there is constant contact with the outside, mainly via the oral route. Inflammation of the stomach and the intestines can cause nausea, vomiting and diarrhea.",
        "Gastroenteritis is responsible for two to three million deaths each year, making it one of the most common causes of mortality .",
        "While bacterial and parasitic gastrointestinal infections are declining as a result of proper disposal of sewage and safe drinking water, viral gastroenteritis is not declining in developing",
        "Mainly children in developing countries, but also immuno-compromised individuals in developed countries, suffer from diarrhea."
      ],
      "computed_relevance": 0.08333333333333333,
      "computed_utilization": 0.08333333333333333,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.15789473684210525,
      "gt_utilization": 0.15789473684210525,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 26,
      "dataset_id": "517",
      "question": "What is Reunion Island?",
      "ground_truth_answer": "Reunion Island is a French overseas department located in the southwestern Indian Ocean, between Madagascar and Mauritius. It has a population of 850,000 and benefits from a healthcare system similar to mainland France.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What is Reunion Island?\" and they provided several contexts from different studies.\n\nFirst, I need to look through the given passages to gather information about Reunion Island. The first context mentions that Reunion Island is a French overseas department in the southwestern Indian Ocean, 700 km east of Madagascar and 200 km southwest of Mauritius. Another passage refers to it as a French overseas territory with 850,000 inhabitants located between Madagascar and Mauritius in the Indian Ocean. So, it's a French territory, an island in the Indian Ocean, and has a population of around 850,000.\n\nAnother part of the context talks about influenza activity and vaccination campaigns, which might not be directly relevant to the question but could be background info. Also, there's mention of healthcare systems similar to mainland France and epidemiological surveillance. But the main question is about what Reunion Island is, so the key points are its status as a French overseas territory, its location relative to Madagascar and Mauritius, and maybe its population.\n\nI should check if there's any conflicting information. Both passages agree on the location and the French connection. The population is given as 850,000 in one of the contexts. Also, the name is spelled as \"R\u00e9union Island\" in one of the titles, but that's probably just a diacritic difference. The answer should include that it's a French overseas department/territory, located in the Indian Ocean between Madagascar and Mauritius, and maybe mention the population. Also, note that it's part of France, so the healthcare system is similar to France's. But the main answer should focus on the geographical and political status aspects.\n</think>\n\nR\u00e9union Island is a French overseas territory located in the southern hemisphere, specifically in the Indian Ocean between Madagascar and Mauritius. It is approximately 700 km east of Madagascar and 200 km southwest of Mauritius. With a population of around 850,000 inhabitants, the island operates under a healthcare system similar to mainland France and follows French public health surveillance practices. It is directly connected to Europe via daily flights to France despite its remote location.",
      "retrieved_chunks": [
        "Title: Pandemic Influenza Due to pH1N1/2009 Virus: Estimation of Infection Burden in Reunion Island through a Prospective Serosurvey, Austral Winter 2009\nPassage: Reunion Island is a French overseas department located in the southwestern Indian Ocean, 700 km east of Madagascar and 200 km southwest of Mauritius.",
        "Title: Etiology of Influenza-Like Illnesses from Sentinel Network Practitioners in R\u00e9union Island, 2011-2012\nPassage: R\u00e9union Island, a French overseas territory with 850,000 inhabitants, is located in the southern hemisphere between Madagascar and Mauritius in the Indian Ocean .",
        "pH1N1/2009v became the predominant circulating influenza virus within four weeks of its first detection, its activity peaked during week 35 and ended at week 38 . Contrary to initial fears, the health care system was not overwhelmed, as morbidity and mortality rates were lower\n\nTitle: Pandemic Influenza Due to pH1N1/2009 Virus: Estimation of Infection Burden in Reunion Island through a Prospective Serosurvey, Austral Winter 2009\nPassage: the population of Reunion Island and a Chi2 test was used to analyse differences in age, sex and geographic location.",
        "Influenza activity generally increases during austral winter, corresponding to summer in Europe . Since 2011, influenza vaccination campaign in Reunion Island starts in April and the vaccine used corresponds to World Health Organization recommendations for the southern\n\nTitle: Etiology of Influenza-Like Illnesses from Sentinel Network Practitioners in R\u00e9union Island, 2011-2012\nPassage: Despite the distance of 9,300 km between R\u00e9union and France, the island is directly connected to Europe with four daily flights to France.",
        "The island benefits from a healthcare system similar to mainland France and epidemiological surveillance has been developed by the regional office of the French Institute for Public Health Surveillance , based on the surveillance system of mainland France ."
      ],
      "computed_relevance": 0.2857142857142857,
      "computed_utilization": 0.2857142857142857,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.16666666666666666,
      "gt_utilization": 0.16666666666666666,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 27,
      "dataset_id": "729",
      "question": "What changes do viruses make to be unrecognizable to previously neutralizing antibodies?",
      "ground_truth_answer": "Viruses can make changes such as accumulation of point mutations on immunodominant regions, glycosylation of functionally pivotal residues, or association with host serum components in order to be unrecognizable to previously neutralizing antibodies.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking what changes viruses make to become unrecognizable to previously neutralizing antibodies. I need to base my answer on the provided context.\n\nFirst, looking at the first passage titled \"Neutralization Interfering Antibodies...\" It mentions that hypervariable viruses use mechanisms like accumulating point mutations in immunodominant regions of surface proteins. These mutations make the proteins unrecognizable to existing neutralizing antibodies. That's one change\u2014point mutations.\n\nAnother part of that same passage talks about other escape mechanisms, like glycosylation of important residues or associating with host serum components to mask them. Glycosylation adds sugars which might hide the viral proteins from the immune system. Also, cell-to-cell transmission is mentioned as a protected route, which might help the virus spread without being detected by antibodies in the bloodstream.\n\nThe second passage about EV71 vaccines mentions that different subgenogroups have viral proteins folded differently, affecting the exposure of neutralizing epitopes. So structural changes in protein folding could hide the epitopes that antibodies target.\n\nThe third passage discusses GAGs (glycosaminoglycans) as receptors or attachment factors. It says that changes in amino acids, like asparagine to tyrosine, might disrupt GAG binding. If the virus can't bind to GAGs as effectively, maybe that's another way to avoid immune detection, though the direct link to antibodies isn't clear here. But since GAGs can enhance viral attachment, disrupting that might be part of an escape strategy.\n\nPutting it all together, the main changes viruses make are point mutations in key regions, glycosylation to mask sites, altering protein structure to hide epitopes, and possibly modifying interactions with host components like GAGs. Also, cell-to-cell spread could bypass antibody responses. The answer should list these mechanisms as the changes viruses make to evade neutralizing antibodies.\n</think>\n\nViruses employ several strategies to evade recognition by previously neutralizing antibodies, as outlined in the provided context:  \n\n1. **Point Mutations in Immunodominant Regions**: Accumulation of mutations in surface proteins (e.g., immunodominant regions) alters their structure, rendering them unrecognizable to existing neutralizing antibodies.  \n2. **Glycosylation of Key Residues**: Adding sugar molecules to functionally critical sites on viral proteins can mask these regions from antibody detection.  \n3. **Association",
      "retrieved_chunks": [
        "This, hence, would lead to the differences in the amount of universal neutralizing antibodies produced, translating to the different neutralizing capacity observed. Title: Neutralization Interfering Antibodies: A \u201cNovel\u201d Example of Humoral Immune Dysfunction Facilitating Viral Escape?",
        "Title: Neutralization Interfering Antibodies: A \u201cNovel\u201d Example of Humoral Immune Dysfunction Facilitating Viral Escape? Passage: Text: Hypervariable viruses adopt several mechanisms to cope with the host humoral immune response.",
        "The most studied mechanism is the accumulation of point mutations on immunodominant regions of surface proteins, making them no longer recognizable by previously generated neutralizing antibodies . Other escape mechanisms involving surface proteins include glycosylation of functionally pivotal residues or their association with host serum components in order to mask them from the immune system . Other known escape mechanisms are a sort of protected route of virus spreading, such as cell-to-cell transmission ; the molecular mimicry between viral proteins and host self-antigens or the viral-induced\n\nTitle: Recent Progress towards Novel EV71 Anti-Therapeutics and Vaccines\nPassage: With the viral proteins being folded differently, the degree of exposure of these neutralizing epitopes is different among the subgenogroups.",
        "Title: Emergence of a Large-Plaque Variant in Mice Infected with Coxsackievirus B3\nPassage: Many viruses attach to cells by binding HS or other GAGs . For some viruses, GAGs are bona fide receptors. Other viruses have nonglycan proteinaceous receptors, but binding to GAGs can enhance attachment. GAGs most commonly interact with viral particles via positively charged amino acids such as lysine or arginine .",
        "It is possible that a change from asparagine to tyrosine disrupts GAG binding to a nearby site on the viral capsid or that noncanonical GAG-capsid interactions occur."
      ],
      "computed_relevance": 0.3333333333333333,
      "computed_utilization": 0.3333333333333333,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.21052631578947367,
      "gt_utilization": 0.10526315789473684,
      "gt_completeness": 0.5,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 28,
      "dataset_id": "1686",
      "question": "What strains were included in  this study?",
      "ground_truth_answer": "The strains included in this study were Detrick 1, Detrick 2, 1013, NRS-356, and the first seven BG strains listed in Table 1.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking which strains were included in the study. I need to look through the provided context to find any mentions of specific strains.\n\nFirst, in the context under section B, it mentions \"each of the six test strains as compared to the 1942 strain.\" So there are six test strains plus the 1942 strain. Wait, but the question is about the strains included in the study, so maybe the six test strains and the 1942 strain?\n\nLooking at the passage under \"globigii, a Historical Biowarfare Simulant,\" it says \"the strains sequenced for this study.\" Then in the next paragraph, it lists \"Detrick 1, Detrick 2, and 1013 strains.\" Also, there's a mention of \"NRS-356 variant.\" \n\nThe passage also states that two biological replicates were done for each strain. So the strains would be the six test strains (which include Detrick 1, Detrick 2, 1013, and NRS-356) plus the 1942 strain as a reference. Wait, the first part says \"six test strains as compared to the 1942 strain.\" So the 1942 is the reference, and the six test strains are the others. The test strains mentioned are Detrick 1, Detrick 2, 1013, and NRS-356. But there are six test strains total. The context only lists four here. Hmm, maybe there are two more not mentioned in the provided text? But the user's context is limited to the given passages. The answer should include all the strains mentioned. The question is about the study's strains, so the six test strains and the 1942. But the user's context only explicitly names Detrick 1, Detrick 2, 1013, and NRS-356. Wait, the first part says \"six test strains,\" but the passage only lists four. However, the user's context might not have the full list. Since the user is providing the context, I can only use what's given. The answer should include the strains mentioned: Detrick 1, Detrick 2, 1013, NRS-356,",
      "retrieved_chunks": [
        "B) Most significant phenotypes for each of the six test strains as compared to the 1942 strain.",
        "globigii, a Historical Biowarfare Simulant\nPassage: the strains sequenced for this study.",
        "globigii, a Historical Biowarfare Simulant\nPassage: Streaks of Detrick 1, Detrick 2, and 1013 strains were grown for two days on TSA plates containing SBA.Bacterial cell mass was scraped using an inoculating loop from the streak and resuspended in PBS.",
        "Given the lack of original records, it is unclear whether the NRS-356 variant in this study might have passed through Camp Detrick and been returned to the University of Wisconsin.",
        "Two biological replicates of the experiment were conducted for each strain."
      ],
      "computed_relevance": 0.4,
      "computed_utilization": 0.4,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.2222222222222222,
      "gt_utilization": 0.1111111111111111,
      "gt_completeness": 0.5,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 29,
      "dataset_id": "331",
      "question": "Which patients were excluded from the study?",
      "ground_truth_answer": "Patients excluded from the study were those who were unwilling or unable to give consent, under 18 yrs of age, pregnant, with advanced directive to withhold or withdraw life-sustaining treatment, admitted for palliative care only, and not eligible for enrolment. Additionally, studies in homogeneous PICU populations reporting diagnosis-related outcome in particular but not intensive care treatment, and studies evaluating mortality only, were also excluded.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking which patients were excluded from the study. The context provided includes two different passages. The first one is from the GenOSept cohort study about community-acquired pneumonia in ICU patients. The second passage is about pediatric ICU survivors.\n\nFirst, I need to focus on the GenOSept study since the question is about excluded patients. The first passage mentions exclusion criteria: patients or legal representatives unwilling or unable to give consent, under 18, pregnant, or those with advanced directives for life-sustaining treatment or admitted for palliative care only. \n\nThe second passage talks about excluding studies, not patients. It's about excluding certain types of studies from a review, like those focusing on diagnosis-related outcomes or mortality only. But the question is about patients excluded from the study, so this part might not be relevant here.\n\nWait, the user's question is about which patients were excluded. The answer should come from the first passage's exclusion criteria. Let me check again. The first passage under the GenOSept study lists the exclusion criteria. The second passage is a different study (pediatric ICU survivors) and excludes different things, but the question is about the GenOSept study. \n\nSo the answer should list the patients excluded from the GenOSept study: those who couldn't give consent, under 18, pregnant, had advanced directives, or were admitted for palliative care. I need to make sure I don't mix up the two different studies mentioned. The second passage's exclusions are about studies, not patients. So the correct answer is the list from the first passage.\n</think>\n\nThe patients excluded from the GenOSept cohort study (on community-acquired pneumonia in European intensive care units) were:  \n1. Patients or their legal representatives unwilling or unable to provide consent.  \n2. Patients under 18 years of age.  \n3. Pregnant patients.  \n4. Patients with advanced directives to withhold or withdraw life-sustaining treatment.  \n5. Patients admitted for palliative care only.  \n\nThe second passage (on pediatric ICU survivors) excluded studies, not patients, and is unrelated to the exclusion criteria for the GenOSept cohort.",
      "retrieved_chunks": [
        "Firstly participating centres were at liberty to decide which patients they would enrol; subjects were not, therefore, enrolled consecutively, thereby introducing a potential for selection bias. Also there was considerable variation in the number of patients recruited in each country and some centres contributed only small numbers of patients.",
        "Title: Patients with community acquired pneumonia admitted to European intensive care units: an epidemiological survey of the GenOSept cohort\nPassage: This study has two important limitations.",
        "Title: Patients with community acquired pneumonia admitted to European intensive care units: an epidemiological survey of the GenOSept cohort\nPassage: Exclusion criteria were as follows: patient or legal representative unwilling or unable to give consent; patient under 18 yrs of age; patient pregnant; advanced directive to withhold or withdraw life-sustaining treatment or admitted for palliative care only . Title: Outcome of paediatric intensive care survivors\nPassage: Excluded were: studies in homogeneous PICU populations reporting diagnosis-related outcome in particular but not intensive care treatment as such, and studies evaluating mortality only.",
        "Nevertheless there was a wide range of ages, severity of physiological derangement and co-morbidities, whereas APACHE II scores and ventilation rates were similar to previous studies, suggesting that a significant, systematic selection bias is unlikely.",
        "Secondly, microbiological protocols were not standardised."
      ],
      "computed_relevance": 0.14285714285714285,
      "computed_utilization": 0.14285714285714285,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.15384615384615385,
      "gt_utilization": 0.15384615384615385,
      "gt_completeness": 1.0,
      "gt_adherence": 0.0,
      "binary_pred": 1,
      "binary_gt": 0,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 30,
      "dataset_id": "1287",
      "question": "In addition to oral swabs, which tests detected the presence of 2019-nCOV virus?",
      "ground_truth_answer": "In addition to oral swabs, blood and anal swabs were used to detect the presence of 2019-nCoV virus.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking which tests, in addition to oral swabs, detected the presence of 2019-nCoV virus based on the provided context.\n\nFirst, I need to go through each passage carefully. The first context mentions that they tested anal swabs and blood along with oral swabs. The second passage says they collected blood, oral swabs, and anal swabs for qPCR tests. They found viral RNA in anal swabs and blood. Also, there's a mention of viral RNA in stool samples inferred from anal swab results and a case in the US. However, they didn't collect stool samples themselves. \n\nAnother part of the context talks about viral antibodies being present in nearly all patients, suggesting serology (antibody tests) should be considered. The last part mentions a possible shift from oral to anal swab positivity over time and recommends using IgM and IgG serological tests for confirmation.\n\nSo, putting this together: the tests that detected the virus besides oral swabs are anal swabs, blood tests (qPCR), and serological tests (IgM/IgG). The stool samples weren't collected, but the presence of virus in stool is inferred from anal swabs. The key here is to list the actual tests that were used and confirmed. The answer should include anal swabs, blood, and serology (antibodies).\n</think>\n\nIn addition to oral swabs, the presence of 2019-nCoV was detected using **anal swabs** and **blood tests (qPCR)**. The study also highlighted the importance of **serological tests** (viral IgM and IgG antibodies) for confirming infection, as viral RNA could persist in anal swabs even after oral swabs tested negative, and serology provided more reliable results. Stool samples were not directly collected, but viral RNA was inferred to be present based on anal swab findings.",
      "retrieved_chunks": [
        "Title: Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes\nPassage: Like SARS-CoV, 2019-nCoV induced pneumonia through respiratory tract by clinical observation. Therefore, the presence of viral antigen in oral swabs was used as detection standard for 2019-nCoV. Similarly, two times of oral swabs negative in a 24-h interval was considered as viral clearance by patients officially. Title: Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes\nPassage: In the first investigation, we aimed to test whether viral positive can be found in anal swab and blood as well as oral swabs. We conducted a molecular investigation to patients in Wuhan pulmonary hospital, who were detected as oral swabs positive for 2019-nCoV upon admission. We collected blood, oral swabs and anal swabs for 2019-nCoV qPCR test using previously established method . Title: Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity\nPassage: Unfortunately, in our study, we did not collect stool samples from patients and did not pursue viral RNA in the stool. But we believe the existence of virus RNA in the stool samples from these patients because that a large amount of viral RNA was detected in anal swabs and that viral RNA had also been detected in a case reported from the United States .",
        "Also, we didn't collect sputum and bronchoalveolar lavage fluid for virus detection because that the dry coughing characteristic of patients infected with 2019-nCoV prevents producing enough amount of sputum and that bronchoalveolar lavage fluid\n\nTitle: Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes\nPassage: through routine surveillance, and thus pose a threat to other people. In contrast, we found viral antibodies in near all patients, indicating serology should be considered for 2019-nCoV epidemiology.",
        "A possible shift from oral positive during early infection to anal swab positive during late infection can be observed. This observation implied that we cannot discharge a patient purely based on oral swabs negative, who may still shed the virus by oral-fecal route. Above all, we strongly suggest using viral IgM and IgG serological test to confirm an infection, considering the unreliable results from oral swabs detection."
      ],
      "computed_relevance": 0.5384615384615384,
      "computed_utilization": 0.7692307692307693,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.3333333333333333,
      "gt_utilization": 0.2777777777777778,
      "gt_completeness": 0.8333333333333334,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 31,
      "dataset_id": "543",
      "question": "How many people were affected as of Feb. 10, 2020?",
      "ground_truth_answer": "The given pieces of context do not provide information on the number of people affected as of Feb. 10, 2020. Therefore, we cannot answer the question based on the provided context. We would need additional information to determine the number of people affected as of that specific date.",
      "generated_response": "<think>\nOkay, let's see. The user is asking how many people were affected as of February 10, 2020. The context provided includes several passages from documents titled \"Estimating the number of infections and the impact of non-\" which probably refers to non-pharmaceutical interventions during a pandemic, like the measures taken during COVID-19.\n\nLooking at the passages, the first one mentions that interventions in 11 countries averted 59,000 deaths up to March 31. The other passages list specific measures like banning gatherings of more than 5 people starting October 3, 2020, ordering no in-person teaching until April 4, 2020, and nationwide school closures on March 14, 2020. \n\nThe question is about February 10, 2020. The earliest date mentioned in the context is March 14, 2020, with school closures. There's no data provided about the number of infections or deaths before March 14. The 59,000 deaths averted up to March 31 is a cumulative figure, but it doesn't specify the number as of February 10. Since the context doesn't include any information about the situation before March 2020, there's no way to determine the number of affected people in February. The answer would have to be that the information isn't available in the provided context.\n</think>\n\nThe provided context does not include any data or estimates related to the number of people affected as of February 10, 2020. The earliest information mentioned in the context refers to interventions and their impacts starting in March 2020. Therefore, it is not possible to determine the number of affected individuals as of February 10, 2020, based on the given passages. \n\nAnswer: The context does not provide information about the number of people affected as of February 10, 2020.",
      "retrieved_chunks": [
        "Title: Estimating the number of infections and the impact of non-\nPassage: estimate that interventions across all 11 countries will have averted 59,000 deaths up to 31 March\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: banned Banning of gatherings of more than 5 people.21 10/3/2020\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: ordered No in person teaching until 4th of April.52 14/3/2020\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: ordered Nationwide school closures.23 14/3/2020"
      ],
      "computed_relevance": 0.0,
      "computed_utilization": 1.0,
      "computed_completeness": 0.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.0,
      "gt_utilization": 0.0,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 32,
      "dataset_id": "1069",
      "question": "How many genotypes of CHIKV have been isilated?",
      "ground_truth_answer": "Three genotypes of CHIKV have been isolated: Asian, East/Central/South African, and West African.",
      "generated_response": "<think>\nOkay, let's see. The question is asking how many genotypes of CHIKV have been isolated. I need to look through the provided context to find the answer.\n\nFirst, in the first passage, it says, \"CHIKV has been isolated into three genotypes based on phylogenetic studies.\" That seems like a direct answer. Then later, there's a mention of the Asian genotype, West African, and East/Central/South African genotypes. So that's three genotypes. \n\nAnother part of the context lists them again: \"These genotypes, based on the gene sequences of an Envelope protein, are Asian, East/Central/South African, and West African.\" Yep, that's three. \n\nI don't see any other numbers mentioned regarding genotypes. The answer should be three. Let me double-check to make sure there's no conflicting information. The rest of the text talks about mutations, epidemics, and experiments, but nothing about more genotypes. So the answer is three.\n</think>\n\nThe context states that CHIKV has been isolated into three genotypes based on phylogenetic studies and further specifies them as Asian, East/Central/South African, and West African. \n\n**Answer:** 3",
      "retrieved_chunks": [
        "Passage: CHIKV has been isolated into three genotypes based on phylogenetic studies.",
        "Comparing mutant spectra of CHIKV isolates from ankles by specific nucleotide substitution frequencies, the only significant differences from the WT were greater frequencies of A\u03feC and G\u03feU substitutions in LoFi CHIKV populations .",
        "estimate that the Asian genotype of CHIKV emerged between 50 and 310 y ago, and the West and East African genotypes diverged between 100 and 840 y ago . Since then, CHIKV has come a long way, with several mutations incorporated, and has continued to wreak epidemics in several regions. Recent activities of CHIKV include the Indian epidemic in 2005-2006, which was\n\nTitle: Genome-Wide Analysis of Codon Usage and Influencing Factors in Chikungunya Viruses\nPassage: The complete genome sequences of 141 CHIKV isolates were obtained from the National Center for Biotechnology GenBank database . The accession numbers and other detailed information of the selected CHIKVs' genomes, such as isolation date, isolation place, host and genome size were also retrieved . Title: Chikungunya Virus Fidelity Variants Exhibit Differential Attenuation and Population Diversity in Cell Culture and Adult Mice\nPassage: preinoculation.",
        "These genotypes, based on the gene sequences of an Envelope protein , are Asian, East/Central/ South African, and West African .",
        "Numbers of feet per group were the following: for CHIKV cohorts 1 to 3 dpi, n \u03ed 32; 4 to 9 dpi, n \u03ed 20; 10 to 11 dpi, n \u03ed 8; for the mock-inoculated group, 1 to 3 dpi, n \u03ed 16; 4 to 9 dpi, n \u03ed 10; 10 to 11 dpi, n \u03ed 4."
      ],
      "computed_relevance": 0.2222222222222222,
      "computed_utilization": 0.2222222222222222,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.09523809523809523,
      "gt_utilization": 0.09523809523809523,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 33,
      "dataset_id": "740",
      "question": "What is the regularity of the virion major coat protein lattice useful for?",
      "ground_truth_answer": "The regularity of the virion major coat protein lattice is useful for the development of an ELISA for testing specific antibodies of clinical pig serum, and it is a valuable tool to monitor the prevalence of the PCV3 virus.",
      "generated_response": "<think>\nOkay, let's see. The question is asking about the regularity of the virion major coat protein lattice and what it's useful for. The context provided is about PCV3 and its capsid protein forming virus-like particles (VLPs). \n\nFirst, I need to recall what a virion's coat protein lattice does. The coat proteins form the structure of the virus, right? They protect the genetic material and are involved in host cell interaction. The regularity here probably refers to the organized, repeating structure of these proteins.\n\nLooking at the context, the passage mentions that VLPs are self-assembled from viral structural proteins without genetic material. The study shows that PCV3's Cap protein (from ORF2) can self-assemble into VLPs. The application mentioned is for antibodies detection. Also, VLPs are used in vaccines because they're safe and can be produced at scale.\n\nSo, the regularity of the coat protein lattice (the structured arrangement) would be important for the self-assembly into VLPs. Since the Cap protein forms a regular lattice, this structure allows the proteins to come together properly to form the VLPs. This regular structure is necessary for the VLPs to mimic the real virus, which is crucial for their use in vaccines and antibody detection. The regular lattice ensures that the VLPs have the correct morphology and immunogenic properties, making them effective for diagnostic and vaccine purposes.\n\nThe answer should tie the regular lattice's role in self-assembly and its application in creating VLPs for antibodies detection and vaccines. The context also mentions that 10 nm particles are a standard, so the regularity helps in forming consistent particles. Therefore, the regularity is useful for the self-assembly process and the functional applications of VLPs.\n</think>\n\nThe regularity of the virion major coat protein lattice is useful for the **self-assembly of virus-like particles (VLPs)** and their application in **antibody detection and vaccine development**. The structured, repeating arrangement of the coat protein (e.g., PCV3's Cap protein) enables the formation of stable, uniform VLPs that mimic the native viral structure. This regularity ensures reproducible morphology (e.g., ~10 nm particles) and immunogenic properties, making VLPs safe, scalable, and effective for diagnostic tools and vaccines compared to traditional viral materials.",
      "retrieved_chunks": [
        "Similar to PCV2, there are two major open reading frames , ORF1 and ORF2, in PCV3 genome. ORF2 encode the immunogenic Cap which is the sole structural protein of the viral coat .",
        "Title: Self-assembly into virus\u2013like particles of the recombinant capsid protein of porcine circovirus type 3 and its application on antibodies detection\nPassage: of factors including storage conditions as well as the process design also influence the characteristics of VLPs . 10 nm particles can be used as a preliminary evaluation standard before the real virus morphology of PCV3 is discovered. Title: Self-assembly into virus\u2013like particles of the recombinant capsid protein of porcine circovirus type 3 and its application on antibodies detection\nPassage: VLPs, composed of viral structural proteins without genetic materials, are self-assembled macromolecules.",
        "In recent years, the technology of expressing capsid protein\n\nTitle: Self-assembly into virus\u2013like particles of the recombinant capsid protein of porcine circovirus type 3 and its application on antibodies detection\nPassage: of PCV2 and self-assembly into virus-like particles has advanced, and can be used in multiple recombinant protein expression systems including baculovirus, yeast and E.",
        "Whether the idea of forming recombinant Cap into VLPs is equally applicable to PCV3 is the main purpose in our research. Title: Self-assembly into virus\u2013like particles of the recombinant capsid protein of porcine circovirus type 3 and its application on antibodies detection\nPassage: In conclusion, this is the first report of the ability of PCV3 VLPs to self-assemble which were successfully expressed in E.",
        "VLPs provide more safety in use and the possibility of large scale production of vaccines with reproducible high quality results compared with traditional live-attenuated or inactivated virus vaccines . Some VLPs, such as Hepatitis B surface antigen VLPs, human papillomavirus VLPs and Malaria VLPbase vaccines have already been clinically used for the prevention of infectious diseases ."
      ],
      "computed_relevance": 0.4,
      "computed_utilization": 0.7,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.3157894736842105,
      "gt_utilization": 0.10526315789473684,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 34,
      "dataset_id": "1077",
      "question": "What are exhibited in the two phases?",
      "ground_truth_answer": "The RNA is exhibited in the bottom, complex-enriched phase in one of the two phases.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What are exhibited in the two phases?\" based on the provided context.\n\nFirst, I need to look at the context given. The title mentions \"Rapid RNA Exchange in Aqueous Two-Phase System and Coacervate Droplets.\" The passage talks about coacervate samples with a labeled RNA 15-mer. On the left, the system separates into two phases with RNA in the bottom, complex-enriched phase. On the right, there are small, dispersed droplets in a turbid solution. Another part mentions Valap and salt concentrations affecting the system.\n\nSo, the key here is understanding what the two phases are. The left side describes a two-phase system where RNA is in the bottom phase, which is complex-enriched. The right side has small droplets in bulk solution. The question is about what's exhibited in the two phases. The answer should relate to the RNA distribution. The left has RNA in the bottom phase, and the right has dispersed droplets. But the question is about the two phases in general. The passage also mentions that at higher salt concentrations, the system tends to become one phase again. \n\nWait, the question is specifically about what is exhibited in the two phases. The answer should be the RNA in the complex-enriched phase and the other phase. The left image shows two phases with RNA in the bottom, and the right has dispersed droplets. But the two phases in the system would be the complex-enriched phase (containing RNA) and the other aqueous phase. So the two phases exhibit RNA in the complex-enriched phase and the other phase without RNA. The answer should mention the RNA being in the complex-enriched phase and the other phase. The answer given in the example is \"RNA in the complex-enriched phase and the other aqueous phase.\" That makes sense. Let me confirm the context again. The left part says \"the system clearly separates into two phases with the RNA in the bottom, complex-enriched phase.\" So the two phases are the complex-enriched (with RNA) and the other aqueous phase. The answer should reflect that.\n</think>\n\nThe two phases exhibit **RNA in the complex-enriched phase** (bottom phase) and **the other aqueous phase** (top phase). The system separates such that the RNA is concentrated in the complex",
      "retrieved_chunks": [
        "Title: Rapid RNA Exchange in Aqueous Two-Phase System and Coacervate Droplets\nPassage: to be:\n\nTitle: Rapid RNA Exchange in Aqueous Two-Phase System and Coacervate Droplets\nPassage: coacervate samples with 5 \u00b5M 5\u2032-6-FAM-labeled RNA 15-mer at room temperature in 100 mM Tris-Cl pH 8. On the left, the system clearly separates into two phases with the RNA in the bottom, complex-enriched phase.",
        "Slides were observed either with a confocal microscope or with a Nikon TE2000 inverted fluorescence microscope with a 100\u00d7 oil objective.",
        "On the right, the system is composed of small, dispersed complex-enriched droplets in bulk aqueous solution and resulted in a turbid solution.",
        "Title: Rapid RNA Exchange in Aqueous Two-Phase System and Coacervate Droplets\nPassage: the corners with Valap, and evaporation was allowed to occur through the edges over several hours.",
        "At increasing salt concentrations, the charge interactions between the pLys and ATP are disrupted and the system starts to tend towards a one-phase system again."
      ],
      "computed_relevance": 0.3333333333333333,
      "computed_utilization": 0.3333333333333333,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.13333333333333333,
      "gt_utilization": 0.06666666666666667,
      "gt_completeness": 0.5,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 35,
      "dataset_id": "1649",
      "question": "Which virus samples  from the 1918 swine flu pandemic have been identified?",
      "ground_truth_answer": "The H1N1 virus samples from the 1918 swine flu pandemic have been identified.",
      "generated_response": "<think>\nOkay, let's try to figure out the answer to the question: \"Which virus samples from the 1918 swine flu pandemic have been identified?\" \n\nFirst, I need to look through the provided context to find relevant information. The context includes several passages from different titles. Let me go through each one step by step.\n\nStarting with the first passage: It mentions that two years later, the H1N1 virus was isolated from humans. Also, sera from humans infected with the 1918 pandemic virus could neutralize the swine virus. The title here is \"1918 Influenza: the Mother of All Pandemics.\" So this suggests that the H1N1 virus is related to the 1918 pandemic. But the question is about swine flu samples from the 1918 pandemic. The first passage talks about the virus being isolated from humans, not swine yet.\n\nNext, the second passage under the title \"Origins of the 1918 Pandemic: Revisiting the Swine 'Mixing Vessel' Hypothesis\" says that there were simultaneous outbreaks in humans and pigs in 1918. Koen noted that it was a novel disease in pigs, implying human-to-swine transmission. Then it mentions that in 1931, Richard Shope isolated the first influenza virus from pigs. However, the question is about samples from the 1918 pandemic. The passage also states that the sequence data from the earliest human samples of 1918 H1N1, 1957 H2N2, and 1968 H3N2 viruses have segments almost entirely avian-like. So the 1918 H1N1 is mentioned here as being from humans.\n\nAnother part of the same title says that the low uracil content of the 1918 virus doesn't rule out a brief circulation in pigs before humans. But again, the main samples discussed are from humans. The passage also mentions that the 1918 virus's genes have avian origins, based on reconstructions from Alaskan permafrost samples. \n\nThe third passage under the same title talks about the difficulty in ruling out a role for swine due to lack of sequence data from that time. But again, the focus is on human samples. \n\nSo putting this together: The",
      "retrieved_chunks": [
        "Two years later, the H1N1 virus was isolated from humans . It was later demonstrated that sera from humans infected with the 1918 pandemic virus could neutralize the swine virus . Title: 1918 Influenza: the Mother of All Pandemics\nPassage: Because the only 1918 pandemic Virus samples we have\n\nTitle: Origins of the 1918 Pandemic: Revisiting the Swine \u201cMixing Vessel\u201d Hypothesis\nPassage: The simultaneous outbreaks of influenza in humans and pigs during the 1918 pandemic naturally raised questions about whether the virus had transmitted from pigs to humans, or humans to pigs. At the time, Koen noted that the flu outbreaks appeared to represent a novel disease in pigs, whereas humans had a long history of influenza pandemics, which suggested that humanto-swine transmission was more likely.",
        "The low uracil content of the 1918 virus does not preclude the possibility that a pandemic virus circulated in pigs briefly before transmitting to humans, but it\n\nTitle: Origins of the 1918 Pandemic: Revisiting the Swine \u201cMixing Vessel\u201d Hypothesis\nPassage: coincidence if not suggesting a close relation between the two conditions\" . Confirmation that influenza was circulating in US swine was achieved in 1931 when Richard Shope isolated the first influenza virus from pigs .",
        "However, the sequence data available from the earliest human samples of 1918 H1N1 viruses, 1957 H2N2 viruses, and 1968 H3N2 viruses indicate that all 3 pandemic viruses have segments almost entirely avianlike in their nucleotide composition .",
        "Title: Origins of the 1918 Pandemic: Revisiting the Swine \u201cMixing Vessel\u201d Hypothesis\nPassage: The low availability of sequence data from influenza viruses circulating in humans, swine, or birds at the time of the 1918, 1957, or 1968 pandemics makes it difficult to conclusively rule out a role for swine.",
        "Almost a century later, the reconstruction of a 1918 virus from human tissues preserved in Alaskan permafrost and autopsy blocks indicated that the virus's genes appeared to have avian origins ."
      ],
      "computed_relevance": 0.4444444444444444,
      "computed_utilization": 0.5555555555555556,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.3125,
      "gt_utilization": 0.1875,
      "gt_completeness": 0.6,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 36,
      "dataset_id": "1449",
      "question": "What are both IFV and RSV infections shown to do?",
      "ground_truth_answer": "Both IFV and RSV infections are shown to trigger cytokine responses and affect immune responses.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking what both IFV and RSV infections are shown to do, based on the provided context. First, I need to recall what the context says about these infections.\n\nLooking at the context, the main focus is on RSV (Respiratory Syncytial Virus) and mentions RLRs (RIG-I-like receptors) and their regulation during RSV infection. There's also a mention of LIF (Leukemia Inhibitory Factor) protecting the lungs during RSV. The second passage talks about cytokines released during RSV and the role of RLRs and Trif pathways. \n\nWait, the question is about both IFV and RSV. But the context provided doesn't mention IFV (Influenza Virus) at all. The only part that comes close is the last sentence in the second passage: \"The generalizability of these findings are limited, however, by the lack of a relevant animal model for influenza and RSV superinfection.\" So here, influenza (IFV) and RSV are mentioned in the context of superinfection, but the main discussion is about RSV. \n\nThe user's question is asking what both IFV and RSV infections are shown to do. Since the context doesn't discuss IFV's effects beyond that one sentence, maybe the answer is related to superinfection? The sentence says that the findings' generalizability is limited because there's no good animal model for influenza and RSV superinfection. But does that mean that both viruses are involved in superinfection scenarios? \n\nAlternatively, maybe the answer is inferred from the context where RSV is discussed in terms of immune responses, and IFV is mentioned in the same context of superinfection. However, without more information on IFV's specific actions, it's tricky. The key part here is that the context does not provide direct information about IFV's effects beyond the mention of superinfection. Therefore, the answer might be that both are involved in superinfection scenarios where the immune response is complex, but the context doesn't state that they both do something specific. \n\nWait, the user's question is phrased as \"What are both IFV and RSV infections shown to do?\" The answer must be something that both are shown to do in the context. Since the context only discusses RSV in detail and mentions IFV in the",
      "retrieved_chunks": [
        "as compared to challenge with RSV .",
        "when compared to the levels observed following RSV challenge .",
        "Title: Leukemia inhibitory factor protects the lung during respiratory syncytial viral infection\nPassage: which may allow RSV to induce RLRs. Our study observed early cytokine responses following RSV infection and identified a pronounced RIG-I response, which could be lost over time following NS1 or NS2 binding to RIG-I/ MDA5 as reported by others . Also, RSV induction of TLR3 is regulated by RIG-I-dependent IFN-\u03b2 secretions from infected epithelial cells, which is mediated by both IFN response-stimulated element and signal transducer and activator of transcription sites in its proximal promoter . Therefore there are multiple levels of RLRs regulation in RSV infections that can both trigger RLRs responses or subsequently adapt to block RLR-mediated\n\nTitle: Leukemia inhibitory factor protects the lung during respiratory syncytial viral infection\nPassage: To our knowledge, these findings represent the first evidence that MIF, LIF, CTAK/CCL27, SDF-1\u03b1/CXCL12, SCGF-\u03b2 and SCF are expressed during an RSV infection and LIF signaling is critical to prevent lung damage. Others and we demonstrate that a spectrum of cytokines is released to counter RSV infection 34 ] but further analysis is required to determine the role of these immune responses in RSV pathology. The results of this study demonstrate that RLRs and Trif signaling pathways play major roles in the immune response to RSV infection for both inflammation induction and resolution.",
        "For instance, the decrease in type I IFN by prior vaccination may reduce its potential adverse effect of increasing the susceptibility to secondary bacterial infections .",
        "The generalizability of these findings are limited, however, by the lack of a relevant animal model for influenza and RSV superinfection."
      ],
      "computed_relevance": 0.1,
      "computed_utilization": 0.5,
      "computed_completeness": 0.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.47619047619047616,
      "gt_utilization": 0.2857142857142857,
      "gt_completeness": 0.6,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 37,
      "dataset_id": "303",
      "question": "What statistical tests were used to compare categorical variables?",
      "ground_truth_answer": "The statistical tests used to compare categorical variables were the Chi-square test and the Fisher exact test.",
      "generated_response": "<think>\nOkay, let's see. The question is asking which statistical tests were used to compare categorical variables based on the provided context.\n\nFirst, I need to go through the context carefully. The context mentions several statistical tests. Let me break it down sentence by sentence.\n\nThe first sentence says, \"We used t tests to compare continuous variables.\" So t-tests are for continuous variables here. Then the next sentence: \"Chi-square tests were used to compare frequencies of demographic and other categorical variables for the three waves.\" Oh, here it's talking about chi-square tests for categorical variables. So that's one test.\n\nThen the next part: \"All variables were tested for normal distributions by using the Kolmogorov-Smirnov test. The Student t test was used for comparing the means of continuous variables with a normal distribution and the Mann-Whitney U test was used for the remaining variables.\" This part is about continuous variables again. The t-test is for normally distributed continuous variables, and Mann-Whitney for non-normal. But the question is about categorical variables, so maybe not relevant here.\n\nNext sentence: \"Chi-squared analysis and Fisher exact test were used to compare categorical variables with powder contamination.\" So here, they mention both chi-squared and Fisher's exact test for categorical variables related to powder contamination. So that's two tests.\n\nThen the last part: \"Non-parametric tests, including the Wilcoxon and Kruskal Wallis tests were used to compare continuous variables such as age and time between illness onset and other dates of interest.\" Again, these are non-parametric tests for continuous variables, not categorical.\n\nSo putting it all together, the tests mentioned for categorical variables are the chi-square test and the Fisher exact test. The first sentence mentioned chi-square tests for categorical variables, and the fourth sentence added Fisher exact test as well. The question is specifically about categorical variables, so the answer should include both chi-square and Fisher exact tests.\n</think>\n\nThe statistical tests used to compare categorical variables were **chi-square tests** and **Fisher exact tests**. The context explicitly states that chi-square tests were used for categorical variables (e.g., demographic frequencies), and Fisher exact tests were specifically applied for categorical variables related to powder contamination.",
      "retrieved_chunks": [
        "We used t tests to compare continuous variables.",
        "Chi-square tests were used to compare frequencies of demographic and other categorical variables for the three waves.",
        "All variables were tested for normal distributions by using the Kolmogorov-Smirnov test. The Student t test was used for comparing the means of continuous variables with a normal distribution and the Mann-Whitney U test was used for the remaining variables.",
        "Chi-squared analysis and Fisher exact test were used to compare categorical variables with powder contamination.",
        "Non-parametric tests, including the Wilcoxon and Kruskal Wallis tests were used to compare continuous variables such as age and time between illness onset and other dates of interest."
      ],
      "computed_relevance": 0.3333333333333333,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.19047619047619047,
      "gt_utilization": 0.19047619047619047,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 38,
      "dataset_id": "834",
      "question": "What is the the primary means for diagnosing the new virus strain?",
      "ground_truth_answer": "The primary means for diagnosing the new virus strain is real time RT-PCR (reverse transcriptase-polymerase chain reaction).",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about the primary means for diagnosing the new virus strain, which I assume is 2019-nCoV based on the first context. Let me check the provided contexts again to make sure.\n\nLooking at the first passage, the title mentions \"Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review.\" The passage states, \"With the emergence of 2019-nCoV, real time RT-PCR remains the primary means for diagnosing the new virus strain among the many diagnostic platforms available...\" So that's pretty clear. The answer here is real time RT-PCR.\n\nBut wait, there are other contexts provided too. The second and third contexts are about influenza viruses, specifically H1N1. They also mention real-time RT-PCR as the method of choice. The fourth context talks about the Swine Flu Panel using rRT-PCR. However, the question specifically refers to the \"new virus strain,\" which in the first context is 2019-nCoV. The other contexts are about influenza, so unless the question is mixing them, but the user's question is about the new virus strain mentioned in the first context. \n\nSo the answer should be real time RT-PCR. Let me confirm again. The first passage explicitly says that real time RT-PCR is the primary means for 2019-nCoV. The other contexts support RT-PCR for influenza, but the question is about the new virus strain (2019-nCoV), so the answer is real time RT-PCR.\n</think>\n\nThe primary means for diagnosing the new virus strain (2019-nCoV) is **real-time reverse transcriptase-polymerase chain reaction (RT-PCR)**. This method is highlighted in the context as the most reliable and rapid diagnostic approach for detecting the virus, particularly in respiratory specimens.",
      "retrieved_chunks": [
        "Title: Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review\nPassage: With the emergence of 2019-nCoV, real time RT-PCR remains the primary means for diagnosing the new virus strain among the many diagnostic platforms available ; Table S3 ). Among the 16 diagnostics studies selected, one study discussed the use of RT-PCR in diagnosing patients with 2019-nCoV . The period and type of specimen collected for RT-PCR play an important role in the diagnosis of 2019-nCoV.",
        "It was found that the respiratory specimens were positive for the virus while serum was negative in the early period. It has also suggested that in the early days of illness, patients have high levels\n\nTitle: Diagnosis of influenza viruses with special reference to novel H1N1 2009 influenza virus\nPassage: A number of different laboratory diagnostic tests can be used for detecting the presence of novel H1N1 infl uenza virus in respiratory specimens, including direct antigen detection tests, virus isolation in cell culture, or detection of infl uenza-specifi c RNA by real-time reverse transcriptasepolymerase chain reaction . Title: Diagnosis of influenza viruses with special reference to novel H1N1 2009 influenza virus\nPassage: of infl uenza virus genome have advantages over other methods and provide sensitive, highly specifi c and rapid diagnosis. The realtime RT-PCR should be the method of choice and both in-house developed and CDC-developed real-time PCR assays can be used for the specifi c detection of novel H1N1 2009 infl uenza virus.",
        "Title: Clinical review: Primary influenza viral pneumonia\nPassage: The real-time reverse transcriptase-polymerase chain reaction Swine Flu Panel for detection of pandemic H1N1 influenza, developed by the Centers for Disease Control and Prevention and distributed to many laboratories in US and worldwide, is a reliable and timely method of diagnosing the pandemic strain . The viral culture, while the gold standard in influenza diagnostics, takes several days before the results are known . The direct fluorescent antigen influenza test was recently reported to have a sensitivity of 93% compared with the rRT-PCR , but the test requires considerable technical expertise in addition to a fluorescent microscope.",
        "The commonly used"
      ],
      "computed_relevance": 0.09090909090909091,
      "computed_utilization": 1.0,
      "computed_completeness": 0.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.1875,
      "gt_utilization": 0.125,
      "gt_completeness": 0.6666666666666666,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 39,
      "dataset_id": "848",
      "question": "What was the performance of the vaccine candidates?",
      "ground_truth_answer": "The vaccine candidates demonstrated acceptable safety profiles and induced immune responses in a significant percentage of participants, with some variability in response rates and durability depending on the vaccine and dosage. Some participants also experienced side effects such as fever and arthritis after vaccination.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about the performance of the vaccine candidates based on the provided context. Let me start by reading through the context carefully.\n\nFirst, the main passage mentions that all candidate vaccines for EVD (Ebola Virus Disease) that went into Phase I studies after the 2013-2016 outbreak had acceptable safety profiles. The next focus was on understanding the magnitude and characteristics of the immune responses they induced. \n\nIn the same trial, 100% of the high-dose group developed antibody responses against the Zaire glycoprotein, while 90% in another group (maybe the lower dose?) had responses. Then there's mention of T-cell responses: 71% after 2 doses and 76% after 3 doses. Also, at week 6, there were no differences in immune responses between dose groups, but by week 60, 77% had humoral responses and 64% cellular. \n\nAnother part talks about fever: 22% had fever after vaccination, higher than the 8% with ChAd3. This is important because if the vaccine causes fever, it might complicate diagnosis during an outbreak where fever is a symptom.\n\nSo, putting this together, the performance of the vaccine candidates in terms of immune response seems good. High antibody responses in the high-dose group, increasing T-cell responses with more doses, and sustained responses over 60 weeks. However, the fever side effect is a consideration, especially in an outbreak scenario where fever is a key symptom. The answer should highlight both the immune response effectiveness and the fever issue.\n</think>\n\nThe performance of the vaccine candidates demonstrated several key outcomes:  \n1. **Immune Response**:  \n   - **Antibody responses**: 100% of the high-dose group developed antibodies against the Zaire glycoprotein, while 90% of another group showed responses.  \n   - **T-cell responses**: Detected in 71% after 2 doses and 76% after 3 doses. By week 60, 77% retained humoral immunity, and 64% retained cellular immunity.  \n   - **Durability**: Immune responses were sustained up to 60 weeks post-vaccination.  \n\n2. **Safety Profile**:  \n   - All candidates showed acceptable safety in Phase I trials.",
      "retrieved_chunks": [
        "Passage: In summary, all of the candidate vaccines for EVD that progressed to Phase I studies in response to the 2013-2016 outbreak demonstrated acceptable safety profiles; therefore, describing the magnitude and characteristics of vaccine-induced immunity was the next scientific aim.",
        "In the same trial, 100% of volunteers in the high dose group developed antibody responses against the vaccine strain of Zaire glycoprotein , while only 90% developed responses\n\nTitle: A review of Phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines?",
        "T-cell responses were detected in 71% and 76% participants after 2 and 3 doses, respectively. There were no differences in immune responses between dose groups after 6 weeks and vaccine-induced humoral and cellular responses were respectively detected in 77% and 64% participants at week 60.",
        "Title: Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review\nPassage: doses, respectively, and was maintained in 79% participants up to study end at week 60.",
        "Passage: 22% of participants across the six trials had documented fever after vaccination, significantly higher than the 8% observed after vaccination with ChAd3 ). Although both vaccines have been evaluated across a range of doses, post-immunization fever levels are an important consideration for a vaccine that may be deployed in an outbreak of a highly febrile illness, such as EVD."
      ],
      "computed_relevance": 0.5714285714285714,
      "computed_utilization": 0.8571428571428571,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.4,
      "gt_utilization": 0.3333333333333333,
      "gt_completeness": 0.8333333333333334,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 40,
      "dataset_id": "903",
      "question": "How does NLRP3 detect RNA viral infection?",
      "ground_truth_answer": "NLRP3 detects RNA viral infection via recognition of viral RNA, disturbances in intracellular ionic concentrations including K+ efflux and Ca2+ influx, and activation by viroporins encoded by RNA viruses. Additionally, RNA cleavage products generated by RNase L and the proton-selective M2 ion channel in the acidic trans-Golgi network can also activate the NLRP3 inflammasome.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how NLRP3 detects RNA viral infection. I need to look through the provided context to find the relevant information.\n\nFirst, looking at the context, there's a mention of Signal 1 and Signal 2. Signal 1 is initiated by TLR7 detecting viral RNA, which activates NF-kB. Then Signal 2 involves the NLRP3 inflammasome. The context says that for influenza virus, the M2 protein is involved in Signal 2. Specifically, the M2 ion channel in the trans-Golgi network activates NLRP3. Also, there's a part about viroporins from RNA viruses activating NLRP3. The influenza virus's M2 is a viroporin here. \n\nAnother part mentions that viral RNA or RNA cleavage products from RNase L can activate NLRP3 via DHX33. But the main points here are the M2 protein's role through ionic imbalance and the viroporin activity. Also, the context states that NLRP3 activation involves two steps: transcription of pro-IL-1\u03b2 and pro-IL-18, and then inflammasome activation. \n\nSo putting it together, NLRP3 detects RNA viruses through the M2 protein's ion channel activity causing pH imbalance and potassium efflux, which are part of the signals for inflammasome activation. Additionally, viroporins like M2 directly activate NLRP3. The answer should mention both the M2 protein's role and the viroporin mechanism.\n</think>\n\nNLRP3 detects RNA viral infection through multiple mechanisms, primarily involving the viral M2 protein and viroporin activity. Specifically:  \n1. **M2 Protein-Induced Ionic Imbalance**: The influenza virus's M2 ion channel disrupts the trans-Golgi pH balance and triggers potassium efflux via the P2X7 receptor, activating the NLRP3 inflammasome.  \n2. **Viroporin-Mediated Activation**: RNA viral viroporins (e.g., influenza M2) directly activate NLRP3 by altering cellular ion homeostasis.  \n3. **RNA-Dependent Pathways**: Viral RNA or RNA cleavage products generated by RNase L may activate NLRP3 via the DExD/H-box helicase",
      "retrieved_chunks": [
        "Signal 1 is initiated by the detection of viral RNA by TLR7, which activates NF-kB. Although initial studies showed that NLRP3 detects influenza virus via recognition of viral RNA , it is now clear that many sources contribute to signal 2 either in combination or alone, and all depend on the newly synthesized viral M2 protein. These include, ionic imbalance of the trans-Golgi pH, potassium efflux through the P2X7 receptor, an ATP-gated\n\nTitle: Severe Acute Respiratory Syndrome Coronavirus Viroporin 3a Activates the NLRP3 Inflammasome\nPassage: The innate immune systems utilizes pattern recognition receptors to detect pathogen-associated molecular patterns .",
        "Second, cathepsin B and L, which are specific lysosomal cysteine proteases, are though to play a\n\nTitle: Innate Immune Sensing and Response to Influenza\nPassage: Studies have shown that NLRP3 , NLRC2 , and NLRX1 are the NLRs responding to influenza virus . Whereas NLRP3 inflammasome induces the secretion of mature IL-1b/IL-18, NLRC2/NOD2, and NLRX1 signals the production of type I IFNs in response to influenza virus. Title: Severe Acute Respiratory Syndrome Coronavirus Viroporin 3a Activates the NLRP3 Inflammasome\nPassage: Thus far, several models have been proposed to explain NLRP3 inflammasome activation by RNA viruses. First, viral RNA or RNA cleavage products generated by RNase L activate the NLRP3 inflammasome via the DExD/H-box helicase, DHX33 . Second, viroporins encoded by RNA viruses activates the NLRP3 inflammasome . In the case of influenza virus, the proton-selective M2 ion channel in the acidic trans-Golgi network activates the NLRP3 inflammasome .",
        "Recognition of virus infection plays an important role in limiting virus replication at the early stages of infection.",
        "Title: Innate Immune Sensing and Response to Influenza\nPassage: Influenza virus-induced NLRP3-mediated IL-1b and IL-18 production involve two steps that include, enhancing the transcription of genes encoding pro-IL-1b and pro-IL-18 and NLRP3 and activating NLRP3 inflammasome .",
        "Nod-like receptor family, pyrin domain-containing 3 is activated by a wide variety of stimuli, including virus infection ."
      ],
      "computed_relevance": 0.16666666666666666,
      "computed_utilization": 0.4166666666666667,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.42857142857142855,
      "gt_utilization": 0.3333333333333333,
      "gt_completeness": 0.6666666666666666,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 41,
      "dataset_id": "1121",
      "question": "What is  an example of anti-viral defense in bats?",
      "ground_truth_answer": "One example of an anti-viral defense in bats is the interferon pathway, which is perpetually switched on in some bat species, helping to keep viral infections in check.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking for an example of an anti-viral defense in bats based on the provided context. Let me go through the passages again to make sure I get the right information.\n\nFirst, the context mentions that bats have a suite of antiviral defenses. One specific example given is the constitutive expression of the antiviral cytokine IFN-\u03b1. The passage says, \"Bats leverage a suite of species-specific mechanisms to limit viral load, which include host receptor sequence incompatibilities for some bat-virus combinations and constitutive expression of the antiviral cytokine, IFN-a, for others.\" So that's one example.\n\nAnother part of the context talks about the interferon pathway being perpetually switched on in some bats. It states, \"some bats have an antiviral immune response called the interferon pathway perpetually switched on.\" This is another example. Additionally, there's mention of anti-inflammatory traits that protect bats from harmful inflammation caused by their hyper-vigilant immune response. They have the loss of certain genes that normally promote inflammation, which is another defense mechanism.\n\nThe question is asking for an example, so I need to pick one. The most direct example from the text is the constitutive expression of IFN-\u03b1 or the perpetually active interferon pathway. Since the answer should be concise, maybe the interferon pathway being always on is a good example. Let me check if there's any other example mentioned. The host receptor sequence incompatibilities are also a defense, but the question is about anti-viral defenses. The answer should be something that actively fights the virus. The IFN-\u03b1 and the interferon pathway are more active defenses. The anti-inflammatory traits are more about preventing self-harm from their own immune system, but they are part of the overall defense strategy.\n\nSo the best answer here would be the constitutive expression of IFN-\u03b1 or the perpetually active interferon pathway. The user might expect one of these. Let me make sure the answer is phrased correctly. The passage says \"constitutive expression of the antiviral cytokine, IFN-a\" and \"interferon pathway perpetually switched on.\" Either of these would be correct. Since the answer needs to be in a box, I should pick the most precise one. Maybe the interferon pathway being always on is a more general example. Let me confirm the",
      "retrieved_chunks": [
        "The experiments and model helped reveal that the bats' defenses may have a potential downside for other animals, including humans. In both bat species, the strongest antiviral responses were\n\nTitle: Accelerated viral dynamics in bat cell lines, with implications for zoonotic emergence\nPassage: Recent research advances are beginning to shed light on the molecular mechanisms by which bats avoid pathology from these otherwise virulent pathogens . Bats leverage a suite of species-specific mechanisms to limit viral load, which include host receptor sequence incompatibilities for some bat-virus combinations and constitutive expression of the antiviral cytokine, IFN-a, for others .",
        "Title: Accelerated viral dynamics in bat cell lines, with implications for zoonotic emergence\nPassage: Bats have a suite of antiviral defenses that keep the amount of virus in check. For example, some bats have an antiviral immune response called the interferon pathway perpetually switched on. In most other mammals, having such a hyper-vigilant immune response would cause harmful inflammation. Bats, however, have adapted anti-inflammatory traits that protect them from such harm, include the loss of certain genes that normally promote inflammation. However, no one has previously explored how these unique antiviral defenses of bats impact the viruses themselves.",
        "In some bat cells, the\n\nTitle: Accelerated viral dynamics in bat cell lines, with implications for zoonotic emergence\nPassage: countered by the virus spreading more quickly from cell to cell. This suggests that bat immune defenses may drive the evolution of faster transmitting viruses, and while bats are well protected from the harmful effects of their own prolific viruses, other creatures like humans are not.",
        "have studied this exact question using bat cells grown in the laboratory. Title: Accelerated viral dynamics in bat cell lines, with implications for zoonotic emergence\nPassage: The experiments made use of cells from one bat species -the black flying fox -in which the interferon pathway is always on, and another -the Egyptian fruit bat -in which this pathway is only activated during an infection. The bat cells were infected with three different viruses, and then Brook et al.",
        "Typically, the presence of viral RNA or DNA in the cytoplasm of mammalian cells will induce secretion of type I interferon proteins , which promote expression and translation of interferon-stimulated genes in neighboring cells and render them effectively antiviral ."
      ],
      "computed_relevance": 0.2857142857142857,
      "computed_utilization": 0.2857142857142857,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.35,
      "gt_utilization": 0.1,
      "gt_completeness": 0.2857142857142857,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 42,
      "dataset_id": "269",
      "question": "What are associated with cancer, diabetes, inflammatory disease, and osteoporosis?",
      "ground_truth_answer": "Obesity, inflammation, stress, and diet are associated with cancer, diabetes, inflammatory disease, and osteoporosis.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking what factors are associated with cancer, diabetes, inflammatory disease, and osteoporosis based on the provided context. Let me go through the passages again to make sure I don't miss anything.\n\nFirst, looking at the first passage: It mentions that in adipose tissue, obesity is linked with nephropathy, atherosclerosis. For neuropathy and retinopathy, stress and inflammation are top. Cardiovascular issues are tied to diet and inflammation. The next passage says that the major risk factors considered are obesity, inflammation, stress, and diet, interacting with T2DM genes. The pancreas, adipose, and skeletal muscle tissues have differentially expressed genes. Obesity is the dominant risk factor, followed by inflammation, diet, and stress. Another part states that obesity and inflammation play major roles in T2DM and its complications, suggesting targeting these for therapy. There's also mention of inflammation leading to vascular calcification with atherosclerosis and hepatokines involved in atherosclerosis.\n\nThe question is about what's associated with cancer, diabetes, inflammatory disease, and osteoporosis. Wait, the context is about T2DM complications. The answer needs to connect the factors from the context to these four conditions. The context repeatedly mentions obesity, inflammation, stress, and diet as key factors in T2DM complications. However, the question includes cancer and osteoporosis, which aren't explicitly mentioned in the provided passages. The user might be expecting the answer to be the factors listed in the context (obesity, inflammation, etc.) even if the specific diseases in the question aren't all covered. Since the context links these factors to T2DM complications, maybe the answer is those factors. But the question lists four diseases, some of which aren't in the context. Hmm. The user might be testing if I can infer based on the context. Since the context doesn't mention cancer or osteoporosis, but does talk about diabetes (T2DM) and inflammatory diseases (like atherosclerosis, which is an inflammatory condition), perhaps the answer is the factors mentioned: obesity, inflammation, stress, diet. The answer should be those four factors as they are the ones associated with the diseases mentioned in the context. Even though the question includes cancer and osteoporosis, the context doesn't cover them, so maybe the answer is the factors from the context. Alternatively, maybe the answer is the complications listed",
      "retrieved_chunks": [
        "However, it is to be\n\nTitle: T2DiACoD: A Gene Atlas of Type 2 Diabetes Mellitus Associated Complex Disorders\nPassage: In Adipose tissue, obesity topped the list with the number of DEG associated with nephropathy, atherosclerosis, whereas in neuropathy and retinopathy, stress and inflammation are at the top and in cardiovascular complication, diet and inflammation topped the list .",
        "It is evident that the complications arising from T2DM are also multifactorial and could be further governed by gene-environment interactions. Title: T2DiACoD: A Gene Atlas of Type 2 Diabetes Mellitus Associated Complex Disorders\nPassage: Among the risk factors considered in this work, are obesity, inflammation, stress and diet and their interactions with the genes of T2DM associated complications. The major share of differentially expressed genes in T2DM patients as observed here is contributed by pancreas tissue followed by adipose and skeletal muscle tissues. Obesity is clearly a dominant risk factor interacting with the genes of T2DM complications followed by inflammation, diet and stress to variable extents.",
        "Title: T2DiACoD: A Gene Atlas of Type 2 Diabetes Mellitus Associated Complex Disorders\nPassage: Thus it is apparent that obesity and inflammation play major role in the development of T2DM and its associated complications and therefore therapeutic regimens may be targeted towards ameliorating these effects.",
        "Title: T2DiACoD: A Gene Atlas of Type 2 Diabetes Mellitus Associated Complex Disorders\nPassage: Hyperglycaemic conditions in late stages of diabetic individuals include well known microvascular complications and macrovascular complications .",
        "Inflammation could lead to vascular calcification in association with atherosclerosis 31 . Hepatokines such as Fibroblast growth factor 21, Fetuin A and selenoprotein P are also implicated in the development of atherosclerosis 32 ."
      ],
      "computed_relevance": 0.2222222222222222,
      "computed_utilization": 0.2222222222222222,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.6470588235294118,
      "gt_utilization": 0.11764705882352941,
      "gt_completeness": 0.18181818181818182,
      "gt_adherence": 0.0,
      "binary_pred": 0,
      "binary_gt": 0,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 43,
      "dataset_id": "191",
      "question": "What are the ages of the patients in this study?",
      "ground_truth_answer": "The ages of the patients in the study range from 10 months to 109 years old, with the median ages being 31 months, 53.2 years, 56.7 years, 36.7 years, and 61 years. The study also mentions a significant number of patients being in the age group of 21 to 40 years and a majority of cases occurring in patients aged 65 years and older.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about the ages of the patients in the study mentioned in the provided context. First, I need to carefully read through the context to gather all the relevant information about the patients' ages.\n\nLooking at the context, there are a few different parts. The first part mentions the median age of patients with co-morbidities being higher than those without. The median age is given as 61 years. Then it says the most affected age group is \u226565 years with 633 cases. For that group, the median age is 79 and the mean is 78.7. There are 296 patients aged \u226580. Also, deaths are noted: 111 in \u226565 and 55 in >80.\n\nThen there's a line stating that the majority acquired AKI in the community. Then another part says the median age was 31 months, with 19% under 3 months. Wait, that seems conflicting with the earlier numbers. The title mentions a study on patients with acute kidney injury requiring dialysis in a developing country. The passage also mentions a mean age of 36.7 \u00b114.5 years, with over two-thirds between 21-40 years.\n\nHmm, so there's a discrepancy here. The first part talks about a median age of 61, then a median age of 31 months. That's a big difference. Maybe these are different studies or different parts of the same study? Let me check the title again. The title is about patients requiring dialysis in a hemodialysis unit. The passage mentions mean age 36.7 years, but the context before that mentions median age 61. Wait, perhaps there's a mix-up here. Let me parse each part carefully.\n\nThe first paragraph in the context says: \"The median age of patients presenting co-morbidities was significantly higher than of those without. The median age was 61 years. The most-affected age group was the \u226565 years age group with 633 cases. The median age of the \u226565 years age group was 79 years and the mean age was 78.7 years: 296 were aged \u226580 years. Of deaths, 111 occurred in patients aged \u226565 years and",
      "retrieved_chunks": [
        "The median age of patients presenting co-morbidities was significantly higher than of those without .",
        "The median age was 61 years . The most-affected age group was the \u2265 65 years age group with 633 cases . The median age of the \u2265 65 years age group was 79 years and the mean age was 78.7 years : 296 were aged \u2265 80 years. Of deaths, 111 occurred in patients aged \u2265 65 years and 55 in patients aged > 80 years .",
        "The majority of patients acquired AKI in the community.",
        "The median age of the patients was 31 months , with 19% of the children having less than 3 months of age .",
        "Title: Clinical profile and outcome of patients with acute kidney injury requiring dialysis\u2014an experience from a haemodialysis unit in a developing country\nPassage: The mean age of patients was 36.7 \u00b1 14.5 years, with more than two third being in the age group between 21 to 40 years."
      ],
      "computed_relevance": 0.625,
      "computed_utilization": 0.625,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.2727272727272727,
      "gt_utilization": 0.22727272727272727,
      "gt_completeness": 0.8333333333333334,
      "gt_adherence": 0.0,
      "binary_pred": 0,
      "binary_gt": 0,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 44,
      "dataset_id": "1610",
      "question": "What has this focus on mammalian defences and pathologies sidelined?",
      "ground_truth_answer": "The focus on mammalian defences and pathologies has sidelined the study of host-pathogen interactions in non-mammalian organisms, such as Drosophila, and the potential insights that could be gained from studying them.",
      "generated_response": "<think>\nOkay, let's try to figure out the answer to this question. The user is asking, \"What has this focus on mammalian defences and pathologies sidelined?\" They provided three different contexts, so I need to go through each one and see what they have to say about mammalian defenses and what might have been sidelined.\n\nFirst, looking at the first context: it's about advances in proteomics in animal and food sciences, focusing on Marek disease as a model for human tumors. The passage mentions that studying toxins can shed light on cellular processes. Then there's a mention of chickens and their MHC (Major Histocompatibility Complex) being a simpler model compared to mammals. The second context is about Drosophila (fruit flies) and host-pathogen interactions, noting that studying virulence factors is harder in intact mammals. The third context talks about MHC Class I molecules and how evolutionary biology approaches with wild populations can provide insights.\n\nThe question is about what has been sidelined due to the focus on mammalian defenses. The answer probably relates to other models or systems that are simpler or different. The first context mentions that chickens have a simpler MHC than mammals, making them useful for discovering phenomena that are hard to see in mammals. The second context says that humans and mice are better for certain studies, but chickens are still useful. The third context mentions wild outbred populations for evolutionary approaches.\n\nPutting this together, the focus on mammals might have sidelined simpler models like chickens or other non-mammalian models. The answer might be that non-mammalian models, like chickens or Drosophila, have been sidelined because the emphasis is on mammals. Alternatively, maybe the study of simpler systems or wild populations has been overlooked. The first context's mention of chickens as a model that provides insights when mammalian systems are too complex suggests that these alternative models are being sidelined. So the answer is likely that the focus on mammalian defenses has sidelined the use of simpler or non-mammalian models, such as chickens or Drosophila, which can offer unique insights into cellular processes and disease mechanisms.\n</think>\n\nThe focus on mammalian defenses and pathologies has sidelined the study of simpler or non-mammalian models, such as chickens or *Drosophila*, which offer unique insights into cellular processes and disease mechanisms. For example, the chicken MHC provides a simpler system to study phenomena obscured by the complexity of mammalian MHC, while *Dros",
      "retrieved_chunks": [
        "Title: Animal board invited review: advances in proteomics for animal and food sciences\nPassage: with a special focus on Marek disease , which is of particular interest as a model for human tumours .",
        "Finally, we highlight in Box 1 how studying the effect of toxins can shed light on basic cellular processes.",
        "Title: Deconstructing host-pathogen interactions in Drosophila\nPassage: virulence factors, which is more challenging in intact mammals.",
        "For detailed disease associations including autoimmunity and for mechanistic studies, humans and mice are obviously much better suited for rapid progress than chickens. However, at the least, the chicken MHC again has provided a simple model to discover phenomena that have been difficult to discern in both the more complicated MHC of typical mammals and the less well-characterized MHC of wild species.",
        "Title: Generalists and Specialists: A New View of How MHC Class I Molecules Fight Infectious Pathogens\nPassage: Finally, much can be learned from evolutionary biology approaches, including observation and simulation, typically with wild outbred populations."
      ],
      "computed_relevance": 0.3333333333333333,
      "computed_utilization": 0.3333333333333333,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.42857142857142855,
      "gt_utilization": 0.42857142857142855,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 45,
      "dataset_id": "657",
      "question": "What happens when a recipient of a vaccine has immune response to the delivery vector?",
      "ground_truth_answer": "When a recipient of a vaccine has an immune response to the delivery vector, it can potentially result in a reduction in the subsequent immune response. This can be due to the induction of neutralizing antibodies, limiting the number of transduced cells and therefore limiting the overall immune response. Additionally, repeated immunization with the same vaccine and dose can counteract the negative impact of vector-specific immune responses by leading to higher priming of naive T cells against the delivered antigen. However, this may not always be practicable in real-world situations.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking what happens when someone who has an immune response to the vaccine's delivery vector receives the vaccine. The context provided is from a study titled \"Pre-existing immunity against vaccine vectors \u2013 friend or foe?\" which discusses how pre-existing immunity affects vaccine effectiveness.\n\nFirst, I need to parse the key points from the context. The passage mentions that for viral vectors, cell-mediated immunity has a significant impact, reducing subsequent immune responses. The reason given is that the first dose induces neutralizing antibodies, which then limit the number of transduced cells in subsequent doses. This reduces the exposure of the antigen to the immune system because the vector is cleared quickly. However, the effect can vary depending on the magnitude of the response to the antigen. Also, pre-existing immunity to the vector can restrict the delivery of the virus into cells, effectively reducing the dose of the antigen.\n\nThere's also a mention of studies where exposure to an empty vector completely abrogated immune responses to the antigen, but this depends on dose and timing. On the other hand, some studies with Listeria vectors showed that pre-existing immunity didn't diminish the immune response to the antigen. So there's a mix of outcomes depending on the vector and circumstances.\n\nThe question is asking for the general outcome when a recipient has an immune response to the vector. The answer should summarize that pre-existing immunity can reduce the effectiveness of the vaccine by neutralizing the vector, leading to lower antigen delivery and thus weaker immune responses. However, there are exceptions where the immune response to the vector doesn't hinder the antigen's effectiveness. The answer should also note that repeated vaccination might counteract this by priming naive T cells more effectively, though this might not be practical in real-world scenarios.\n\nI need to make sure the answer is concise and covers both the negative impact (reduced immune response due to neutralizing antibodies) and the exceptions where pre-existing immunity doesn't affect the outcome. Also, mention the factors like dose, timing, and vector type that influence the result.\n</think>\n\nWhen a recipient has an immune response to the vaccine's delivery vector, **pre-existing immunity can reduce the effectiveness of the vaccine**. This occurs because neutralizing antibodies from prior exposure to the vector may rapidly clear the vector upon subsequent doses, limiting the delivery of the antigen to cells and reducing the immune system's exposure to it. This often results in diminished antigen-specific immune responses. However, the impact varies depending",
      "retrieved_chunks": [
        "also demonstrated that the negative impact of vector-specific immune responses can also be countered by repeated immunization with the same vaccine and dose; this in effect leads to higher priming of naive T cells against the delivered antigen. Of course, such repeated vaccination may not be practicable in real-world situations. Title: Pre-existing immunity against vaccine vectors \u2013 friend or foe? Passage: For viral vectors, the impact of cell-mediated immunity was more pronounced, and as depicted in Table 2 , almost always resulted in a reduction in the subsequent immune response. Presumably this is because viruses will induce neutralizing antibody on the first dose, and in subsequent doses this antibody will limit the number of transduced cells, therefore limiting the responses.",
        "This will theoretically reduce the exposure of the heterologous antigen to the immune system, as the vector is rapidly cleared. Surprisingly, as will be seen in some of the examples given below, this can have results that differ depending on the magnitude of the response to the vectored antigen. Similarly, for virally vectored antigens, the existence of pre-existing immunity to the vector will restrict delivery of the virus into cells, thereby effectively reducing the dose of the vectored antigen.",
        "indicated that exposure to the empty vector may completely abrogate immune responses against the delivered antigens . However, these studies also indicate that downregulation of antigenspecific immune responses is highly dependent on dose and time.",
        "Title: Pre-existing immunity against vaccine vectors \u2013 friend or foe?",
        "indicates that pre-existing immune responses against the Listeria vector do not diminish immune responses against the delivered heterologous antigen, and a similar study by Starks et al. also concluded that prior exposure of mice to the empty Listeria vector did not influence anti-cancer immune responses when a similar mutant was used as a carrier of a melanoma cancer antigen."
      ],
      "computed_relevance": 0.5384615384615384,
      "computed_utilization": 0.6923076923076923,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.7,
      "gt_utilization": 0.2,
      "gt_completeness": 0.2857142857142857,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 46,
      "dataset_id": "1752",
      "question": "Approximately how many people died during the 1918-1919 influenza pandemic?",
      "ground_truth_answer": "Between 21 and 25 million people died of influenza worldwide during the 1918-1919 influenza pandemic.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how many people died during the 1918-1919 influenza pandemic. I need to look through the provided context to find the correct number.\n\nFirst, I'll scan through each passage. The first context mentions that between 21 and 25 million people died worldwide from influenza during 1918-1919. Then, in another passage titled \"Influenza, evolution, and the next pandemic,\" it says the 1918 pandemic killed as many as 50-100 million people. Another passage under \"Making Universal Influenza Vaccines...\" also states the 1918 virus killed an estimated 50-100 million people. \n\nWait, there's a discrepancy here. The first context says 21-25 million, while others mention 50-100 million. Which one is correct? Let me check the sources again. The first context says \"between 21 and 25 million people died of influenza worldwide\" during 1918-1919. The other passages refer to the 1918 pandemic killing 50-100 million. The difference might be due to different estimates or sources. The higher numbers (50-100 million) are more commonly cited in historical records for the 1918 pandemic. The lower number might be from a specific region or a different source. Since the question is about the worldwide death toll, the higher estimates are more likely the correct answer here. The answer should be 50-100 million.\n</think>\n\nThe 1918-1919 influenza pandemic resulted in an estimated **50\u2013100 million deaths worldwide**, as stated in multiple passages. This figure is widely cited in historical and scientific contexts, reflecting the pandemic's unprecedented scale and lethality.",
      "retrieved_chunks": [
        "For example, about 700,000 Germans died from malnutrition-related diseases in the years of 1914-1918. During the 1918-1919 influenza pandemic, between 21 and 25 million people died of influenza worldwide. Those people were killed both directly and indirectly by influenza virus infections.",
        "Title: It is Unlikely That Influenza Viruses Will Cause a Pandemic Again Like What Happened in 1918 and 1919\nPassage: deaths in the world in that period of time.",
        "Title: A year of terror and a century of reflection: perspectives on the great influenza pandemic of 1918\u20131919\nPassage: It is postulated that 10% of the worldwide population is infected by an influenza virus each year, resulting in a total economic burden of $87.1 billion USD . As a testament to the significant toll posed by influenza on public health and healthcare systems, the US Centers for Disease Control and Prevention estimated that from 2010 to 2015, influenza infections resulted in 9.23-35.6 million illnesses and 139,000-707,000 hospitalizations annually in the US alone . It has been suggested that children are likely the primary transmitters of influenza . Lethal influenza infections are primarily associated with high risk populations, including infants\n\nTitle: Influenza, evolution, and the next pandemic\nPassage: The 1918 influenza pandemic is remembered because it killed as many as 50-100 million people worldwide: an estimated 2.5% or more of the global population . Remarkably, the mortality rate was much higher in younger adults than it was in children, giving rise to the familiar W-shaped pandemic mortality curve . A similar mortality pattern has not been described for subsequent pandemics .",
        "Influenza virus could infect all members of a family, and this could result in no one left to feed the fires, and to prepare food for the whole\n\nTitle: Making Universal Influenza Vaccines: Lessons From the 1918 Pandemic\nPassage: The novel 1918 pandemic virus killed an estimated 50-100 million people within the span of a year , which would equate, given the same degree of lethality, to as many as 400 million or more deaths today. Preventing a repeat of such an unimaginable disaster is a litmus test, and the ultimate standard, for any universal influenza vaccine.",
        "Many families were too poor to buy food and coal, and to afford health care expenses when their family members were ill."
      ],
      "computed_relevance": 0.15384615384615385,
      "computed_utilization": 0.15384615384615385,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.15789473684210525,
      "gt_utilization": 0.05263157894736842,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 0.0,
      "binary_pred": 1,
      "binary_gt": 0,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 47,
      "dataset_id": "438",
      "question": "What structural proteins are coded by Rotavirus?",
      "ground_truth_answer": "Rotavirus codes for four major structural proteins: VP4, VP6, VP7, and VP8*.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking which structural proteins are coded by the rotavirus. I need to look through the provided context to find the answer.\n\nFirst, looking at the first passage: it mentions that rotaviruses have a triple-layered protein capsid with four major structural proteins. Then there's a part about VP1-VP3 having high identity with group G rotavirus, and other structural proteins having lower identities. But it doesn't list all the structural proteins here.\n\nNext, the third passage says the genome has 11 segments encoding 12 proteins, six structural and six non-structural. It specifically mentions VP4 as a structural protein, part of the spike, and talks about VP5* and VP8* as subunits of VP4. Also, VP4 is important for entry and exit, and it's used in vaccines. Then it mentions that both VP4 and VP7 are required for cell binding and infectivity. So VP7 is another structural protein.\n\nIn the fourth passage, it says the six structural proteins showed hits to group G rotavirus. So there are six structural proteins in total. The first passage mentions VP1-VP3 as structural proteins (since they're part of the capsid), and the third passage adds VP4, VP7. Wait, but there are six structural proteins total. Let me check again.\n\nThe third passage says six structural proteins and six non-structural. The first passage mentions four major structural proteins (VP1-VP3 and maybe VP6?), since VP6 is mentioned in the classification. The second part of the first passage says classification is based on VP6. Then in the third passage, VP4 and VP7 are structural. Also, VP6 is part of the inner capsid. So putting it all together, the six structural proteins would be VP1, VP2, VP3, VP4, VP6, and VP7. Let me confirm each:\n\n- VP1, VP2, VP3: part of the core (maybe VP1 is RNA-dependent RNA polymerase, but they are structural as part of the capsid layers).\n- VP4: outer layer spike protein.\n- VP6: inner capsid protein, used for classification.\n- VP7: outer capsid protein, involved in cell binding.\n\nYes, that makes six structural proteins. The non-structural ones are NSP1-NSP6. So the",
      "retrieved_chunks": [
        "The rotavirus genome\n\nTitle: Rotavirus Structural Proteins and dsRNA Are Required for the Human Primary Plasmacytoid Dendritic Cell IFN\u03b1 Response\nPassage: Rotaviruses are characterized by a triple-layered protein capsid composed of four major structural proteins.",
        "While VP1-VP3 shared 84%-94% aa-identities with group G rotavirus, other structural proteins showed lower aa-identities, ranging from 35% to 67% . Classification of rotavirus is based mainly on the inner capsid protein VP6 and according to ICTV definition the members of the same rotavirus species should share .60% nt-identity in VP6 region . The sequence of the VP6-encoding genome segment shared 68% nt-identity to group G rotavirus . Direct observation of VP6 alignment between HK18 and its closest\n\nTitle: Rotavirus Structural Proteins and dsRNA Are Required for the Human Primary Plasmacytoid Dendritic Cell IFN\u03b1 Response\nPassage: is also observed during infection.",
        "Title: The Eukaryotic Translation Initiation Factor 4F Complex Restricts Rotavirus Infection via Regulating the Expression of IRF1 and IRF7\nPassage: The genome of rotavirus contains 11 segments encoding 12 proteins including six structural and six non-structural proteins . Among the structural proteins, as a spike protein, rotavirus VP4 plays an essential role in both viral entry and exit . VP4 was also demonstrated to be of importance in viral attachment and internalization , which is often used for the development of rotavirus vaccines . VP4 contains two subunits including a C-terminal subunit VP5* and a N-terminal subunit VP8*, and both VP5* and VP8* help virus entry by interacting with several putative partners and cell surface receptors .",
        "Although both triple-and doublelayered particles are generated during rotavirus replication, only TLPs are infectious, due to the requirements of VP4 and VP7 for cell binding, and trypsin cleavage of VP4 for viral entry and infectivity . Formation of noninfectious empty TLPs and DLPs, which lack the viral genome,\n\nTitle: The Viruses of Wild Pigeon Droppings\nPassage: The six structural proteins showed best hits by BLASTx to group G rotavirus, first described in chicken feces from Northern Ireland .",
        "The nonstructural proteins are involved in viral replication, morphogenesis and assembly, but they are not expressed by nonreplicating virus and are not part of the infectious virion ."
      ],
      "computed_relevance": 0.3333333333333333,
      "computed_utilization": 0.25,
      "computed_completeness": 0.75,
      "computed_adherence": 0.0,
      "gt_relevance": 0.38095238095238093,
      "gt_utilization": 0.14285714285714285,
      "gt_completeness": 0.375,
      "gt_adherence": 0.0,
      "binary_pred": 0,
      "binary_gt": 0,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 48,
      "dataset_id": "798",
      "question": "How many people did SARS-CoV infect?",
      "ground_truth_answer": "SARS-CoV infected 8098 reported cases and 774 deaths in 37 countries before the epidemic was controlled.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how many people SARS-CoV infected. I need to look through the provided context to find the correct number.\n\nFirst, I'll scan through each passage. The first context mentions that SARS-CoV caused 8098 reported cases. That seems like a key number. The other passages talk about different things, like R0 estimates and other coronaviruses like MERS-CoV and 2019-nCoV (which is SARS-CoV-2). \n\nWait, there's another passage that says \"up to 28th March, countries between 7 and 43 million individuals have been infected with SARS-CoV-Z\". But SARS-CoV-Z isn't mentioned elsewhere. Maybe that's a typo or a different virus? The original question is about SARS-CoV, not SARS-CoV-2 or another variant. The first passage clearly states 8098 cases for SARS-CoV. \n\nAnother part mentions a situation report from WHO on 28 January 2020 about 2019-nCoV cases, but that's a different virus (the one causing COVID-19). The question is specifically about SARS-CoV. \n\nSo the correct answer should be 8098 reported cases as per the first passage. The other numbers either refer to different viruses or might be errors. The 7-43 million number seems way too high for SARS-CoV, which is known to have around 8,000 cases globally. Also, the mention of Toronto with 400 cases aligns with the total being in the thousands. Therefore, the answer is 8098.\n</think>\n\nThe SARS-CoV infected **8,098 reported cases** globally, as stated in the first passage. This figure is explicitly mentioned in the context and refers to the total cases reported across 37 countries before the SARS epidemic was controlled. Other numbers in the context (e.g., 7\u201343 million or 2,798) pertain to different viruses (like SARS-CoV-2/2019-nCoV) or specific regions, not the global total for SARS-CoV.",
      "retrieved_chunks": [
        "Title: Preparation for Possible Sustained Transmission of 2019 Novel Coronavirus\nPassage: SARS-CoV and MERS-CoV cause severe disease, but despite the initial R0 estimations of greater than 2.0 for SARS-CoV , and some large outbreaks, neither were as transmissible as initial concerns suggested. SARS-CoV caused 8098 reported cases and 774 deaths in 37 countries before the epidemic was controlled.",
        "Title: Estimating the number of infections and the impact of non-\nPassage: countries between 7 and 43 million individuals have been infected with SARS-CoV-Z up to 28th March,\n\nTitle: SARS to novel coronavirus \u2013 old lessons and new lessons\nPassage: According to the situation report published by the WHO on 28 January 2020 , a total of 2798 confirmed 2019-nCoV cases have been reported globally; of these, 2761 cases were from China, including Hong Kong , Macau and Taipei .",
        "Later estimates of R0 were less than 1, indicating that SARS-CoV may not have been capable of sustained transmission, especially in the setting of control measures.4",
        "There was no secondary transmission in the United States from the 8 imported cases, although\n\nTitle: Preparation for Possible Sustained Transmission of 2019 Novel Coronavirus\nPassage: in Toronto, Canada, a single importation is thought to have led to about 400 cases and 44 deaths.",
        "Control was thought to have been possible because a high proportion of cases were severe, making it easier to rapidly identify and isolate infected individuals."
      ],
      "computed_relevance": 0.16666666666666666,
      "computed_utilization": 0.16666666666666666,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.06666666666666667,
      "gt_utilization": 0.06666666666666667,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 49,
      "dataset_id": "867",
      "question": "What was a characteristic of  SARS-CoV and MERS-CoV, specimens collected from the lower respiratory tract such as sputum and tracheal aspirates?",
      "ground_truth_answer": "The characteristic of SARS-CoV and MERS-CoV specimens collected from the lower respiratory tract, such as sputum and tracheal aspirates, was that they had higher and more prolonged levels of viral RNA compared to specimens collected from the upper respiratory tract.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about a characteristic of SARS-CoV and MERS-CoV related to specimens collected from the lower respiratory tract like sputum and tracheal aspirates.\n\nFirst, I need to look at the provided context. The first paragraph mentions that for both SARS-CoV and MERS-CoV, lower respiratory tract specimens have higher and more prolonged levels of viral RNA due to the virus's tropism. It also notes that for MERS-CoV, viral loads are higher in severe cases and last longer compared to mild ones. Upper respiratory specimens like nasopharyngeal swabs might have lower viral loads and a higher risk of false negatives.\n\nLooking at the other passages, the WHO recommends lower respiratory tract (LRT) sampling for MERS-CoV testing, especially if collection is delayed. They mention that LRT samples are better for isolating the virus, though culture success decreases with prolonged disease. Another study found that tracheal aspirates and BAL had the highest viral loads, followed by NPA and sputum. Higher viral loads correlate with better sequencing and culture success, and in NPA, they're linked to severe disease.\n\nThe question specifically asks about SARS-CoV and MERS-CoV. The key point from the context is that lower respiratory specimens (sputum, tracheal aspirates) have higher and more prolonged viral RNA levels. The answer should reflect that characteristic. The answer given in the example is \"higher and more prolonged levels of viral RNA because of the tropism of the virus,\" which matches the first part of the context. I need to confirm that this is the correct answer based on the provided information. The other parts of the context support this by showing that LRT samples are recommended for testing and have higher viral loads, leading to better detection. So the answer is accurate.\n</think>\n\nThe characteristic of SARS-CoV and MERS-CoV specimens collected from the lower respiratory tract (e.g., sputum and tracheal aspirates) is **higher and more prolonged levels of viral RNA because of the tropism of the virus**. This is supported by the context, which states that lower respiratory tract (LRT) specimens exhibit elevated viral loads compared to upper respiratory samples, reduce the risk of false negatives, and correlate with better diagnostic outcomes (e.g., successful viral culture and genome sequencing). For MERS-CoV, severe cases also",
      "retrieved_chunks": [
        "For SARS-CoV and MERS-CoV, specimens collected from the lower respiratory tract such as sputum and tracheal aspirates have higher and more prolonged levels of viral RNA because of the tropism of the virus. MERS-CoV viral loads are also higher for severe cases and have longer viral shedding compared to mild cases. Although upper respiratory tract specimens such as nasopharyngeal or oropharyngeal swabs can be used, they have potentially lower viral loads and may have higher risk of false-negatives among\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: The WHO recommends sampling from the LRT for MERS-CoV RT-rtPCR testing, especially when sample collection is delayed by a week or more after onset of symptoms. LRT samples are also best for attempting isolation of infectious virus, although the success of culture is reduced when disease persists .",
        "Title: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: In the only study to examine the effect of sample type on molecular analysis, 64 nasopharyngeal aspirates , 30 tracheal aspirates, 13 sputa and three BAL were examined. The tracheal aspirates and BAL returned the highest viral load values followed by NPA and sputum. Unsurprisingly, higher viral loads generally paralleled whole genome sequencing and culture success and, in NPA testing, were significantly correlated with severe disease and death .",
        "Specimens were nasal swabs , throat swabs , nasal aspirates , tracheal aspirates , bronchoalveolar lavages , gargles , and sputum .",
        "To increase the number of virus-positive samples more than one specimen per patient was collected.",
        "Recommended sample types include bronchoalveolar lavage , tracheal/tracheobronchial aspirate, pleural fluid and sputum ."
      ],
      "computed_relevance": 0.1,
      "computed_utilization": 0.1,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.17391304347826086,
      "gt_utilization": 0.043478260869565216,
      "gt_completeness": 0.25,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 50,
      "dataset_id": "1251",
      "question": "Which city has had has had more MERS cases than any other region of the KSA ?",
      "ground_truth_answer": "Riyadh has had more MERS cases than any other region of the KSA.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking which city in the Kingdom of Saudi Arabia (KSA) has had the most MERS cases. The context provided mentions that Riyadh is a nexus for camel and human travel and has had more MERS cases than any other region. Additionally, there's a passage about a hospital-based cluster in the Ar Riyad region, which includes Riyadh, starting in late June 2015. Another study from the Riyadh Regional Laboratory also discusses demographic variations in MERS-CoV infections there.\n\nFirst, I need to confirm that \"Riyadh\" is the correct answer. The context explicitly states that Riyadh has had more cases than any other region. The other passages mention studies conducted in Riyadh, reinforcing that it's a significant area for MERS cases. The South Korean outbreak is mentioned but that's not in KSA. The other regions in Saudi Arabia aren't named as having higher cases. So, the answer should be Riyadh. I should make sure there's no confusion between regions and cities. The Ar Riyad region includes Riyadh city, so it's accurate to say Riyadh is the city with the most cases.\n</think>\n\nThe city that has had more MERS cases than any other region of the Kingdom of Saudi Arabia (KSA) is **Riyadh**. The context explicitly states that Riyadh is a major hub for travel and has reported the highest number of MERS cases, including a significant hospital-based cluster in 2015. Studies from the Riyadh Regional Laboratory further highlight the region's specific epidemiological characteristics, confirming its central role in the MERS-CoV epidemic.",
      "retrieved_chunks": [
        "Riyadh is a nexus for camel and human travel and has had more MERS cases than any other region of the KSA to date but also harbours a wide range of MERS-CoV variants .",
        "Title: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: In the region of Ar Riyad, including the capital city of Riyadh, a hospital based cluster began, within a single hospital, from late June 2015 .",
        "However the South Korean outbreak originated from a single infected person, resulting in three to four generations of cases . Studies of this apparently recombinant viral variant did not find an increased evolutionary rate and no\n\nTitle: Demographic Variations of MERS-CoV Infection among Suspected and Confirmed Cases: An Epidemiological Analysis of Laboratory-Based Data from Riyadh Regional Laboratory\nPassage: Our study covered two main regions in Saudi Arabia and provides evidence that the MERS-CoV epidemic in these two regions has specific characteristics that might help future plans for prevention and management of such contagious diseases.",
        "Future studies should aim to confirm such findings in other regions in Saudi\n\nTitle: Demographic Variations of MERS-CoV Infection among Suspected and Confirmed Cases: An Epidemiological Analysis of Laboratory-Based Data from Riyadh Regional Laboratory\nPassage: Our data reported a higher prevalence of infection among Saudi nationals as compared with non-Saudi. Another study also showed similar results but with a much higher percentage among Saudis, which may be due to the fact that it included Saudis from all regions .",
        "Title: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: been rare ."
      ],
      "computed_relevance": 0.2857142857142857,
      "computed_utilization": 0.2857142857142857,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.05555555555555555,
      "gt_utilization": 0.05555555555555555,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 51,
      "dataset_id": "1492",
      "question": "Which Western European country is estimated to have the lowest attack rate?",
      "ground_truth_answer": "Germany.",
      "generated_response": "<think>\nOkay, let's see. The user is asking which Western European country has the lowest attack rate based on the provided context. The context has four different passages, each mentioning different countries and their attack rates.\n\nFirst, I need to parse each passage carefully. The first passage says the attack rate is highest in Spain, followed by Italy, and lowest in Germany. That's a clear statement. The second passage mentions Germany having one of the lowest attack rates at 0.7% with 600,000 infected. The third passage talks about Spain with an attack rate of 9.8%. The fourth mentions France at 3.0%.\n\nSo, putting this together: Spain is highest at 9.8%, France is 3.0%, and Germany is 0.7%. The first passage says Germany is the lowest, which aligns with the second passage's 0.7%. The other countries mentioned are Italy (but no specific rate given except being after Spain) and France. Since Germany's rate is explicitly stated as 0.7%, which is lower than France's 3.0%, and the first passage says Germany is the lowest, the answer should be Germany.\n</think>\n\nThe Western European country estimated to have the lowest attack rate is **Germany**, with an attack rate of 0.7%. This is explicitly stated in the context, which also notes that Germany has one of the lowest attack rates compared to other countries like Spain (9.8%) and France (3.0%).",
      "retrieved_chunks": [
        "Title: Estimating the number of infections and the impact of non-\nPassage: to date \u2014 the attack rate - is estimated to be highest in Spain followed by Italy and lowest in Germany\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: infected to date. Germany is estimated to have one of the lowest attack rates at 0.7% with 600,000\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: infected as of March 28th, giving an attack rate of 9.8% of the population . Spain\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: France 3.0%"
      ],
      "computed_relevance": 0.6666666666666666,
      "computed_utilization": 0.6666666666666666,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.3333333333333333,
      "gt_utilization": 0.2222222222222222,
      "gt_completeness": 0.6666666666666666,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 52,
      "dataset_id": "1301",
      "question": "What was the focus of the study?",
      "ground_truth_answer": "The focus of the study was to investigate community responses to communication campaigns for influenza A (H1N1) and to provide evidence-based practical information to guide the development and delivery of key health messages for H1N1 and other health campaigns. The study specifically focused on the responses of different target groups, including M\u0101ori, Pacific Peoples, children, general population, and vulnerable people with chronic conditions, to the key health messages in the 2009 and 2010 H1N1 campaigns.",
      "generated_response": "<think>\nOkay, let's see. The user is asking what the focus of the study was. I need to look through the provided context to find the answer.\n\nFirst, looking at the titles and passages. The title mentions \"Community responses to communication campaigns for influenza A (H1N1): a focus group study.\" So the study is about how communities responded to H1N1 communication campaigns.\n\nIn the first passage, it says the primary objective was to provide health authorities with evidence-based info to guide developing health messages for H1N1 and other campaigns. They focused on community responses to key messages in 2009 and 2010 H1N1 campaigns.\n\nAnother part mentions that the study was part of a rapid response initiative using focus groups as efficient data collection. They had eight groups with 7-13 participants each, targeting five populations: M\u0101ori, Pacific Peoples, children, general population, and vulnerable people with chronic conditions.\n\nSo putting it all together, the focus was on understanding how different community groups responded to the H1N1 communication campaigns, specifically the key health messages from 2009-2010, to help improve future health messaging. The answer should mention the community responses, the specific campaigns, and the purpose of guiding health authorities in message development.\n</think>\n\nThe focus of the study was to investigate **community responses to key health messages in the 2009 and 2010 influenza A (H1N1) communication campaigns**. It aimed to provide health authorities with evidence-based insights to improve the development and delivery of health messages for H1N1 and other public health campaigns. The study specifically examined responses across five target populations: M\u0101ori, Pacific Peoples, children, the general population, and vulnerable individuals with chronic conditions.",
      "retrieved_chunks": [
        "Title: Community responses to communication campaigns for influenza A (H1N1): a focus group study\nPassage: The analysis of the focus group data was undertaken by a single researcher who was neither present at the focus groups nor had read any preliminary findings.",
        "Title: Community responses to communication campaigns for influenza A (H1N1): a focus group study\nPassage: The primary objective of this study was to provide health authorities with evidence-based practical information to guide the development and delivery of key health messages for H1N1 and other health campaigns. The study focused on community responses to key health messages in the 2009 and 2010 H1N1 campaigns. Title: Community responses to communication campaigns for influenza A (H1N1): a focus group study\nPassage: The study was part of a rapid response initiative; therefore focus groups were selected as the most efficient means of data collection in the time available.",
        "Eight semi-structured focus groups were recruited between May and July 2010 comprising 7 to 13 participants each and lasting approximately 1 hour. Separate focus groups were conducted for each of the target groups with a total of 80 participants representative of five target populations groups identified in consultation with Ministry of Health staff: M\u0101ori, Pacific Peoples, children , general population, and vulnerable people with chronic conditions (defined as those who are eligible for subsidised\n\nTitle: Community responses to communication campaigns for influenza A (H1N1): a focus group study\nPassage: All focus group sessions were recorded and independently, professionally transcribed.",
        "This work was verified by the focus group facilitators to ensure that any \"contextual richness\" had not been missed in the data.",
        "The extracts used to illustrate the content of each theme are identified by codes which correspond to the focus group transcripts from which they were taken ."
      ],
      "computed_relevance": 0.375,
      "computed_utilization": 0.5,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.29411764705882354,
      "gt_utilization": 0.17647058823529413,
      "gt_completeness": 0.6,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 53,
      "dataset_id": "171",
      "question": "What organ produces hepcidin?",
      "ground_truth_answer": "The liver and airway epithelial cells (AECs) produce hepcidin.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking which organ produces hepcidin. I need to look through the provided context and passages to find the answer.\n\nFirst, in the first context, it says, \"Evidence suggests that other cells may express the hepcidin mRNA at a much lower level than the hepatocytes...\" Hepatocytes are liver cells, so that's a hint that the liver is involved. Then later, in the passage titled \"Silencing airway epithelial cell-derived hepcidin exacerbates sepsis-induced acute lung injury,\" the first sentence states, \"Hepcidin is produced predominantly by hepatocytes.\" That's pretty clear. Another part of the same passage mentions, \"Hepcidin is a \u03b2-defensin-like antimicrobial peptide that is mainly produced by the liver.\" So both the liver and hepatocytes (which are liver cells) are mentioned here.\n\nWait, but there's also a mention of airway epithelial cells (AECs) producing hepcidin in response to interferon-\u03b3 and during sepsis. However, the passages emphasize that the primary production is by the liver. The other contexts talk about extrahepatic production (meaning outside the liver) but note that it's at a lower level and the significance is uncertain. So while other cells might produce some hepcidin, the main organ is the liver.\n\nSo putting it all together, the primary organ that produces hepcidin is the liver. The answer should be the liver.\n</think>\n\nThe primary organ that produces hepcidin is the **liver**. While other cells, such as airway epithelial cells (AECs), may express hepcidin mRNA in response to specific conditions (e.g., inflammation or sepsis), the liver (specifically hepatocytes) is the main site of hepcidin production. This is explicitly stated in the context: \"Hepcidin is produced predominantly by hepatocytes\" and \"mainly produced by the liver.\" Extrahepatic production occurs at lower levels, but the liver remains the central organ for hepcidin synthesis. \n\n**Answer:** The liver.",
      "retrieved_chunks": [
        "Evidence suggests that other cells may express the hepcidin mRNA at a much lower level than the hepatocytes; the biological significance of the extra hepatic production of hepcidin remains uncertain. Plasma hepcidin is freely treated through glomeruli and in animals with normal kidney activity it quickly passes through the urine. In addition, a part of hepcidin is cleansed through degradation along with ferritin .",
        "A recent study reported that hepcidin is expressed in AECs in response to interferon-\u03b3 . In the current study, an increased hepcidin level in AECs was observed during polymicrobial sepsis. Because the lung is the first vital organ that is adversely affected at the onset of sepsis , the elevated expression of hepcidin may protect the mice against lung injury. To support this hypothesis, knockdown of hepcidin in AECs exacerbated sepsisinduced lung injury .",
        "Factors that cause hepcidin production are increased in bone marrow and anemia. Other factors that increase the production of hepcidin are iron accumulation and inflammation .",
        "Title: Silencing airway epithelial cell-derived hepcidin exacerbates sepsis-induced acute lung injury\nPassage: Hepcidin is a \u03b2-defensin-like antimicrobial peptide that is mainly produced by the liver. Hepcidin not only shows antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and yeasts, but also functions as a principal iron regulatory hormone . Hepcidin binds to the iron export protein ferroportin and induces its internalization and degradation, which leads to decreased cellular iron export and increased intracellular iron retention . Because iron is an essential nutrient for all organisms, hepcidin also restricts the iron available to invading microbes, thereby enhancing the host defense against pathogens . Furthermore, hepcidin can modulate the lipopolysaccharide -induced acute inflammatory response via\n\nTitle: Silencing airway epithelial cell-derived hepcidin exacerbates sepsis-induced acute lung injury\nPassage: Hepcidin is produced predominantly by hepatocytes.",
        "Considering that\n\nTitle: Performance evaluation of antimicrobial peptide ll-37 and hepcidin and \u03b2-defensin-2 secreted by mesenchymal stem cells\nPassage: Hepcidin is bound to plasma alpha-2 macroglobulin ."
      ],
      "computed_relevance": 0.13333333333333333,
      "computed_utilization": 0.4,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.15384615384615385,
      "gt_utilization": 0.15384615384615385,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 54,
      "dataset_id": "737",
      "question": "What makes phage display technology useful for other applications?",
      "ground_truth_answer": "The unique physicochemical properties of the phage, in combination with modular display of peptides and proteins with known binding specificity, have spawned novel materials with diverse applications. Additionally, the unusual biophysical properties of filamentous phage can be exploited in the study of structures of other macromolecules, such as partially ordering DNA, RNA, proteins, and other biomolecules for measurement of dipolar coupling interactions in NMR spectroscopy.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking what makes phage display technology useful for other applications. The context provided is from a paper titled \"Beyond phage display...\" which discusses non-traditional uses of filamentous bacteriophage.\n\nFirst, I need to recall what phage display is. From what I remember, phage display is a technique where phages (viruses that infect bacteria) are used to display peptides or proteins on their surface. This is typically used for selecting molecules that bind to specific targets, like in antibody development. But the question is about other applications beyond the traditional use.\n\nLooking at the provided passages, there are a few key points. The first passage mentions that phage display mimics the immune system's somatic evolution strategy, allowing for improved binding. However, other systems like yeast display have advantages for affinity maturation. But the main point here is that despite challenges, phage display has unique properties.\n\nThe second and fourth passages talk about the unique physicochemical and biophysical properties of filamentous phage. These properties, combined with the ability to display peptides and proteins with known binding specificity, have led to novel materials with diverse applications. Additionally, the phage's properties can be used to study other macromolecules. For example, magnetic alignment of phage in solution can partially order biomolecules for NMR spectroscopy measurements, like dipolar coupling interactions.\n\nSo, putting this together, the answer should highlight the unique properties of the phage (physicochemical and biophysical) that allow for modular display of specific binding molecules. These properties enable applications beyond traditional display methods, such as creating novel materials and aiding in structural studies of other biomolecules through techniques like NMR. The mention of magnetic alignment and its use in ordering molecules for NMR is a specific example of how these properties are exploited in other applications.\n\nI need to make sure the answer addresses both the modular display aspect and the unique properties that allow for these other uses. Also, the fact that they can be used as scaffolds for bioconjugation, vaccines, etc., as hinted in the title. The answer should not focus on the traditional use but on the non-traditional ones mentioned in the context.\n</think>\n\nThe filamentous bacteriophage's utility for non-traditional applications stems from its **unique physicochemical and biophysical properties**, combined with its ability to **modularly display peptides and proteins with known binding specificity",
      "retrieved_chunks": [
        "Title: Beyond phage display: non-traditional applications of the filamentous bacteriophage as a vaccine carrier, therapeutic biologic, and bioconjugation scaffold\nPassage: of improved or altered binding, roughly mimicking the somatic evolution strategy of the immune system . However, other in vitro display systems, such as yeast display, have important advantages over the filamentous phage for affinity maturation , and regardless of the display method, selection of \"improved\" variants can be slow and cumbersome.",
        "Title: Beyond phage display: non-traditional applications of the filamentous bacteriophage as a vaccine carrier, therapeutic biologic, and bioconjugation scaffold\nPassage: of improved or altered binding, roughly mimicking the somatic evolution strategy of the immune system . However, other in vitro display systems, such as yeast display, have important advantages over the filamentous phage for affinity maturation , and regardless of the display method, selection of \"improved\" variants can be slow and cumbersome.",
        "Title: Beyond phage display: non-traditional applications of the filamentous bacteriophage as a vaccine carrier, therapeutic biologic, and bioconjugation scaffold\nPassage: Thus, the unique physicochemical properties of the phage, in combination with modular display of peptides and proteins with known binding specificity, have spawned wholly novel materials with diverse applications. It is worth noting that the unusual biophysical properties of the filamentous phage can also be exploited in the study of structures of other macromolecules. Magnetic alignment of high-concentration filamentous phage in solution can partially order DNA, RNA, proteins, and other biomolecules for measurement of dipolar coupling interactions in NMR spectroscopy.",
        "Title: Beyond phage display: non-traditional applications of the filamentous bacteriophage as a vaccine carrier, therapeutic biologic, and bioconjugation scaffold\nPassage: Thus, the unique physicochemical properties of the phage, in combination with modular display of peptides and proteins with known binding specificity, have spawned wholly novel materials with diverse applications. It is worth noting that the unusual biophysical properties of the filamentous phage can also be exploited in the study of structures of other macromolecules. Magnetic alignment of high-concentration filamentous phage in solution can partially order DNA, RNA, proteins, and other biomolecules for measurement of dipolar coupling interactions in NMR spectroscopy.",
        "Iterative methods have been developed to combine computationally designed mutations and circumvent the screening of combinatorial libraries, but these have had limited success to date."
      ],
      "computed_relevance": 0.5454545454545454,
      "computed_utilization": 0.7272727272727273,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.75,
      "gt_utilization": 0.375,
      "gt_completeness": 0.5,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 55,
      "dataset_id": "1468",
      "question": "What is the structure of Hantaan virus?",
      "ground_truth_answer": "The structure of Hantaan virus is spherical or ovoid, composed of 20-30% fat, >50% protein, 7% carbohydrates, and 2% RNA. The genome comprises three negative sense, single-stranded RNAs that consist of the small, medium, and large segments encoding the nucleoprotein, envelope glycoproteins, and viral RNA-dependent RNA polymerase, respectively. The outer membrane of Hantaan virus is composed of Gn and Gc glycoproteins.",
      "generated_response": "<think>\nOkay, let's tackle this question about the structure of Hantaan virus. The user wants to know what the structure is, so I need to extract relevant information from the provided context.\n\nFirst, looking at the first passage: it mentions the diameter of hantavirus particles is 80-210 nm and that the structure is spherical or ovoid. That's a basic shape and size. Then it talks about the outer membrane being composed of Gn and Gc glycoproteins. These glycoproteins help in recognizing and entering host cells. Another part says the crystal structure of HTNV Gn is similar to PUUV Gn, indicating conservation among hantaviruses.\n\nAnother passage mentions the genome has three segments: S, M, and L. The S segment codes for nucleocapsid protein and a small non-structural protein. The M segment is for the glycoprotein precursor (Gn and Gc), and the L segment is the RNA polymerase. Also, the genome is negative-sense, single-stranded RNA. \n\nThere's also info about the composition: 20-30% fat, over 50% protein, 7% carbs, 2% RNA. So the structure includes a lipid envelope with glycoproteins, a nucleocapsid with nucleoprotein, and the three RNA segments. \n\nPutting this together, the structure should mention the shape (spherical/ovoid), size, outer membrane components (Gn and Gc), the three RNA segments and their encoded proteins, and the overall composition percentages. Need to make sure all these points are covered concisely in the answer.\n</think>\n\nThe structure of Hantaan virus (HTNV) includes a spherical or ovoid shape with a diameter of 80\u2013210 nm. It has an outer lipid membrane embedded with glycoproteins **Gn** and **Gc**, which mediate host cell recognition and entry. The viral genome consists of three negative-sense, single-stranded RNA segments:  \n1. **S segment**: Encodes the nucleocapsid protein and a small non-structural protein.  \n2. **M segment**: Encodes the glycoprotein precursor (Gn and Gc).  \n3. **L segment**: Encodes the RNA-dependent RNA polymerase.  \n\nThe virus is composed of approximately 20\u201330% lipid, >50",
      "retrieved_chunks": [
        "Title: Vaccines and Therapeutics Against Hantaviruses\nPassage: The diameter of hantavirus particles is 80-US210 nm, and the structure is spherical or ovoid.",
        "The outer membrane of hantavirus is composed of Gn and Gc\n\nTitle: Vaccines and Therapeutics Against Hantaviruses\nPassage: glycoprotein, which mediates the recognition of and entry into host cells. The crystal structure of HTNV Gn is very similar to that of PUUV Gn, which confirms that hantavirus Gn is conserved in hantavirus . Title: Complete Genome and Phylogeny of Puumala Hantavirus Isolates Circulating in France\nPassage: negative polarity: S segment codes for the nucleocapsid protein and a small non-structural s protein in several viral species; M segment for the glycoprotein precursor of the envelope glycoproteins Gn and Gc; and L segment for the RNA-dependent RNA polymerase . Each hantavirus is predominantly associated with one or a few distinct mammal species and this stable virus-host association underscore the importance of host-related factors for understanding current distribution, evolution and epidemiology and mechanisms of emergence. Title: Novel Identified HLA-A*0201-Restricted Hantaan Virus Glycoprotein Cytotoxic T-Cell Epitopes Could Effectively Induce Protective Responses in HLA-A2.1/K(b) Transgenic Mice May Associate with the Severity of Hemorrhagic Fever with Renal Syndrome\nPassage: Hantaan virus antigens in the supernatants of the tissue samples of Tg mice were detected by sandwich ELISA.",
        "The anti-HTNV NP mAb 1A8 was prepared in the Department of Microbiology of our university.",
        "The genome comprises three negative sense, single-stranded RNAs that consist the small , medium , and large segments that encode the nucleoprotein , envelope glycoproteins , and viral RNA-dependent RNA polymerase , respectively .",
        "They are composed of 20-30% fat, >50% protein, 7% carbohydrates, and 2% RNA."
      ],
      "computed_relevance": 0.4444444444444444,
      "computed_utilization": 0.4444444444444444,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.3,
      "gt_utilization": 0.3,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 56,
      "dataset_id": "1628",
      "question": "Are the modern day Influenza viruses related to the 1918 Spanish Influenza virus?",
      "ground_truth_answer": "Based on the given context, it is suggested that modern day Influenza viruses may be related to the 1918 Spanish Influenza virus. The passages mention the origin and evolution of the 1918 influenza virus, and also discuss the possibility of a 1918-like virus circulating in Europe and North America in the 19th century. Furthermore, there is a question posed about whether a 1918-like pandemic could appear again, indicating a potential relation between the 1918 virus and modern day Influenza viruses.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking if modern-day influenza viruses are related to the 1918 Spanish Influenza virus. I need to base my answer on the provided context.\n\nLooking at the context, there are a few passages mentioned. The first one talks about the origin and evolution of the 1918 virus's hemagglutinin gene. The title \"The 1918 Influenza Pandemic: Looking Back, Looking Forward\" suggests that they're discussing both past and future aspects. The second passage mentions that a 1918-like virus might have circulated in the late 19th century in Europe and North America, but Madrid might have been an exception. Another passage asks if a 1918-like pandemic could appear again, and another one titled \"12. If So, How and Why?\" probably discusses the mechanisms.\n\nThe key points here are about the evolution of the hemagglutinin gene and the possibility of a similar virus re-emerging. Hemagglutinin is a surface protein in influenza viruses that's crucial for infection. If the 1918 virus's hemagglutinin has evolved, then modern viruses might be descendants or have related genes. The mention of a 1918-like virus circulating in the late 1800s implies that the virus has been around for a long time, possibly evolving into current strains.\n\nThe authors listed (Reid AH, Fanning TG, Hultin JV, Taubenberger JK) are likely researchers who studied the 1918 virus. Their work probably shows genetic links between the 1918 strain and modern ones. The fact that the context mentions reconciling the idea of the 1918 virus's presence in the late 19th century with Madrid's possible exemption suggests that the virus has a long history and might have evolved into current strains.\n\nSo, putting it all together, the answer should state that modern influenza viruses are related to the 1918 Spanish flu through genetic evolution, particularly in the hemagglutinin gene. The 1918 virus's lineage might have persisted and evolved over time, leading to current strains. The possibility of a 1918-like pandemic reappearing is also mentioned, indicating that the virus's genetic makeup could still influence modern strains.\n</think>\n\nAnswer",
      "retrieved_chunks": [
        "Origin and evolution of the 1918 \u201cSpanish\u201d influenza virus hemagglutinin gene. Title: The 1918 Influenza Pandemic: Looking Back, Looking Forward\nPassage: finding, and it will be important for future work to reconcile the well-accepted idea that a 1918-like virus may have circulated in Europe and North America in the second half of the 19th century, with the notion that Madrid would have escaped this virus. Title: 1918 Influenza: the Mother of All Pandemics\nPassage: by the Same Virus?",
        "Title: 1918 Influenza: the Mother of All Pandemics\nPassage: Could a 1918-like Pandemic Appear Again?",
        "Title: 1918 Influenza: the Mother of All Pandemics\nPassage: 12.",
        "If So, How and Why?",
        "Reid AH, Fanning TG, Hultin JV, Taubenberger JK."
      ],
      "computed_relevance": 0.2857142857142857,
      "computed_utilization": 0.2857142857142857,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 57,
      "dataset_id": "1239",
      "question": "What is the transmission of MERS-CoV is defined as?",
      "ground_truth_answer": "The transmission of MERS-CoV is defined as sporadic, intra-familial, often healthcare associated, inefficient, and requiring close and prolonged contact.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how the transmission of MERS-CoV is defined based on the provided context. I need to look through the passages given to find the relevant information.\n\nFirst, I'll scan each passage. The first one mentions that transmission is \"sporadic, intra-familial, often healthcare associated, inefficient and requiring close and prolonged contact.\" That seems like a direct answer. The second passage talks about transmission between DCs and humans, but the key point here is the definition from the first passage. The third passage reinforces that MERS-CoV spreads ineffectively and is mostly in healthcare settings due to poor infection control. The fourth passage is about case definitions but not directly about transmission.\n\nSo the main points are sporadic, intra-familial, healthcare-associated, inefficient, and requiring close and prolonged contact. I should make sure there's no other info in other passages that adds to this. The third passage also mentions that transmission occurs in healthcare settings, which aligns with the \"often healthcare associated\" part. The household study in the first passage supports the close contact aspect. \n\nI think that's all. The answer should include those key terms from the first passage, as they directly answer the question.\n</think>\n\nThe transmission of MERS-CoV is defined as **sporadic, intra-familial, often healthcare-associated, inefficient, and requiring close and prolonged contact**. This is explicitly stated in the first passage, which emphasizes that transmission occurs primarily through close and prolonged exposure, particularly in healthcare settings or households, rather than through efficient community spread.",
      "retrieved_chunks": [
        "Title: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: MERS-CoV was found and characterized because of its apparent association with severe, and therefore more obvious, illness in humans; we were the canaries in the coal mine. Sero-assays and prospective cohort studies have yet to determine the extent to which milder or asymptomatic cases contribute to MERS-CoV transmission chains. However, transmission of MERS-CoV is defined as sporadic , intra-familial, often healthcare associated, inefficient and requiring close and prolonged contact In a household study, 14 of 280 contacts of 26 MERS-CoV positive index patients were RNA or antibody positive; the rate of general transmission, even in outbreaks is around 3 %\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: of \"contact\" during these interviews has been defined for one study . Despite this lack of clarity, the WHO consider that evidence linking MERS-CoV transmission between DCs to humans is irrefutable .",
        "From July 2013, the revised WHO case definition included the importance of seeking out and understanding the role of asymptomatic cases and from June 2014, the WHO definition more\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: It became apparent early on that MERS-CoV spread relatively ineffectively from human-to-human. Despite ongoing and possibly seasonal introduction of virus to the human population via infected DCs and perhaps other animals yet to be identified, the vast majority of MERS-CoV transmission has occurred from infected to uninfected humans in close and prolonged contact through circumstances created by poor infection control in health care settings. This opportunistic virus has had its greatest impact on those with underlying diseases and such vulnerable people, sometimes suffering multiple comorbidities, have been most often associated with hospitals, creating a perfect storm of exposure, transmission and",
        "Title: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: The first WHO case definition defined probable cases of MERS based on the presence of febrile illness, cough and requirement for hospitalization with suspicion of lower respiratory tract involvement.",
        "If strictly adhered to, only the severe syndrome would be subject to laboratory testing, which was the paradigm early on .",
        "It also included roles for contact with a probable or confirmed case or for travel or residence within the Arabian Peninsula."
      ],
      "computed_relevance": 0.1,
      "computed_utilization": 0.1,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.25,
      "gt_utilization": 0.0625,
      "gt_completeness": 0.25,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 58,
      "dataset_id": "495",
      "question": "What is carageenan?",
      "ground_truth_answer": "Carrageenan is a high molecular weight sulfated polymer derived from red seaweed that has been extensively used in food, cosmetic and pharmaceutical industry and is generally recognized as safe by the FDA. It has three main forms: kappa, iota, and lambda, which differ in their degree of sulfation, solubility, and gelling properties.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What is carrageenan?\" I need to base my answer on the provided context.\n\nFirst, I'll look through the context given. The first paragraph says that carrageenan is a high molecular weight sulfated polymer derived from red seaweed. It's used in food, cosmetics, and pharmaceuticals and is considered safe by the FDA. There are three main types: kappa, iota, and lambda.\n\nThen there's mention of a stock solution with iota and kappa carrageenan in specific concentrations. Another part talks about the antiviral mechanism involving interference with viral attachment, preventing viral entry. The title mentions a study on using zanamivir and carrageenan against influenza, and another passage notes that carrageenan creates a protective barrier in the nasal cavity. Also, there's a mention of NMR analysis confirming purity and the presence of lambda being below detection.\n\nSo, putting this together, carrageenan is a substance from red seaweed, used in various industries. It has different types (kappa, iota, lambda), and it's used in antiviral treatments by creating a barrier and blocking viral entry. The answer should include its source, types, uses, and maybe the antiviral mechanism briefly. Need to make sure not to include any extra info not in the context. Also, check if the answer is concise but covers all key points.\n</think>\n\nCarrageenan is a high molecular weight sulfated polymer derived from red seaweed, widely used in the food, cosmetic, and pharmaceutical industries. It is generally recognized as safe by the FDA and exists in three main forms: kappa, iota, and lambda. The context highlights its antiviral properties, which involve creating a protective physical barrier (e.g., in the nasal cavity) and interfering with viral attachment to prevent viral entry. Specific subtypes like iota- and kappa-carrageenan are used in formulations for antiviral applications, such as combating influenza A virus.",
      "retrieved_chunks": [
        "Carrageenan is a high molecular weight sulfated polymer derived from red seaweed that has been extensively used in food, cosmetic and pharmaceutical industry and is generally recognized as safe by the FDA ). Three main forms of carrageenans are commercially used: kappa, iota and lambda.",
        "For further testing the stock solution was diluted to a mixture containing 1.2 mg/ml iota-carrageenan and 0.4 mg/ml kappa-carrageenan .",
        "The antiviral mechanism of carrageenan is based on the interference with viral attachment; as a consequence, viral entry is\n\nTitle: The Intranasal Application of Zanamivir and Carrageenan Is Synergistically Active against Influenza A Virus in the Murine Model\nPassage: Kappa-carrageenan and iota-carrageenan were purchased from FMC Biopolymers . The identity, purity of carrageenan subtypes and the molecular weight was confirmed by NMR analysis as described elsewhere and the presence of lambda-carrageenan was below the detection limit of 3%.",
        "Title: The Intranasal Application of Zanamivir and Carrageenan Is Synergistically Active against Influenza A Virus in the Murine Model\nPassage: One approach for a broad antiviral therapy is the creation of a protective physical barrier in the nasal cavity using carrageenan.",
        "Molecular cartoon drawn with Chimera."
      ],
      "computed_relevance": 0.2857142857142857,
      "computed_utilization": 0.7142857142857143,
      "computed_completeness": 0.5,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2631578947368421,
      "gt_utilization": 0.15789473684210525,
      "gt_completeness": 0.6,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 59,
      "dataset_id": "1740",
      "question": "What is an effective public health hygiene?",
      "ground_truth_answer": "An effective public health hygiene is hand hygiene, which includes handwashing, safe cough practices, and social distancing to prevent the spread of respiratory viruses such as SARS-CoV-2. It has been shown to be a highly effective intervention in reducing the impact of COVID-19 and other respiratory infections.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What is an effective public health hygiene?\" based on the provided context. Let me go through each of the given passages to find relevant information.\n\nFirst, the first context talks about a study on pandemic influenza A (H1N1) in Hong Kong. It mentions that self-efficacy in preventing H1N1 influences hand hygiene but not social distancing. It also says that formal health education focusing on self-efficacy in hygiene practices is effective for improving hand hygiene. However, if the practice is already established, trust in messages doesn't significantly increase it. So, hand hygiene is highlighted here as effective.\n\nThe second context is a focus group study on community responses to H1N1 communication campaigns. Participants remembered hygiene self-efficacy measures like handwashing, using sanitizer, covering coughs, and staying home. This again points to hand hygiene as a key measure.\n\nThird, the passage about Korea's National Handwashing Survey from 2006-2014 states that hand hygiene education in public facilities reduced infection risks. In hospitals, compliance reduced in-hospital infections and resource use. It also mentions that handwashing programs are a high priority in public health, with role models like healthcare workers promoting it. Institutional support is crucial here. So, hand hygiene education and institutional support are emphasized.\n\nThe fourth context discusses responding to COVID-19 in humanitarian crises. It notes that respiratory hygiene, including hand hygiene, safe coughing, and social distancing, is effective against respiratory viruses. The example of Pacific Peoples groups shows that these measures can be translated into action effectively.\n\nPutting this all together, the common theme across all contexts is hand hygiene. Each passage underscores the importance of handwashing, use of sanitizers, and education programs. Additionally, social distancing is mentioned but less effective in some contexts. The effectiveness of hand hygiene is supported by multiple studies showing reduced infection rates and the role of education and institutional support in promoting these practices. Therefore, the answer should highlight hand hygiene as the effective public health measure, supported by education and infrastructure like soap distribution.\n</think>\n\nAn effective public health hygiene measure is **hand hygiene**, which includes practices such as **handwashing with soap**, using hand sanitizers, and maintaining respiratory hygiene (e.g., covering coughs and sneezes). The provided contexts highlight that:  \n- Hand hygiene is a **readily implemented behavior** with strong evidence of reducing",
      "retrieved_chunks": [
        "Title: Situational Awareness and Health Protective Responses to Pandemic Influenza A (H1N1) in Hong Kong: A Cross-Sectional Study\nPassage: Self-efficacy in preventing A/H1N1 influences hand hygiene but has little influence on social distancing. Formal health education messages that focus on enhancing the public's sense of their ability to protect themselves by adopting hygiene practices would seem to be the most effective to improve hand hygiene, but where the practice is already established, high levels of trust in these messages are not likely to significantly increase hand hygiene.",
        "Title: Community responses to communication campaigns for influenza A (H1N1): a focus group study\nPassage: Recall of key health messages was varied, however most participants were aware of hygiene self-efficacy measures such as hand washing, sanitiser use, covering of coughs and sneezes, and staying at home.",
        "Hand hygiene is a readily implemented behavior: the distribution of soap to households in humanitarian settings has been shown to increase handwashing by over 30% . Furthermore, hand hygiene is an avenue of agency for protecting one's own health, consistent with the\n\nTitle: Handwashing with soap and national handwashing projects in Korea: focus on the National Handwashing Survey, 2006-2014\nPassage: Hand hygiene education in public facilities such as schools and kindergartens resulted in reduced risk of infection, and hand hygiene compliance in hospital settings reduced the incidence of in-hospital infections and, thus, reduced demand for hospital resources . Worldwide, handwashing and hand hygiene education programs have high priority in public health programs, in which role models such as healthcare workers and community members encourage hand hygiene. Institutional support for funded studies and interventions should be a top-priority agenda item in order to improve hand hygiene behaviors .",
        "Title: Responding to the COVID-19 pandemic in complex humanitarian crises\nPassage: To mitigate the impact of COVID-19 on crisesaffected populations, governments and agencies will implement the familiar, global evidence-based approaches for combatting respiratory viruses. Respiratory hygiene is a highly effective public health intervention, supported by evidence demonstrating that the spread of respiratory viruses, such as SARS-CoV-2, can be prevented by hand hygiene, safe cough practice, and social distancing .",
        "This was particularly strong in one of the Pacific Peoples groups and for many appeared to be translated into action."
      ],
      "computed_relevance": 0.7,
      "computed_utilization": 0.8,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.4666666666666667,
      "gt_utilization": 0.2,
      "gt_completeness": 0.42857142857142855,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 60,
      "dataset_id": "1255",
      "question": "What would  aid accurate calculation of a case fatality ratio?",
      "ground_truth_answer": "The accurate calculation of a case fatality ratio would be aided by considering the probability of dying from the disease and accounting for biases in data reporting.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking what would aid in accurately calculating the case fatality ratio (CFR). The context provided mentions that a crude estimator like D/N (deaths divided by notified cases) underestimates the true CFR. The passage explains that this underestimation happens because of the integral part of an equation being less than 1, which I think relates to the time lag between when cases are reported and when deaths occur.\n\nSo, the key issue here is that if you just take the number of deaths divided by the number of reported cases at a given time, you're not accounting for the fact that some people who are infected might still be in the process of developing the disease and haven't died yet. This leads to an underestimation because the denominator (notified cases) includes people who might die later, but the numerator (deaths) doesn't account for them yet.\n\nThe context also mentions that the problem has been addressed by various authors with different assumptions about data availability. So, to get a more accurate CFR, you need to adjust for these time lags. One approach might be to use a distribution of times between infection and death. For example, if you know how long it typically takes from infection to death, you can adjust the calculation to account for the fact that some cases will result in death later. This would involve more sophisticated statistical methods rather than a simple D/N ratio.\n\nAnother point from the context is the mention of the infection fatality ratio (IFR) and how non-pharmaceutical interventions (like lockdowns) can influence the rate of death and estimated cases. This suggests that understanding the distribution of time from infection to death (as mentioned in the passage with \"distribution of times\") is crucial. If you can model the time it takes for someone to progress from infection to death, you can adjust the CFR calculation to account for the delay, thereby getting a more accurate estimate.\n\nSo, putting this together, the answer should involve adjusting for the time lag between case notification and death. This could be done by using a more sophisticated model that incorporates the distribution of the time from infection to death, rather than using a simple ratio. Additionally, ensuring that the data accounts for all cases, including those that are not yet reported or have not resulted in death, would help. The context also hints at the importance of data availability and making assumptions that account for biases in reporting, which are necessary for accurate estimation",
      "retrieved_chunks": [
        "Title: Estimating the number of infections and the impact of non-\nPassage: to the infection fatality ratio. Title: Estimation in emerging epidemics: biases and remedies\nPassage: Another useful application of the above result is to countbased estimation of the case fatality rate .",
        "It is well known that a crude estimator of the type D/N, D denoting number of dead individuals and N number of notified individuals in , will underestimate the 'true' CFR. In theory, disregarding biased reporting, the underestimation is reflected in the integral part of equation , which is always less than 1, where h\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: influence the rate of death and hence the estimated number of true underlying cases. Title: Estimating the number of infections and the impact of non-\nPassage: 19 infection-fatality-ratio ifr 9 together with a distribution oftimes",
        "In this case, p represents the probability of dying from the disease.",
        "The problem has been treated by many authors under many different assumptions of data availability )."
      ],
      "computed_relevance": 0.2857142857142857,
      "computed_utilization": 0.2857142857142857,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.5833333333333334,
      "gt_utilization": 0.3333333333333333,
      "gt_completeness": 0.5714285714285714,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 61,
      "dataset_id": "1718",
      "question": "Why might we underestimate the spread of COVID19?",
      "ground_truth_answer": "The spread of COVID-19 might be underestimated due to the inaccuracies in describing the geographic spread of the virus, as well as the high level of uncertainty and bias in estimating the number of infections and the impact of non-social distancing interventions. Additionally, data quality and availability impose limitations on modeling analysis, which could also contribute to underestimating the spread of COVID-19.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking why we might underestimate the spread of COVID-19. I need to look at the provided context to find clues.\n\nFirst, the context mentions that initial seeding of the infection uses region-specific probabilities based on data. But then there are several passages with titles and content about estimating infections and the impact of non-... something. Maybe non-pharmaceutical interventions? The passage says that social distancing was one of the first interventions. \n\nThen there's a part about detecting low transmission distance in the 2009 flu pandemic. The results support the idea that geographic spread might be inaccurately described by raw commuting data. Also, they mention that other factors could have caused changes in infection rates, and data quality and availability are limitations.\n\nPutting this together, possible reasons for underestimating spread could be data quality issues, like incomplete or inaccurate reporting. Also, if models rely on commuting data which doesn't account for behavioral changes (like people reducing travel due to social distancing), that could lead to underestimation. Additionally, other factors not considered in the models might influence transmission rates, making the estimates less accurate. The mention of high uncertainty in the passage also points to possible underestimation because of unknown variables or limitations in data collection methods.\n</think>\n\nThe spread of COVID-19 might be underestimated due to several factors highlighted in the context:  \n1. **Data quality and availability limitations**: Incomplete or inaccurate reporting of cases can lead to biased estimates of infection trends.  \n2. **Reliance on commuting fluxes**: Models using raw commuting data to predict geographic spread may fail to account for human behavioral adaptations (e.g., reduced travel due to social distancing), leading to inaccuracies.  \n3. **Unaccounted factors**: Changes in transmission rates could be influenced by variables not included in the analysis (e.g., asymptomatic cases, varying compliance with interventions), creating uncertainty in projections.  \n4. **High uncertainty in modeling**: The inherently complex and dynamic nature of pandemics, combined with evolving human behavior, introduces significant uncertainty into predictions.  \n\nThese issues collectively risk underestimating the true scale and spread of the virus.",
      "retrieved_chunks": [
        "First, concerning the initial seeding of the infection, we compute the region-specific probability of importing cases by using data on the\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: gives a systematically biased view of trends. Title: Estimating the number of infections and the impact of non-\nPassage: with a high level of uncertainty. Title: Estimating the number of infections and the impact of non-\nPassage: Social distancing encouraged: As one of the first interventions against the spread of the COVID-19",
        "Title: Detecting a Surprisingly Low Transmission Distance in the Early Phase of the 2009 Influenza Pandemic\nPassage: Our results support the idea already presented by Birrell et al. 53 that the geographic spread of influenza might be inaccurately described by raw commuting fluxes.",
        "However, although our results point in the direction of a human behavioral adaptation to the pandemic threat, they are far from conclusive.",
        "In fact, other factors could have been responsible for the changes in the force of infection that we measured.",
        "Clearly, data quality and availability impose several limitations on our modeling analysis."
      ],
      "computed_relevance": 0.25,
      "computed_utilization": 0.625,
      "computed_completeness": 0.5,
      "computed_adherence": 0.0,
      "gt_relevance": 0.5833333333333334,
      "gt_utilization": 0.3333333333333333,
      "gt_completeness": 0.5714285714285714,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 62,
      "dataset_id": "658",
      "question": "What is the effect of host immune response to the delivery vector on the efficacy of vaccination?",
      "ground_truth_answer": "The effect of host immune response to the delivery vector on the efficacy of vaccination varies. Some studies indicate that pre-existing immunity to the delivery vector may decrease immune responses against the delivered antigens, particularly impacting humoral responses and CD8+ responses. However, repeated immunization with the same vaccine and dose may counteract the negative impact and lead to higher priming of naive T cells against the delivered antigen. Additionally, controlling pre-host evolution of the vaccine vector may be a feasible way to limit within-host evolution and minimize the loss of immunity from vaccine evolution. For viral vectors, cell-mediated immunity may have a more pronounced impact, often resulting in a reduction in subsequent immune response, especially with common viral vectors like Ad which many people have immunological memory against.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about the effect of the host's immune response to the delivery vector on vaccine efficacy. I need to base my answer on the provided context.\n\nFirst, I'll look through the context passages. The first passage mentions that repeated immunization with the same vaccine can counteract the negative impact of vector-specific immune responses. It says this leads to higher priming of naive T cells against the antigen. But then it notes that repeated vaccination might not be practical in real-world scenarios. \n\nAnother part of the context says that exposure to the empty vector can completely abrogate immune responses against the delivered antigens. Also, the downregulation of antigen-specific responses depends on dose and time. \n\nThe second passage titled \"Pre-existing immunity against vaccine vectors \u2013 friend or foe?\" mentions that for viral vectors, cell-mediated immunity has a more pronounced effect, leading to reduced subsequent immune responses. The reasoning is that the first dose induces neutralizing antibodies, which then limit transduced cells in subsequent doses, thus limiting the immune response.\n\nPutting this together, the host's immune response to the vector (like developing neutralizing antibodies) can reduce the vaccine's efficacy. This is because the immune system attacks the vector itself, preventing it from delivering the antigen effectively. However, repeated vaccination might help by priming more naive T cells, but that's not always feasible. Also, pre-existing immunity (like from prior exposure to the vector) can abrogate the immune response to the antigen. \n\nSo the main points are: the immune response against the vector can reduce vaccine efficacy by neutralizing the vector, limiting antigen delivery. But factors like dose, timing, and repeated immunization can influence this effect. The answer should mention both the negative impact and possible mitigation strategies.\n</think>\n\nThe host immune response to the delivery vector can significantly reduce the efficacy of vaccination. Specifically, pre-existing immunity against the vector (e.g., from prior exposure) may **abrogate immune responses to the delivered antigens**, as the host's immune system targets the vector itself rather than the antigen. For viral vectors, this often involves the induction of **neutralizing antibodies** after the first dose, which limit the number of transduced cells in subsequent doses, thereby diminishing the antigen-specific immune response. Additionally, vector-specific immune responses (e.g., cell-mediated immunity) can downregulate antigen-specific immunity, with the magnitude of this effect depending on **dose and timing**.",
      "retrieved_chunks": [
        "also demonstrated that the negative impact of vector-specific immune responses can also be countered by repeated immunization with the same vaccine and dose; this in effect leads to higher priming of naive T cells against the delivered antigen. Of course, such repeated vaccination may not be practicable in real-world situations.",
        "Title: Recombinant vector vaccine evolution\nPassage: The effect of any 'pre-host' evolution on the host immune response is potentially as important as the effect of within-host evolution.",
        "indicated that exposure to the empty vector may completely abrogate immune responses against the delivered antigens . However, these studies also indicate that downregulation of antigenspecific immune responses is highly dependent on dose and time.",
        "An important difference between the two realms is that pre-host evolution may be more easily mitigated than is within-host evolution. That is, controlling pre-host evolution may be a feasible way to limit within-host evolution and to limit the loss of immunity from vaccine evolution. Title: Pre-existing immunity against vaccine vectors \u2013 friend or foe?",
        "Title: Pre-existing immunity against vaccine vectors \u2013 friend or foe? Passage: For viral vectors, the impact of cell-mediated immunity was more pronounced, and as depicted in Table 2 , almost always resulted in a reduction in the subsequent immune response. Presumably this is because viruses will induce neutralizing antibody on the first dose, and in subsequent doses this antibody will limit the number of transduced cells, therefore limiting the responses."
      ],
      "computed_relevance": 0.45454545454545453,
      "computed_utilization": 0.45454545454545453,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.5882352941176471,
      "gt_utilization": 0.47058823529411764,
      "gt_completeness": 0.7,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 63,
      "dataset_id": "1612",
      "question": "What is another  case in point?",
      "ground_truth_answer": "Another case in point is the use of case examples as training material for public health nurses based on real cases that have come to the attention of the RKI in the quality control process.",
      "generated_response": "<think>\nOkay, let's see. The user is asking for another case in point based on the provided context. The context is about a study on the reliability of case definitions in public health surveillance using a Round-Robin test methodology. \n\nFirst, I need to understand what \"another case in point\" refers to. A \"case in point\" is an example that illustrates a particular idea or situation. In the context given, the study mentions that 220 out of 396 respondents found the case examples realistic. The case examples were based on real cases from RKI's quality control and hotline. They also mention that the case examples were created from facsimile excerpts of sources like lab reports, physician forms, and patient interviews.\n\nThe question is asking for another example of a case in point. The original case examples are the ones created from real cases. So another case in point would be another instance where case examples were used effectively. The passage also mentions that the case example book is now used as training material for public health nurses. That could be another case in point. Alternatively, the fourth outcome variable used to assess different styles of case definitions (narrative vs. checklist) might be another example. \n\nWait, the fourth outcome variable was about comparing narrative descriptions to checklist formats. The study used this to analyze the effect of different case definition styles. So maybe that's another case in point. The user is looking for another example from the context that serves as a case in point. The answer should be something specific mentioned in the context. Let me check the context again.\n\nThe context says that the case examples were based on real cases from RKI's quality control and hotline. Another case in point could be the use of the case example book as training material. The passage states that the book is now used as training material for public health nurses. That's another example of how the case examples were applied beyond just the study. So that's a valid case in point. Alternatively, the fourth outcome variable is another case in point in terms of the study's methodology. But the question is about another case example, not another variable. The answer should be the training material use. Let me confirm. The original case examples were the ones created from real cases. The training material is a result of the study, so it's another case in point showing the application of the case examples. Yes, that makes sense. So the answer would be that the case example",
      "retrieved_chunks": [
        "With respect to the case examples presented to the participants, 220 of 396 respondents stated that the case examples were realistic.",
        "The clinical classification was considered correct if the part regarding the clinical picture was classified according to the gold standard, regardless whether other parts of the case definition were correctly classified or not. This analysis was done to compare case definitions with narrative description of the clinical pic-ture to case definitions with a more explicit check-list format of clinical criteria, that was implemented for diseases additionally notifiable in specific states and for the new IfSG case definitions.",
        "The case examples were created based on real cases that have come to the attention of the RKI in the quality control process and in the information service hotline that the RKI is offering to the health departments.",
        "Title: Reliability of case definitions for public health surveillance assessed by Round-Robin test methodology\nPassage: The case example book, which resulted from this study, constitutes a detailed feed back for the participants of the study and is now being used as training material for public health nurses. Title: Reliability of case definitions for public health surveillance assessed by Round-Robin test methodology\nPassage: The case examples consisted in facsimile excerpts of one or more of the following sources: laboratory report form, physician form, and protocol of the patient interview .",
        "Title: Reliability of case definitions for public health surveillance assessed by Round-Robin test methodology\nPassage: To specifically assess the effect of different styles in formulating case definitions, a fourth outcome variable was used."
      ],
      "computed_relevance": 0.5714285714285714,
      "computed_utilization": 0.5714285714285714,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.25,
      "gt_utilization": 0.16666666666666666,
      "gt_completeness": 0.6666666666666666,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 64,
      "dataset_id": "39",
      "question": "How many antigens could be detected by Liew's multiplex ELISA test?",
      "ground_truth_answer": "Liew's multiplex ELISA test could detect 9 antigens.",
      "generated_response": "<think>\nOkay, let's see. The question is asking how many antigens could be detected by Liew's multiplex ELISA test.\n\nLooking at the context provided, the first sentence says: \"Liew validated one multiplex ELISA for the detection of 9 antigens.\" So that seems straightforward. The key part here is \"detection of 9 antigens.\" That should be the answer.\n\nBut wait, I need to make sure there's no other information conflicting or adding to this. The rest of the context talks about Anderson using microarray ELISA for antibodies in breast cancer and mentions other studies about ELISA-arrays for encephalitis viruses. However, those don't relate to Liew's specific work. The other passages mention things like antibody concentrations, protocols, and other studies, but they don't mention the number of antigens for Liew's test. \n\nSo the answer should be 9 antigens. The first sentence in the context clearly states that. I don't see any other numbers related to Liew's work here. The other parts discuss different applications or other researchers' methods, but not Liew's specific count. Therefore, the answer is 9.\n</think>\n\nThe context explicitly states that Liew validated a multiplex ELISA for the detection of **9 antigens**. This information is directly provided in the first sentence of the passage and is not contradicted or modified elsewhere in the context. Other details in the text pertain to different studies (e.g., Anderson\u2019s work or ELISA-array protocols for encephalitis viruses) and do not affect the count of antigens in Liew\u2019s test.\n\n**Answer:** 9 antigens.",
      "retrieved_chunks": [
        "Liew validated one multiplex ELISA for the detection of 9 antigens; Anderson used microarray ELISA for multiplex detection of antibodies to tumor antigens in breast cancer, and demonstrated that ELISA-based array assays had the broadest dynamic range and lowest sample volume requirements compared with the other assays.",
        "Title: Development of an ELISA-array for simultaneous detection of five encephalitis viruses\nPassage: for printing than for coating ELISA plates.",
        "Coating of a single well in microtiter plate requires 100 \u03bcl of a 1 \u03bcg/ml antibody solution, which is equivalent to 100 ng of IgG. For the ELISA-array, only 30 nl of a 50 \u03bcg/ml antibody solution is required for each spot, which is equivalent to 1.5 ng of IgG. With the characteristics of ease of use, sensitivity, specificity, and accuracy, the ELISA-array assay would be widely accepted for clinical use.",
        "Title: Development of an ELISA-array for simultaneous detection of five encephalitis viruses\nPassage: Antibody arrays for simultaneous multiple antigen quantification are considered the most accurate methods .",
        "Title: Development of an ELISA-array for simultaneous detection of five encephalitis viruses\nPassage: antibodies demonstrated that 0.05 mg/ml was also suitable. Title: Development of an ELISA-array for simultaneous detection of five encephalitis viruses\nPassage: Antigen binding was performed in PBS at 37\u00b0C for 2 h, followed by washing 3 times. Incubation of ELISA plates with biotinylated detecting antibody cocktails was performed in PBS at 37\u00b0C for 2 h. After washing, specific binding of the detecting antibodies was reported by streptavidin-HRP and stained with Super Signal ELISA Femto Maximum sensitive substrate ."
      ],
      "computed_relevance": 0.1,
      "computed_utilization": 0.1,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.125,
      "gt_utilization": 0.0625,
      "gt_completeness": 0.5,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 65,
      "dataset_id": "1270",
      "question": "How were the radiology department areas divided?",
      "ground_truth_answer": "The radiology department areas were divided into contaminated, semicontaminated, and clean areas.",
      "generated_response": "<think>\nOkay, let's see. The user is asking how the radiology department areas were divided. The context provided has a few passages from the same article titled \"The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management.\" \n\nLooking at the first passage: \"The radiology department was divided into four areas : contaminated, semicontaminated,\" but it seems like the sentence is cut off. The second passage mentions \"Figure 1. Diagram of the layout of our radiology department was divided into four areas: contaminated\" again, which also seems incomplete. The third passage just says \"Reconfiguration of the radiology department\" without details. The fourth passage gives numbers about staff but not the division.\n\nSo, the key information is in the first two passages. They both mention that the department was divided into four areas, and the first two areas listed are contaminated and semicontaminated. However, the sentences are incomplete, so maybe the original text had more areas but they got cut off. But since the user is asking specifically how the areas were divided, the answer should be that they were divided into four areas, with the first two being contaminated and semicontaminated. The other two areas aren't mentioned in the provided context, so I can't include them. The answer should reflect the information given, even if incomplete.\n</think>\n\nThe radiology department was divided into four areas, with the first two explicitly mentioned as **contaminated** and **semicontaminated**. The provided context does not specify the names or details of the remaining two areas.",
      "retrieved_chunks": [
        "Title: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: The radiology department was divided into four areas : contaminated, semicontaminated,\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Figure 1. Diagram of the layout of our radiology department was divided into four areas: contaminated\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Reconfiguration of the radiology department\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: The radiology department has 65 diagnostic radiologists and 161 other staff members"
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.3333333333333333,
      "gt_utilization": 0.2222222222222222,
      "gt_completeness": 0.6666666666666666,
      "gt_adherence": 0.0,
      "binary_pred": 0,
      "binary_gt": 0,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 66,
      "dataset_id": "1428",
      "question": "What is an example of this?",
      "ground_truth_answer": "An example of this is the transition from ice ages to interglacial periods, which is an Earth system threshold point and phase change.",
      "generated_response": "<think>\nOkay, let's see. The user is asking for an example of a phase change based on the provided context. The context mentions social phase changes like an audience applauding or a crowd fleeing a storm. It also mentions \"eco-social\" changes and examples like transitions to something (the passage is cut off). Then there are other passages about infectious diseases, Chinese journals, Earth system thresholds, and health in the Anthropocene. The examples given there include ice ages to interglacial periods and water freezing.\n\nThe question is asking for an example of a phase change. The answer needs to be based on the context provided. The user's answer should probably be one of the examples mentioned. Let me check the context again. The first context says social phase changes include audience standing to applaud, fleeing a storm, or open hostility. The other examples in the passages include Earth system thresholds like ice ages to interglacial periods. The health passage mentions awakening as a phase change. But the user's answer should be from the context given. The answer given in the example is \"an audience standing to applaud\" which is from the first context. So the correct answer here would be one of those examples. The user's answer should be one of the social phase changes mentioned. The answer provided in the example is \"an audience standing to applaud\" so that's likely the expected answer here.\n</think>\n\nAnswer: An example of a social phase change is when an audience stands to applaud.",
      "retrieved_chunks": [
        "Social phase changes also occur, such as when an audience stands to applaud, or when a crowd in an uncovered stadium flees a violent storm. The onset of open hostility is another example of a social phase change. \"Eco-social\" changes can also occur, and are discussed below.",
        "Examples include the transition to\n\nTitle: The interconnected and cross-border nature of risks posed by infectious diseases\nPassage: It is instructive to provide a few examples of how such risks are interconnected in the context of infectious disease.",
        "Title: Chinese journals: a guide for epidemiologists\nPassage: an example of how a colonial legacy has left a language heritage that fosters internationalisation in this globalising world.",
        "Examples of Earth system threshold points and phase changes include the switch from ice ages to interglacial periods.",
        "Title: Sounding the Alarm: Health in the Anthropocene\nPassage: Examples of phase changes are when water solidifies at freezing point or when we awaken."
      ],
      "computed_relevance": 0.14285714285714285,
      "computed_utilization": 0.14285714285714285,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.16666666666666666,
      "gt_utilization": 0.1111111111111111,
      "gt_completeness": 0.6666666666666666,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 67,
      "dataset_id": "959",
      "question": "What  did the first report on adenovirus as a vector demonstrate?",
      "ground_truth_answer": "The first report on adenovirus as a vector demonstrated its ability to stimulate both innate and adaptive immune responses and induce both T and B cell responses. Adenovirus vectors have been extensively examined as a delivery vector in several preclinical and clinical studies for infectious diseases.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking what the first report on adenovirus as a vector demonstrated. The context provided includes several passages about adenovirus vectors used in vaccines.\n\nFirst, I need to look at the first passage mentioned. The first passage's title is \"Nasal Delivery of an Adenovirus-Based Vaccine Bypasses Pre-Existing Immunity to the Vaccine Carrier and Improves the Immune Response in Mice.\" The passage mentions using an affinity column according to the manufacturer's instructions. But the key point here is about nasal delivery and bypassing pre-existing immunity. \n\nThe next passage is from another study titled \"Vaccination to Conserved Influenza Antigens in Mice Using a Novel Simian Adenovirus Vector, PanAd3...\" which talks about cross-blocking being minimal when using different vectors. However, the first report would be the first one listed here. \n\nThe context also mentions that adenovirus vectors are evaluated for their ability to stimulate both innate and adaptive immune responses, induce T and B cells, and their ease of production. The first report's main finding seems to be that nasal delivery allows the vaccine to bypass pre-existing immunity to the vector itself, which is a problem because if someone has been exposed to adenovirus before, their immune system might attack the vector before it can work. By bypassing that, the vaccine's effectiveness is improved. \n\nSo the answer should focus on the nasal delivery method overcoming pre-existing immunity and enhancing the immune response. The other passages talk about different aspects like simian adenovirus vectors and particle measurements, but the first one is specifically about nasal delivery and pre-existing immunity.\n</think>\n\nThe first report on adenovirus as a vector demonstrated that **nasal delivery of an adenovirus-based vaccine can bypass pre-existing immunity to the vaccine carrier (the adenovirus vector) and improve the immune response in mice**. This is significant because pre-existing immunity to adenovirus vectors often limits their effectiveness, but nasal administration circumvents this issue, enhancing the vaccine's ability to induce immune responses.",
      "retrieved_chunks": [
        "The adenovirus vector is another of the most widely evaluated vectors to date to express heterologous antigens, due to ease of production, safety profile, genetic stability, the ease of DNA genome manipulation, and the ability to stimulate both innate and adaptive immune responses and induce both T and B cell responses .",
        "Title: Nasal Delivery of an Adenovirus-Based Vaccine Bypasses Pre-Existing Immunity to the Vaccine Carrier and Improves the Immune Response in Mice\nPassage: an affinity column according to the manufacturer's instructions.",
        "Title: Vaccination to Conserved Influenza Antigens in Mice Using a Novel Simian Adenovirus Vector, PanAd3, Derived from the Bonobo Pan paniscus\nPassage: and four chimpanzee adenovirus vectors, prior immunization with a GFPexpressing construct blocked subsequent responses to the transgene product only for homologous vector; cross-blocking was minimal . Title: Vaccination to Conserved Influenza Antigens in Mice Using a Novel Simian Adenovirus Vector, PanAd3, Derived from the Bonobo Pan paniscus\nPassage: Viral particle measurements of adenovirus stocks were made by measurement of absorbance at 260 nm as described .",
        "They have been extensively examined as a delivery vector in several preclinical and clinical studies for infectious diseases such as anthrax, hepatitis B, human immunodeficiency virus -1, influenza, measles, severe acute respiratory syndrome , malaria and tuberculosis M.",
        "Particle number and infectivity of vectors were determined by standard optical density reading and immunodetection of the hexon protein, respectively, following infection of 293 cells with limiting dilutions of each vector preparation according to the recommendations by the manufacturer ."
      ],
      "computed_relevance": 0.16666666666666666,
      "computed_utilization": 0.8333333333333334,
      "computed_completeness": 0.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.23076923076923078,
      "gt_utilization": 0.15384615384615385,
      "gt_completeness": 0.6666666666666666,
      "gt_adherence": 0.0,
      "binary_pred": 1,
      "binary_gt": 0,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 68,
      "dataset_id": "344",
      "question": "What has been correlated with the pathogenicity of the H5N1 infection?",
      "ground_truth_answer": "The pathogenicity of the H5N1 infection has been correlated with various factors, including viral replication overwhelming the host immune system, specific amino acid substitutions in PB2, and exposure to poultry. It has also been noted that comorbidities are a major risk for death from the H5N1 virus.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking what has been correlated with the pathogenicity of H5N1 infection. I need to look through the provided context to find the relevant information.\n\nFirst, looking at the first passage, it mentions that the severity of illnesses from avian influenza is linked to host factors like chronic diseases, immunosuppressive disorders, delayed diagnosis, and late antiviral treatment. Also, virus factors such as pathogenicity, replication, and mutations are mentioned. But the question is specifically about H5N1, which is a high pathogenicity virus mentioned in the titles.\n\nIn the second passage, it states that poultry exposure and comorbidities are major risks for death from H5N1. However, the question is about pathogenicity, not just risk factors for death. The third passage talks about the pathogenesis of HPAIV (Highly Pathogenic Avian Influenza Virus) being complex and dependent on host and viral factors. It mentions that pathogenicity is related to viral replication, which can overwhelm the host's immune system or cause it to malfunction. Also, various viral factors are linked to differences in pathogenicity.\n\nSo putting this together, the answer should include both host factors (like comorbidities, exposure) and viral factors (replication, mutations, specific amino acid substitutions in PB2). The specific mention of PB2 substitutions is from the first passage. The third passage also emphasizes viral replication and immune system interaction. The second passage adds poultry exposure as a risk, but since the question is about pathogenicity, maybe the main factors are viral replication, mutations, and host factors like comorbidities. Wait, the user is asking what is correlated with pathogenicity, not just risk of death. The passage says pathogenicity is related to viral replication and factors that affect the immune system. Also, the first passage mentions specific amino acid substitutions in PB2 as a virus factor. So combining all these points, the answer should list those factors.\n</think>\n\nThe pathogenicity of H5N1 infection has been correlated with **viral factors** such as **viral replication**, **amino acid substitutions in viral proteins (e.g., PB2)**, and **mutations** that enhance virulence. Additionally, **host factors** like **poultry exposure** and **comorbidities** (e.g., chronic diseases, immunos",
      "retrieved_chunks": [
        "Title: Comparative Epidemiology of Human Fatal Infections with Novel, High (H5N6 and H5N1) and Low (H7N9 and H9N2) Pathogenicity Avian Influenza A Viruses\nPassage: Previous studies have shown that the severities of the illnesses caused by avian influenza are linked to host factors, including chronic diseases, immuno-suppressive disorders, delayed confirmation of infection and late antiviral treatment , as well as virus factors such as pathogenicity, replications and mutations .",
        "Specific amino acid substitutions in PB2 ,\n\nTitle: Comparative Epidemiology of Human Fatal Infections with Novel, High (H5N6 and H5N1) and Low (H7N9 and H9N2) Pathogenicity Avian Influenza A Viruses\nPassage: generally had significantly higher levels of exposure to poultry, while the secondary cases subsequently became infected after providing care for the ill index patients or after spending prolonged periods of time with them. These findings show that poultry exposure and comorbidities are the major risks of death from the H5N1 virus. Title: Pathogenicity of Genetically Similar, H5N1 Highly Pathogenic Avian Influenza Virus Strains in Chicken and the Differences in Sensitivity among Different Chicken Breeds\nPassage: As the pathogenesis of HPAIV is complicated and is dependent on various host and viral factors, in this study, we compared the pathogenicity of five genetically related H5N1 viruses isolated from wild birds in Thailand between 2004 and 2005 to that in a commercial chicken breed, White Leghorn. Then, Thai indigenous chickens were inoculated with an H5N1 virus, and their sensitivity to infection and the genetic components related to the host response were examined.",
        "However, the mechanism underlying the highly pathogenic manifestation of the H5N1 viruses in chickens has not been fully elucidated.",
        "Viruses like influenza are continually exposed to host immune systems, and their pathogenicity is thought to be related to viral replication, which either overwhelms the host immune system or causes it to malfunction. Various viral factors have been shown to be related to differences in pathogenicity.",
        "Title: Pathogenicity of Genetically Similar, H5N1 Highly Pathogenic Avian Influenza Virus Strains in Chicken and the Differences in Sensitivity among Different Chicken Breeds\nPassage: The H5N1 virus is endemic in poultry and has caused occasional infections in mammals."
      ],
      "computed_relevance": 0.2222222222222222,
      "computed_utilization": 0.2222222222222222,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.375,
      "gt_utilization": 0.125,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 0.0,
      "binary_pred": 1,
      "binary_gt": 0,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 69,
      "dataset_id": "674",
      "question": "What factors determine an effective mucosal immune response?",
      "ground_truth_answer": "The factors that determine an effective mucosal immune response include the induction of systemic antibody responses, the stability of the mucus barrier, the secretion of intact, gel-forming mucus, the availability of mucosal immune proteins, including immunoglobulins and trefoil factor peptides, and the regulation of the unfolded protein response at the mucosal barrier. Additionally, the presence of cytokines such as IL-4, IL-13, and IL-10 can also contribute to an effective mucosal immune response.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking what factors determine an effective mucosal immune response. I need to base my answer on the provided context and passages. Let me start by going through each part of the context carefully.\n\nFirst, the context mentions that factors ensure mucosal cell integrity and epithelial homeostasis through restitution and regeneration. So, processes like cell repair and regeneration are important. Then, there's something about Th2-oriented immunity leading to limited Th1-related antibodies, which are better for viral clearance. That suggests that the balance between Th1 and Th2 responses might be a factor. \n\nLooking at the passages, the first one talks about IL-23/Th17 phenotype and mucin glycosylation changes helping clear parasites. The second passage mentions cytokines like IL-4, IL-13, and IL-10 boosting mucin production in goblet cells. The third passage discusses the mucus barrier stability relying on intact mucus and immune proteins like immunoglobulins and trefoil factors.\n\nSo, putting this together, factors could include the balance of Th1/Th2 responses, the role of specific cytokines (IL-4, IL-13, IL-10, IL-23, Th17), mucin production and glycosylation, the integrity of the mucus barrier, and the interaction between the gut microbiota and the mucus layer. Also, the unfolded protein response mentioned in the title might relate to cellular stress responses affecting immunity. \n\nI need to make sure I don't miss any key points. The context also mentions Goblet cell depletion in NEC, which indicates that Goblet cell function is crucial. The passages also talk about microbial sensing by colonic goblet cells leading to inflammation if disrupted. So microbial sensing and appropriate immune cell activation are factors. \n\nAnother point is the unfolded protein response (UPR) regulation in the mucosal barrier during viral infections. The UPR might help in managing cellular stress, which is important for maintaining immune function. \n\nSo summarizing, the factors would involve cytokine regulation (specific ones mentioned), Th cell subsets (Th1, Th2, Th17), mucin production and glycosylation, mucus barrier integrity, goblet cell function, microbial sensing, and the UPR. Also, the interaction between innate and adaptive immunity components like immunoglobulins and trefoil factors. \n\nI need to",
      "retrieved_chunks": [
        "Together these factors normally ensure mucosal cell integrity and epithelial homeostasis through restitution and regeneration processes.",
        "Furthermore, due to the default Th2oriented nature of mucosal immunity, mucosal immunization shows limited induction of Th1-related antibody subtypes , which are preferable for viral clearance .",
        "A role for the mucins in the pathogenesis of NEC is indicated by the depletion of Goblet cells seen in the mucosa of neonates with NEC and this is expected\n\nTitle: Immune regulation of the unfolded protein response at the mucosal barrier in viral infection\nPassage: of both innate and adaptive immunities with an IL-23/T H 17 phenotype. 28, 29 Immune-regulated alterations in mucin glycosylation following Trichuris muris infection contribute to clearance of parasitic infection.",
        "31 Overriding GC microbial sensing to open colonic GAPs or inappropriate delivery of luminal pathogens through GAPs resulted in the influx of leucocytes and the production of inflammatory cytokines in the setting of normal, non-pathogenic, microbiota. 31, 32 This microbial sensing by colonic GCs has a critical role\n\nTitle: Immune regulation of the unfolded protein response at the mucosal barrier in viral infection\nPassage: As discussed, cytokines such as IL-4, IL-13 and IL-10 can boost protein production in mucin-secreting goblet cells.",
        "Title: The Interaction of the Gut Microbiota with the Mucus Barrier in Health and Disease in Human\nPassage: The stability of the mucus barrier and the innate defense mechanisms rely on the secretion of intact, gel forming mucus and the availability of mucosal immune proteins, including immunoglobulins and the trefoil factor peptides."
      ],
      "computed_relevance": 0.5714285714285714,
      "computed_utilization": 0.5714285714285714,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.4444444444444444,
      "gt_utilization": 0.3333333333333333,
      "gt_completeness": 0.75,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 70,
      "dataset_id": "843",
      "question": "What are potential vaccines based on?",
      "ground_truth_answer": "Potential vaccines are based on various platforms including viral vector-based vaccine, DNA vaccine, subunit vaccine, virus-like particles-based vaccine, inactivated whole-virus vaccine, and live attenuated vaccine.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What are potential vaccines based on?\" and they provided some context. Let me go through the context step by step.\n\nFirst, the context mentions several types of vaccines in development: viral vector-based, DNA, subunit, virus-like particles-based, inactivated whole-virus, and live attenuated vaccines. The latest findings are from a review by Yong et al. So that's a list of vaccine types.\n\nThen there's a passage titled \"Viral vector-based influenza vaccines\" which says more novel vector-based vaccines will be developed and tested. Another passage titled \"Vaccines for the future...\" talks about traditional vaccines using inactivated or attenuated pathogens, purified subunits like toxins, proteins, polysaccharides. These work by eliciting antibodies. It also mentions multivalent vaccines for pathogens with moderate antigen variability. There's a mention of the Yellow fever vaccine YF-17D and challenges with regulatory approval for vector-based vaccines.\n\nThe question is asking about potential vaccines based on what. The answer should list the types mentioned. The context lists several, so I need to make sure I include all of them. Let me check again:\n\nFrom the first paragraph: viral vector-based, DNA, subunit, virus-like particles-based, inactivated whole-virus, live attenuated. The other passages mention traditional ones like inactivated, attenuated, subunits (proteins, toxins, polysaccharides), and multivalent vaccines. But the question is about potential vaccines, so maybe the ones in development. The first list is the main one here. The answer should include all those types listed in the context. Also, the mention of virus-like particles and subunit vaccines. Let me confirm if there's any other type mentioned. The Yellow fever vaccine is an example of a live attenuated vaccine perhaps? But the main list is the first one. So the answer should list all those types as the basis for potential vaccines.\n</think>\n\nPotential vaccines are based on several platforms, including **viral vector-based**, **DNA**, **subunit**, **virus-like particles (VLPs)-based**, **inactivated whole-virus**, and **live attenuated** approaches. These are highlighted in the context as being in development or review. Additionally, traditional methods such as **inactivated or attenuated pathogens** and **purified pathogen subunits** (e.g., toxins,",
      "retrieved_chunks": [
        "The vaccines in development include viral vector-based vaccine, DNA vaccine, subunit vaccine, virus-like particles -based vaccine, inactivated whole-virus vaccine and live attenuated vaccine. The latest findings for these vaccines arebased on the review by Yong et al.",
        "Title: Viral vector-based influenza vaccines\nPassage: In the future, more novel vector-based influenza candidate vaccines will be developed and tested in clinical trials.",
        "There was one SARS vaccine trial conducted by\n\nTitle: Vaccines for the future: learning from human immunology\nPassage: Traditional vaccines based on inactivated or attenuated pathogens or on purified pathogen subunits, such as toxins, proteins and polysaccharides, have been very efficient in preventing infections of pathogens with low degree of antigen variability.",
        "These vaccines work mainly by eliciting functional antibodies that can neutralize viral invasion, neutralize bacterial toxins and induce opsono-phagocytosis or complement-mediated killing of bacteria . It has also been possible to develop effective vaccines to prevent pathogens that have a moderate degree of antigen variability and exist in multiple strains. The problem has been solved by developing multivalent vaccines, which combine multiple antigens, each directed against\n\nTitle: Vaccines for the future: learning from human immunology\nPassage: vaccinated with the Yellow fever vaccine YF-17D .",
        "226, 227 The biggest challenge of taking vector-based vaccines to the market may be obtaining approval from the regulatory authorities."
      ],
      "computed_relevance": 0.25,
      "computed_utilization": 0.25,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.18181818181818182,
      "gt_utilization": 0.045454545454545456,
      "gt_completeness": 0.25,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 71,
      "dataset_id": "383",
      "question": "What is the conclusion of this study?",
      "ground_truth_answer": "The conclusion of this study is that any conclusions drawn from the study should be considered tentative and further research is needed to explore the complexities involved in the way in which the framing of risk messages impacts on people's reactions.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking for the conclusion of the study based on the provided context. Let me look through the passages again.\n\nFirst, there's a study titled \"Community responses to communication campaigns for influenza A (H1N1): a focus group study.\" The passage says that conclusions should be tentative because the findings can't be generalized. They had diverse participants but the sample doesn't allow conclusions about socio-demographic factors like age or gender. Also, they mention needing more research on how risk message framing affects people.\n\nThen there's another study titled \"Estimating the number of infections and the impact of non-\" with a section labeled \"4 Conclusion and Limitations.\" The passage mentions that the appendix and general limitations are presented in the conclusions. But there's not much detail here.\n\nThe third title is \"Outcome of paediatric intensive care survivors,\" and the passage states that it's difficult to make strong conclusive statements. \n\nThe question is asking for the conclusion of \"this study.\" However, the context includes multiple studies. The first study's conclusion is that their findings are tentative and can't be generalized. The second study's conclusion section is mentioned but not detailed. The third study's conclusion is that strong statements are hard to make.\n\nSince the user is asking for \"this study,\" but the context includes multiple studies, I need to see which one is relevant. The first study's passage has a clear conclusion about tentative findings and limitations. The other studies don't have detailed conclusions provided. The answer should focus on the first study's conclusion because it's the one with the most detailed information. The key points are that conclusions are tentative, findings can't be generalized, and further research is needed on risk message framing.\n</think>\n\nThe conclusion of the study titled **\"Community responses to communication campaigns for influenza A (H1N1): a focus group study\"** is that its findings are **tentative and cannot be generalized to the broader population**. While the study included participants from diverse cultural and vulnerable groups, the sample size and composition do not allow for conclusions about socio-demographic factors like age or gender. The authors emphasize the need for further research to explore how the framing of risk messages influences public responses. \n\nOther studies mentioned in the context (e.g., on infections or pediatric intensive care outcomes) are not detailed enough to draw specific conclusions, as their summaries highlight limitations or note that strong conclusions are difficult to establish.",
      "retrieved_chunks": [
        "Title: Community responses to communication campaigns for influenza A (H1N1): a focus group study\nPassage: Any conclusions drawn from this study should be considered tentative as the findings cannot be generalised to the population at large.",
        "Whilst this study intentionally involved participants with diverse cultural and ethnic backgrounds, and included individuals from vulnerable groups, the sample does not permit conclusions regarding the effect of socio-demographic factors such as age or gender.",
        "Further research is needed to explore the complexities involved in the way in which the framing of risk messages impacts on people's\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: 4 Conclusion and Limitations",
        "Title: Estimating the number of infections and the impact of non-\nPassage: the appendix, and general limitations presented below in the conclusions.",
        "Title: Outcome of paediatric intensive care survivors\nPassage: and, therefore, strong conclusive statements difficult."
      ],
      "computed_relevance": 0.2,
      "computed_utilization": 0.2,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2727272727272727,
      "gt_utilization": 0.18181818181818182,
      "gt_completeness": 0.6666666666666666,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 72,
      "dataset_id": "453",
      "question": "What does ANFIS offer?",
      "ground_truth_answer": "ANFIS offers flexibility in determining nonlinearity in time series data and combines the properties of both artificial neural networks and fuzzy logic systems.",
      "generated_response": "<think>\nOkay, let's see. The question is asking what ANFIS offers. The context provided talks about ANFIS being used in various forecasting models. Let me go through the context again to pick out the relevant parts.\n\nFirst, the context mentions that FPASSA-ANFIS uses an improved FPA to train the ANFIS model by optimizing its parameters. It also states that ANFIS has five layers like the classic model. Then there are examples of Ekici and Aksoy using ANFIS for building energy consumption forecasting, and others using it for electricity loads, return products, and product development performance. Additionally, it says that ANFIS links fuzzy logic and neural networks.\n\nSo, putting this together, ANFIS seems to be a model that combines fuzzy logic with neural networks. The examples show it's used for forecasting different things. The key points here are the combination of fuzzy logic and neural networks, and its application in forecasting. The answer should mention that ANFIS offers a hybrid approach by integrating these two technologies, enabling it to be used in various forecasting applications. Also, since the context mentions parameter optimization with methods like FPASSA, maybe that's part of what makes it effective. But the main thing is the combination of the two systems and the forecasting capabilities.\n</think>\n\nANFIS offers a hybrid approach by integrating **fuzzy logic** and **neural networks**, enabling it to model complex, non-linear relationships. This combination allows ANFIS to be applied effectively in forecasting tasks such as building energy consumption, electricity loads, return products, and product development performance. Its ability to optimize parameters (e.g., via methods like FPASSA) further enhances its adaptability and accuracy in predictive modeling.",
      "retrieved_chunks": [
        "The FPASSA-ANFIS utilizes the improved FPA to train the ANFIS model by optimizing its parameters. The FPASSA-ANFIS contains five layers as the classic ANFIS model.",
        "However, estimating ANFIS parameters is a challenge that needs to be improved.",
        "Ekici and Aksoy presented an ANFIS based building energy consumption forecasting model. More so, ANFIS is also applied to forecast electricity loads .",
        "proposed an ANFIS based model to forecast return products. Ho and Tsai applied ANFIS to forecast product development performance.",
        "The ANFIS model links the fuzzy logic and neural networks ."
      ],
      "computed_relevance": 0.375,
      "computed_utilization": 0.75,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.10714285714285714,
      "gt_utilization": 0.07142857142857142,
      "gt_completeness": 0.6666666666666666,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 73,
      "dataset_id": "70",
      "question": "What medications have shown good promise to in vivo delivery via dry powder inhalers?",
      "ground_truth_answer": "Insulin and low-molecular-weight heparin have shown promise for in vivo delivery via dry powder inhalers.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking what medications have shown good promise for in vivo delivery via dry powder inhalers (DPIs). I need to look through the provided context to find the answer.\n\nFirst, I'll check the first passage titled \"RNAi Therapeutic Platforms for Lung Diseases.\" The passage mentions that DPIs have shown promise for delivering therapeutic macromolecules like insulin and low-molecular-weight heparin. It also suggests that DPIs could be better for delivering siRNAs to the lungs. \n\nThen, looking at the second passage about intradermal vaccination, it talks about epidermal powder immunization using helium gas, but that's probably not relevant here since the question is about DPIs. The first passage is the key one here.\n\nSo the answer should include insulin and low-molecular-weight heparin as the medications that have shown promise with DPIs. The passage also mentions that DPIs could be used for siRNAs, but the question is about medications that have already shown promise. Since siRNA is mentioned as a potential future use but not yet proven, the answer should stick to the ones already tested: insulin and heparin.\n</think>\n\nThe medications that have shown good promise for in vivo delivery via dry powder inhalers (DPIs) are **insulin** and **low-molecular-weight heparin**. The passage explicitly states that DPIs have already demonstrated potential for delivering these therapeutic macromolecules, suggesting their suitability for such delivery methods.",
      "retrieved_chunks": [
        "Overall, great expectations are coming\n\nTitle: RNAi Therapeutic Platforms for Lung Diseases\nPassage: The use of aerosols to deliver medication to the lungs has a long history. Administration by inhalation is a popular and non-invasive method of delivering agents into the lungs. There are several inhalation devices available for the delivery of drugs into the lungs. Metered dose inhalers and dry powder inhalers are the most common modes of inhaled delivery.",
        "DPIs are devices that deliver medication to the lungs in the form of dry powder. The use of DPIs has already shown promise for the in vivo delivery of therapeutic macromolecules such as insulin and low-molecular-weight heparin ; thus, it could be a better device for delivering siRNAs to the lungs.",
        "Indeed, some of these formulations can be stored at room temperature for several months and can be administered in such form via the nasal, oral, or sublingual routes. Dry powder nasal vaccines have already been tested , oral delivery of capsules is not a problem , and many allergy-related immunotherapy tablets have been considered for sublingual administration .",
        "The advantages of\n\nTitle: Delivery Systems for Intradermal Vaccination\nPassage: Epidermal powder immunization and particle-mediated epidermal delivery utilize helium gas to deliver powdered proteins, polysaccharides, inactivated pathogens, or DNA-coated particles into the epidermis at supersonic speeds .",
        "MDIs are the most commonly used inhalers for several lung diseases, such as asthma, bronchitis, and chronic obstructive pulmonary disease , and a spacer is an external device that is attached to an MDI to allow for better drug delivery by enhanced"
      ],
      "computed_relevance": 0.2,
      "computed_utilization": 0.8,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.19230769230769232,
      "gt_utilization": 0.038461538461538464,
      "gt_completeness": 0.2,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 74,
      "dataset_id": "1135",
      "question": "What was demonstrated in deriving the equation for R 0?",
      "ground_truth_answer": "The passage demonstrates the derivation of the equation for R 0 and the sensitivity of R 0 to dispersion in the underlying distributions.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking what was demonstrated in deriving the equation for R0 based on the provided context. \n\nFirst, I need to look through the context passages to find relevant information. The first passage mentions that they identify popular methods to calculate R0, describe their limitations, and demonstrate a core problem with R0: how biologists interpret it from mathematical models. Then, there's a part about a graph-theoretic method where they start with R0 = \u03c1 and derive rules to reduce a digraph to zero weight, leading to \u03bb = R0. \n\nAnother passage talks about different curves labeled with various R0 methods (Adding and subtracting 9, Next generation, etc.), each given by different sources. The third passage mentions de Camino-Beck et al. deriving limiting values of \u03c6 to gauge R0's sensitivity to dispersion.\n\nPutting this together, the key points are the different methods for calculating R0, their limitations, and the challenges in interpreting R0 biologically. The derivation part specifically refers to the graph-theoretic approach reducing the digraph, leading to \u03bb equals R0. The main demonstration here seems to be about the process of simplifying the digraph to find R0, highlighting a core problem in its calculation. The answer should mention the graph-theoretic method's derivation steps and the resulting equation \u03bb=R0, as well as the broader issue of biological interpretation from models.\n</think>\n\nThe derivation of the equation for $ R_0 $ demonstrated a **graph-theoretic method** where researchers reduced a directed graph (digraph) associated with the next-generation matrix $ F(\\lambda^{-1} - V) $ to a zero-weight digraph. This process led to the equation $ \\lambda = R_0 $, illustrating how $ R_0 $ can be calculated mathematically. However, the context also highlights a core problem: **biologists struggle to interpret $ R_0 $ from mathematical models** due to its abstract derivation and the variability in calculation methods (e.g., \"Next generation,\" \"Exponential,\" etc.), which can yield different results depending on assumptions and simplifications. The derivation thus underscores both the technical process of calculating $ R_0 $ and the challenges in linking it to biological intuition.",
      "retrieved_chunks": [
        "Title: The Failure of R (0)\nPassage: In this section, we identify some of the more popular methods used to calculate R 0 . We also describe the limitations that each method presents and demonstrate one of the core problems with R 0 . Specifically, we address a key problem with R 0 : how do biologists make sense of it from mathematical models?",
        ", a graph-theoretic method for calculating R 0 is given. Starting from the definition of R 0 = \u03c1, they derived a series of rules for reducing the digraph associated with F\u03bb \u22121 \u2212 V to a digraph with zero weight, from which \u03bb = R 0 .",
        "Title: The Failure of R (0)\nPassage: The curve labelled \"Adding and subtracting 9\" illustrates the value R 0,9 as given by . The curve labelled \"Next generation\" illustrates R 0,N , as given by . The curve labelled \"Constant term of the characteristic polynomial\" illustrates R 0,C , as given by . The curve labelled \"Exponential\" illustrates R 0,e , as given by .",
        "Title: The Failure of R (0)\nPassage: In de Camino-Beck et al.",
        "They were able to derive limiting values of \u03c6 and used this to gauge the sensitivity of R 0 to dispersion in the underlying distributions."
      ],
      "computed_relevance": 0.2727272727272727,
      "computed_utilization": 0.9090909090909091,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.3125,
      "gt_utilization": 0.0625,
      "gt_completeness": 0.2,
      "gt_adherence": 0.0,
      "binary_pred": 0,
      "binary_gt": 0,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 75,
      "dataset_id": "235",
      "question": "What was the prevalence of Coronavirus OC 229 E/NL63 in clinical subjects in Ilorin, Nigeria?",
      "ground_truth_answer": "Coronavirus OC 229 E/NL63 was detected in 12.5% of the clinical subjects in Ilorin, Nigeria.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about the prevalence of Coronavirus OC 229 E/NL63 in clinical subjects in Ilorin, Nigeria. I need to find the answer in the provided context.\n\nFirst, I'll scan through the passages. The first context mentions that Coronavirus OC43 was common in the community, while a different strain, OC 229 E/NL63, was detected in clinic subjects but not in the community. Then, in the second passage under the same title, it says \"E/NL63 was detected in 12.5% of the clinical subjects and not detected in the community.\" That seems like the key number here. \n\nAnother part mentions that some viruses detected in the study haven't been reported in Nigeria before, like coronavirus in ARIs, detected in 12 subjects. But wait, that's about coronavirus in general, not specifically OC 229 E/NL63. The 12.5% figure is specifically about E/NL63 in clinical subjects. \n\nAlso, the abstract mentions the study's goal to compare community and clinical samples. The other percentages given (like 93.8% for parainfluenza virus 4, etc.) are for different viruses, so they're not relevant here. \n\nSo the answer should be 12.5%, as that's the exact percentage given for E/NL63 in clinical subjects. The fact that it wasn't detected in the community is also noted, but the question is only about clinical subjects. I don't see any conflicting numbers, so 12.5% is the correct answer.\n</think>\n\nThe prevalence of Coronavirus OC 229 E/NL63 in clinical subjects in Ilorin, Nigeria, was **12.5%**, as explicitly stated in the passage: \"E/NL63 was detected in 12.5% of the clinical subjects and not detected in the community.\"",
      "retrieved_chunks": [
        "Coronavirus OC43 was the most common virus detected in community members . A different strain, Coronavirus OC 229 E/NL63 was detected among subjects from the clinic and not detected in the community. This pilot study provides evidence that data from the community can potentially represent different information than that sourced clinically, suggesting the need for community surveillance to enhance public health efforts and scientific understanding of\n\nTitle: Etiology of respiratory tract infections in the community and clinic in Ilorin, Nigeria\nPassage: E/NL63 was detected in 12.5% of the clinical subjects and not detected in the community.",
        "Title: Etiology of respiratory tract infections in the community and clinic in Ilorin, Nigeria\nPassage: viruses in the clinical sample and their prevalence in the community. Finally, some of the viruses detected in this study have not been detected and implicated with ARIs in Nigeria. There is no report, to the best of our knowledge, implicating coronavirus in ARIs in Nigeria, and it was detected in 12 subjects in this study.",
        "Although cases of double and triple infections were observed in a study in Nigeria in 2011 , as far as we are aware, reports of quadruple infections are rare and have not been reported in Nigeria previously. Title: Etiology of respiratory tract infections in the community and clinic in Ilorin, Nigeria\nPassage: Abstract: OBJECTIVE: Recognizing increasing interest in community disease surveillance globally, the goal of this study was to investigate whether respiratory viruses circulating in the community may be represented through clinical surveillance in Nigeria.",
        "Parainfluenza virus 4, respiratory syncytial virus B and enterovirus were the most common viruses in the clinical sample; present in 93.8% of clinical subjects, and 6.7% of community subjects .",
        "Title: Etiology of respiratory tract infections in the community and clinic in Ilorin, Nigeria\nPassage: and 5 of quadruple."
      ],
      "computed_relevance": 0.3,
      "computed_utilization": 0.3,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.05,
      "gt_completeness": 0.25,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 76,
      "dataset_id": "585",
      "question": "How was HFRS  first brought to the attention of western medicine ?",
      "ground_truth_answer": "HFRS was first brought to the attention of western medicine in association with an outbreak that occurred among United Nations troops during the Korean conflict between 1951 and 1954, where more than 3,200 soldiers were afflicted.",
      "generated_response": "<think>\nOkay, let's see. The user is asking how HFRS was first brought to the attention of western medicine. I need to look at the provided context to find the answer.\n\nLooking at the first paragraph of the context, it says: \"HFRS as a distinct syndrome, however, was first brought to the attention of western medicine in association with an outbreak that occurred among United Nations troops during the Korean conflict between 1951 and 1954, where more than 3,200 soldiers were afflicted.\" \n\nSo the key points here are the outbreak among UN troops during the Korean conflict from 1951-1954, with over 3,200 soldiers affected. That's when western medicine first recognized HFRS as a distinct syndrome. The answer should include the outbreak, the location (Korean conflict), the group affected (UN troops), and the time frame. I need to make sure I don't add any extra information from other parts of the context. The other parts talk about treatments and vaccines, which aren't relevant to this question. Just stick to the first paragraph's details.\n</think>\n\nHFRS was first brought to the attention of western medicine through an outbreak among United Nations troops during the Korean conflict between 1951 and 1954, where over 3,200 soldiers were affected.",
      "retrieved_chunks": [
        "HFRS as a distinct syndrome, however, was first brought to the attention of western medicine in association with an outbreak that occurred among United Nations troops during the Korean conflict between 1951 and 1954, where more than 3,200 soldiers were afflicted .",
        "It has been demonstrated that admission to the ICU and supportive treatment could greatly reduce the mortality rate of HFRS . In general, the treatment principle for HFRS patients is using intravenous hydration and electrolyte therapy to maintain physiological blood pressure.",
        "Similarly, another randomized prospective study did not show any benefit from corticosteroid treatment in HFRS patients .",
        "Continuous\n\nTitle: Vaccines and Therapeutics Against Hantaviruses\nPassage: It is wildly accepted that HFRS and HCPS are caused by uncontrolled systemic inflammatory responses, in which multiple inflammatory cytokines, especially TNF-\u03b1, IL-8, and RANTES, contributed to disease progression ; however, immunoregulation treatment in HFRS or HCPS is undesirable.",
        "It took more than two decades until the etiologic agent, Hantaan virus , was isolated from the striped field mouse Apodemus agrarius, detected in part by the binding of antibodies from patient serum samples to\n\nTitle: Vaccines and Therapeutics Against Hantaviruses\nPassage: The initiation of careful observation and prompt but judicious supportive treatment is crucial to improve patient survival condition for both HFRS and HCPS ."
      ],
      "computed_relevance": 0.16666666666666666,
      "computed_utilization": 0.16666666666666666,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.10526315789473684,
      "gt_utilization": 0.05263157894736842,
      "gt_completeness": 0.5,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 77,
      "dataset_id": "991",
      "question": "What is the Newcastle disease virus?",
      "ground_truth_answer": "The Newcastle disease virus is an avian paramyxovirus type I that causes a serious disease in chickens and other birds known as ND. It has caused several outbreaks in poultry and domestic pigeons in the last four decades, leading to the development of new vaccines and vaccination protocols.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What is the Newcastle disease virus?\" I need to base my answer on the provided context.\n\nFirst, I'll look through the passages given. The first passage mentions that NDV is an avian paramyxovirus type I that causes a serious disease in chickens and other birds called ND. The title also refers to its use in vaccination for poultry and as an adjuvant in cancer patients. \n\nAnother part of the context says that NDV outbreaks were first reported in Indonesia and then in Newcastle-upon-Tyne in 1926. That's the origin story. There's also a mention of it being transcribed into mRNAs and translated into viral proteins, which relates to its replication process. \n\nThe context also notes that new viruses or variants can cause epidemics and economic losses, which highlights the impact of NDV. The fact that there have been several panzootics in poultry and pigeons in the last four decades shows how widespread the problem is. Efforts to control it involve vaccines and vaccination protocols.\n\nPutting this together, the answer should define NDV as an avian paramyxovirus causing Newcastle disease in birds, mention its impact on poultry, its origin, and its use in vaccines. I need to make sure not to include information not in the context, like specific details about cancer treatments unless the context mentions it as an adjuvant. Also, check if all the key points are covered: classification, disease caused, origin, impact, and control measures.\n</think>\n\nThe Newcastle disease virus (NDV) is an avian paramyxovirus type I that causes a serious disease in chickens and other birds, known as Newcastle disease (ND). It was first reported in outbreaks in Indonesia and later in Newcastle-upon-Tyne in 1926. The virus replicates by being transcribed into mRNAs and translated into viral proteins. NDV has led to widespread panzootics (epidemics in animals) in poultry and domestic pigeons over the past four decades, resulting in significant economic losses. Efforts to control the disease include the development of vaccines and vaccination protocols for poultry. Additionally, NDV is explored for its potential as an adjuvant in therapeutic vaccinations for cancer patients.",
      "retrieved_chunks": [
        "Title: Immunobiology of Newcastle Disease Virus and Its Use for Prophylactic Vaccination in Poultry and as Adjuvant for Therapeutic Vaccination in Cancer Patients\nPassage: NDV is an avian paramyxovirus type I which causes a serious disease in chickens and other birds known as ND . NDV outbreaks were first reported in Indonesia, and, subsequently, in Newcastle-upon-Tyne in the year 1926.",
        "Title: Immunobiology of Newcastle Disease Virus and Its Use for Prophylactic Vaccination in Poultry and as Adjuvant for Therapeutic Vaccination in Cancer Patients\nPassage: the interferon regulatory factor IRF-9. Title: Immunobiology of Newcastle Disease Virus and Its Use for Prophylactic Vaccination in Poultry and as Adjuvant for Therapeutic Vaccination in Cancer Patients\nPassage: New viruses or variants can cause epidemics and pose huge public health problems and economic losses within a short time. Title: Immunobiology of Newcastle Disease Virus and Its Use for Prophylactic Vaccination in Poultry and as Adjuvant for Therapeutic Vaccination in Cancer Patients\nPassage: is transcribed into mRNAs and is translated into viral proteins .",
        "There have been several panzootics of this disease in poultry and in domestic pigeons during the last four decades .",
        "Efforts in controlling the disease involved the development of new vaccines and vaccination protocols ."
      ],
      "computed_relevance": 0.2857142857142857,
      "computed_utilization": 0.8571428571428571,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.45454545454545453,
      "gt_utilization": 0.36363636363636365,
      "gt_completeness": 0.8,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 78,
      "dataset_id": "561",
      "question": "What is the conclusion of this report?",
      "ground_truth_answer": "The conclusion of the report is that strong conclusive statements are difficult to make due to limitations presented in the conclusions.",
      "generated_response": "<think>\nOkay, let's see. The user is asking for the conclusion of a report based on the provided context. The context includes four different titles and passages. Let me break this down.\n\nFirst, the first context is from a report titled \"Estimating the number of infections and the impact of non-\" with a passage that mentions \"4 Conclusion and Limitations\". Then there's another title \"Outcome of paediatric intensive care survivors\" with a passage stating that strong conclusive statements are difficult. The third title is \"Globalization and emerging governance modalities\" with a passage asking for two conclusions. The fourth context again refers to the same first title's appendix and general limitations in the conclusions.\n\nThe user's question is about the conclusion of \"this report\". The problem is that there are multiple contexts here. The first and fourth contexts are from what seems like the same report, given the repeated title. The passage in the first context mentions \"Conclusion and Limitations\" section, and the fourth one refers to the appendix and limitations in conclusions. The second context is about pediatric ICU survivors, making it hard to have strong conclusions. The third is a different topic altogether asking for two conclusions.\n\nSo, the key here is to determine which report the user is referring to. Since the question is about \"this report\", and the first and fourth contexts share the same title, it's likely they are part of the same report. The passage in the first context says \"4 Conclusion and Limitations\", which is a section heading. The fourth passage mentions \"the appendix, and general limitations presented below in the conclusions.\" So, the conclusion section is discussed here, but the actual conclusion isn't provided. The second context's passage says \"strong conclusive statements difficult,\" which might be part of the limitations, but that's from a different report. The third context is a separate report asking for two conclusions, but no actual conclusion is given there either.\n\nPutting this together, the main report in question is the one titled \"Estimating the number of infections and the impact of non-...\" The conclusion section is mentioned in the first and fourth contexts, but the actual conclusion isn't explicitly stated. The fourth passage refers to the appendix and general limitations in the conclusions. Since the user is asking for the conclusion, but the provided contexts don't include the actual conclusion text, the answer would have to be that the conclusion is discussed in the mentioned sections (4 Conclusion and Limitations, appendix) but isn't provided here",
      "retrieved_chunks": [
        "Title: Estimating the number of infections and the impact of non-\nPassage: 4 Conclusion and Limitations\n\nTitle: Outcome of paediatric intensive care survivors\nPassage: and, therefore, strong conclusive statements difficult.",
        "Title: Globalization and emerging governance modalities\nPassage: me two conclusions.",
        "Title: Estimating the number of infections and the impact of non-\nPassage: the appendix, and general limitations presented below in the conclusions."
      ],
      "computed_relevance": 0.6666666666666666,
      "computed_utilization": 0.6666666666666666,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.375,
      "gt_utilization": 0.125,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 79,
      "dataset_id": "881",
      "question": "What factors make bacterial and viral co-infections so lethal?",
      "ground_truth_answer": "The synergy between bacterial and viral infectious agents is related to a variety of factors, including epithelial barrier damage, exaggerated innate immune response, and cytokine storm. These factors contribute to enhanced morbidity and mortality in co-infections of the respiratory tract.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking what factors make bacterial and viral co-infections so lethal. I need to base my answer on the provided context.\n\nLooking at the context, there's a mention of synergy between bacterial and viral agents related to factors like epithelial barrier damage, exaggerated innate immune response, and cytokine storm. The passage also states that these co-infections are highly lethal and a burden on the global health system. \n\nFirst, I should identify the key factors listed. The context explicitly lists three factors: epithelial barrier damage, exaggerated innate immune response, and cytokine storm. These are the main points to include. \n\nI need to make sure there aren't any other factors mentioned. The passage also mentions that the synergistic mechanisms are poorly understood and that in vivo studies in mice don't resemble human physiology well. However, those points don't directly answer the question about the factors making co-infections lethal. They might be background info but not the answer itself.\n\nSo the answer should list the three factors from the context. I should present them clearly, maybe in a numbered or bullet format, but since the answer is to be in a box, perhaps just list them in a sentence. Also, the user wants the answer to be based solely on the context provided. No need to add external knowledge. \n\nWait, the question is \"What factors make bacterial and viral co-infections so lethal?\" The context says the synergy is related to those three factors. So the answer is those three factors. Let me check again. Yes, the exact sentence is: \"The synergy between bacterial and viral infectious agents is related to a variety of factors, including epithelial barrier damage, exaggerated innate immune response, and cytokine storm.\"\n\nTherefore, the answer should include those three factors. I need to present them as the answer. The user might also want a concise answer, so just list them. The example answer in the history used a similar structure. So the answer is those three factors.\n</think>\n\nThe lethality of bacterial and viral co-infections is attributed to factors such as epithelial barrier damage, exaggerated innate immune response, and cytokine storm. These mechanisms create a synergistic effect that enhances morbidity and mortality in respiratory tract infections.",
      "retrieved_chunks": [
        "The synergy between bacterial and viral infectious agents is related to a variety of factors, including epithelial barrier damage, exaggerated innate immune response, and cytokine storm.",
        "Title: Port d\u2019Entr\u00e9e for Respiratory Infections \u2013 Does the Influenza A Virus Pave the Way for Bacteria? Passage: In summary, bacterial and viral co-infections of the respiratory tract are highly lethal and present a dramatic burden for the global health system.",
        "The synergy between bacterial and viral infectious agents is related to a variety of factors, including epithelial barrier damage, exaggerated innate immune response, and cytokine storm.",
        "The synergistic mechanisms between viruses and bacteria leading to enhanced morbidity and mortality are poorly understood. In vivo characterizations of these severe infections are mainly performed in mice which poorly resemble the human physiology\n\nTitle: Port d\u2019Entr\u00e9e for Respiratory Infections \u2013 Does the Influenza A Virus Pave the Way for Bacteria? Passage: In summary, bacterial and viral co-infections of the respiratory tract are highly lethal and present a dramatic burden for the global health system.",
        "The synergistic mechanisms between viruses and bacteria leading to enhanced morbidity and mortality are poorly understood. In vivo characterizations of these severe infections are mainly performed in mice which poorly resemble the human physiology\n\nTitle: The human viral challenge model: accelerating the evaluation of respiratory antivirals, vaccines and novel diagnostics\nPassage: The clinical significance of viral/bacterial co-infections has long been a controversial topic."
      ],
      "computed_relevance": 0.2222222222222222,
      "computed_utilization": 0.2222222222222222,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.375,
      "gt_utilization": 0.16666666666666666,
      "gt_completeness": 0.4444444444444444,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 80,
      "dataset_id": "1728",
      "question": "How does COVID19 get spread?",
      "ground_truth_answer": "COVID-19 is suspected to be spread through contact with infected respiratory secretions, close contact with an infected person, and potentially through faecal-oral transmission. It can also be transmitted through large respiratory droplets and fine particle aerosols. There have been instances of sustained human-to-human transmission across generations of cases.",
      "generated_response": "<think>\nOkay, let's tackle this question about how COVID-19 spreads based on the provided context. First, I need to go through each of the given passages and titles to gather all the relevant information.\n\nStarting with the first passage: It mentions that respiratory viruses like coronaviruses can spread through large respiratory droplets, fine particle aerosols, and indirect transmission via fomites. Also, there's a note about possible faecal-oral transmission since coronaviruses can infect the gastrointestinal tract. \n\nThe second passage says it's unclear how 2019-nCoV (which is the same as COVID-19) is spread, but it's suspected to be through contact with infected respiratory secretions, similar to other coronaviruses. \n\nThe third part talks about community spread in many countries and mentions that there's no treatment. Then there's a reference to the SARS-CoV superspreading event at Amoy Gardens, which was linked to faecal-oral and then airborne spread via plumbing systems. This suggests that similar mechanisms might be possible for 2019-nCoV, though it's not explicitly stated here. \n\nThe CDC summary from March 21, 2020, mentions symptoms and considerations for testing but doesn't add much about transmission methods beyond what's already discussed.\n\nPutting this all together, the main transmission routes mentioned are respiratory droplets, aerosols, fomites (surfaces), and possibly faecal-oral. The first passage also notes that indirect transmission via fomites can play a role. The Amoy Gardens example for SARS-CoV implies that faecal-oral followed by airborne spread is possible, which might be a consideration for 2019-nCoV as well. However, the second passage states that the exact method for 2019-nCoV is still unclear but similar to other coronaviruses. \n\nI need to make sure I don't include information that's not directly supported. For example, while the SARS-CoV case is mentioned, the context doesn't explicitly say that 2019-nCoV spreads the same way through plumbing. But since the first passage mentions faecal-oral transmission as a possibility for coronaviruses in general, and the Amoy Gardens event is an example of that, it's reasonable to include it as a potential route for 2019-nCoV.",
      "retrieved_chunks": [
        "Healthcare facilities in China have reported spread from person to\n\nTitle: Epidemiological research priorities for public health control of the ongoing global novel coronavirus (2019-nCoV) outbreak\nPassage: Transmission of respiratory viruses generally happens through large respiratory droplets, but some respiratory viruses can spread through fine particle aerosols , and indirect transmission via fomites can also play a role. Coronaviruses can also infect the human gastrointestinal tract , and faecal-oral transmission might also play a role in this instance.",
        "Cases have been detected in most countries worldwide and community spread is being detected in a growing number of countries.",
        "Title: 2019-nCoV: The Identify-Isolate-Inform (3I) Tool Applied to a Novel Emerging Coronavirus\nPassage: It is currently unclear how 2019-nCoV is spread, but it is suspected to be transmitted through contact with infected respiratory secretions, like other known coronaviruses.",
        "is seeing some level of community spread of COVID-19. Testing for COVID-19 may be accessed through medical providers or public health departments, but there is no treatment for this virus.",
        "The SARS-CoV superspreading event at Amoy Gardens where more than 300 cases were infected was attributed to faecal-oral, then airborne, spread through pressure differentials between contaminated effluent pipes, bathroom floor drains and flushing toilets . The first large identifiable superspreading event during the present 2019-nCoV outbreak has apparently taken\n\nTitle: CDC Summary 21 MAR 2020,\nPassage: People who get a fever or cough should consider whether they might have COVID-19, depending on where they live, their travel history or other exposures."
      ],
      "computed_relevance": 0.25,
      "computed_utilization": 0.25,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.4,
      "gt_utilization": 0.25,
      "gt_completeness": 0.625,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 81,
      "dataset_id": "1421",
      "question": "Which viruses may not cause prolonged inflammation due to strong induction of antiviral clearance?",
      "ground_truth_answer": "The viruses that may not cause prolonged inflammation due to strong induction of antiviral clearance are murine norovirus, human astrovirus, and murine cytomegalovirus.",
      "generated_response": "<think>\nOkay, let's try to figure out the answer to this question. The question is asking which viruses may not cause prolonged inflammation because they strongly induce antiviral clearance. The context provided includes three different studies related to viral infections and the immune response.\n\nFirst, looking at the first context about Type I Interferon Receptor Deficiency in Dendritic Cells and systemic murine norovirus persistence. It mentions that HCV (hepatitis C virus) persists partly due to loss of innate immune function. Also, other RNA viruses like chikungunya, measles, and polyomavirus might persist because of ineffective innate responses. So, these viruses are associated with persistence because the innate immune response isn't working well enough. That suggests that if a virus can't inhibit the innate response, maybe it doesn't cause prolonged inflammation because the body can clear it quickly.\n\nThe second context talks about UNC93B1 and its role in antiviral defense during cytomegalovirus (MCMV) infection. It mentions that mice lacking certain components (3d) have fewer plasmacytoid dendritic cells (pDCs) producing IFN-alpha, which is important for antiviral responses. Also, lacking adaptive immune components (B cells, CD4/CD8 T cells) reduces vaccine effectiveness and delays viral clearance. So, here, the presence of these adaptive components helps clear the virus, implying that viruses that are cleared with strong adaptive responses might not cause prolonged inflammation.\n\nThe third context is about norovirus vaccination and clearance. It states that human norovirus (HuNV) infection is rapid, with symptoms appearing within 24-48 hours and lasting a few days. This suggests that the virus is cleared quickly, so maybe it doesn't cause prolonged inflammation because the immune system can handle it effectively. The study also mentions immune mechanisms responsible for clearance, which might involve both innate and adaptive responses.\n\nPutting this together, the question is about viruses that don't cause prolonged inflammation because they induce strong antiviral clearance. The examples given in the contexts where viruses persist are HCV, chikungunya, measles, polyomavirus, and murine norovirus (in the first study where there's a receptor deficiency leading to persistence). However, the HuNV in the third context is cleared quickly. Also, the second study's MCMV might be cleared if the adaptive response is present. \n\nBut the question is",
      "retrieved_chunks": [
        "Title: Type I Interferon Receptor Deficiency in Dendritic Cells Facilitates Systemic Murine Norovirus Persistence Despite Enhanced Adaptive Immunity\nPassage: successful treatment for HCV serves to circumvent the viral inhibition of IFN induction. Thus, HCV may be an example of a medically relevant persistent viral infection that persists due, in part, to loss of innate immune function.",
        "Persistence of other continuously replicating RNA viruses, such as chikungunya, measles, polyomavirus, may be similarly due to ineffective innate responses.",
        "Title: UNC93B1 Mediates Innate Inflammation and Antiviral Defense in the Liver during Acute Murine Cytomegalovirus Infection\nPassage: 4-fold fewer PDCA-1+ pDCs expressing intracellular IFN-a at 40 h, and 3-fold fewer at 48 h post-infection, in 3d mice as compared to WT . This trend was also reflected in the proportion of PDCA-1+ IFN-a+ pDCs at 40 h and 48 h after infection in 3d mice compared with WT .",
        "Lack of any of the three components of the adaptive response: B cells, CD4 T cells, or CD8 T cells significantly diminished vaccine effects generated by either live virus or VP1 capsid protein immunization, and delayed viral clearance during primary infection.",
        "Title: Immune Mechanisms Responsible for Vaccination against and Clearance of Mucosal and Lymphatic Norovirus Infection\nPassage: HuNV infection and disease is rapid, with symptoms developing within 24-48 hours of infection and lasting for a few days."
      ],
      "computed_relevance": 0.2857142857142857,
      "computed_utilization": 0.2857142857142857,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.4117647058823529,
      "gt_utilization": 0.17647058823529413,
      "gt_completeness": 0.42857142857142855,
      "gt_adherence": 0.0,
      "binary_pred": 0,
      "binary_gt": 0,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 82,
      "dataset_id": "189",
      "question": "When was HBoV1 first identified?",
      "ground_truth_answer": "HBoV1 was first identified in respiratory secretions of children with respiratory tract disease in 2005.",
      "generated_response": "<think>\nOkay, let's see. The question is asking when HBoV1 was first identified. I need to look through the provided context to find the answer.\n\nLooking at the first passage, it says, \"Human bocavirus 1, which belongs to family Parvoviridae, was firstly identified in respiratory secretions of children with respiratory tract disease in 2005.\" That seems to directly answer the question. The key words here are \"firstly identified\" and the year 2005. \n\nI should check the other passages to make sure there's no conflicting information. The other passages talk about the epidemiology, age distribution, and co-infections but don't mention the discovery date. The answer is definitely in the first passage. So the answer should be 2005.\n</think>\n\nHBoV1 was first identified in **2005** in respiratory secretions of children with respiratory tract disease. \n\n**Answer:** 2005.",
      "retrieved_chunks": [
        "The male-to-female ratio was 2.54:1 in HBoV1-positive patients and 1.81:1 in HBoV1-negative patients .",
        "Title: Epidemiology of HBoV1 infection and relationship with meteorological conditions in hospitalized pediatric patients with acute respiratory illness: a 7-year study in a subtropical region\nPassage: Text: Human bocavirus 1 , which belongs to family Parvoviridae, was firstly identified in respiratory secretions of children with respiratory tract disease in 2005 . HBoV1 has been confirmed as an important respiratory pathogen and is found in respiratory infections in children and adults worldwide. The prevalence of HBoV1 nucleic acid detection varies from 1.5 to 33% in patients with acute respiratory illness , according to different studies . Serological and nucleic acid test results are generally consistent , showing HBoV1 infection is very common. HBoV1 can cause both upper respiratory illness and lower respiratory illness . Infection with HBoV1\n\nTitle: Epidemiology of HBoV1 infection and relationship with meteorological conditions in hospitalized pediatric patients with acute respiratory illness: a 7-year study in a subtropical region\nPassage: Two hundred forty-eight of 11,399 patients tested positive for HBoV1 infection. Of the HBoV1-positive patients, 112 were co-infected with other pathogens, most frequently with RSV .",
        "Title: Epidemiology of HBoV1 infection and relationship with meteorological conditions in hospitalized pediatric patients with acute respiratory illness: a 7-year study in a subtropical region\nPassage: To clarify the age distribution of HBoV1, patients were divided into seven age groups; 0-3 months, 4-6 months, 7-12 months, 1-2 years, 3-5 years, 6-10 years and 11-14 years old. There was a significant difference in the prevalence of HBoV1 in patients in different age groups and the peak prevalence was found in patients aged 7-12 months . Title: Epidemiology of HBoV1 infection and relationship with meteorological conditions in hospitalized pediatric patients with acute respiratory illness: a 7-year study in a subtropical region\nPassage: and analyzed immediately or stored at \u2212 80\u00b0C before analysis, as described previously .",
        "The median age was 1 year ."
      ],
      "computed_relevance": 0.08333333333333333,
      "computed_utilization": 0.08333333333333333,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.058823529411764705,
      "gt_utilization": 0.058823529411764705,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 83,
      "dataset_id": "1081",
      "question": "What explains the pain associated with CHIKV?",
      "ground_truth_answer": "The passage \"can explain pain associated with CHIKF\" from the title \"Chikungunya: A Potentially Emerging Epidemic?\" suggests that the pain associated with CHIKV (Chikungunya virus) is due to the sudden appearance of high fever, rash, headache, nausea, vomiting, myalgia and arthalgia or severe joint pain. Joint pain is a defining symptom of CHIKV disease, and the word \"Chikungunya\" originated from the Tanzanian and Mozambique region of Africa, meaning \"that which bends up,\" indicating the bent posture often taken by those experiencing severe joint pain after being infected with CHIKV. It is also mentioned that blood samples were analyzed for cytokine profiles during the acute phase and disease convalescence, indicating a potential link between inflammatory cytokine expression and the pain associated with CHIKV.",
      "generated_response": "<think>\nOkay, let's see. The user is asking what explains the pain associated with CHIKV, which is Chikungunya virus. I need to look through the provided context to find the answer.\n\nFirst, the context mentions that the title of one of the passages is \"Inflammatory Cytokine Expression Is Associated with Chikungunya Virus Resolution and Symptom Severity.\" That seems relevant because cytokines are involved in inflammation, which can cause pain. \n\nLooking at the passage under that title, it says that inflammatory cytokine expression is linked to both the resolution of the virus and the severity of symptoms. The passage also talks about analyzing cytokines in patients during the acute phase and convalescence. Since severe joint pain is a defining symptom of CHIKV, and cytokines are part of the immune response, it's possible that these inflammatory cytokines are causing the pain. \n\nAnother part of the context mentions that the clinical criteria include acute fever and severe arthralgia (joint pain) not explained by other conditions. The passage also notes that a bent posture is taken by those with severe joint pain. But the key here is the connection between cytokines and the symptoms. The title and the content about cytokine profiles suggest that the inflammatory response mediated by these cytokines is what's responsible for the pain. \n\nSo putting it all together, the answer should be that inflammatory cytokines are associated with the pain in CHIKV infections. The context doesn't mention other possible causes, so this seems to be the main explanation provided.\n</think>\n\nThe pain associated with Chikungunya virus (CHIKV) is explained by **inflammatory cytokine expression**, as highlighted in the provided context. The study titled *Inflammatory Cytokine Expression Is Associated with Chikungunya Virus Resolution and Symptom Severity* links the production of inflammatory cytokines to both the resolution of the virus and the severity of symptoms, including severe joint pain (arthralgia). These cytokines, part of the immune response during the acute phase of infection, contribute to inflammation and tissue damage, which are likely responsible for the persistent pain experienced by patients. The context emphasizes that cytokine profiles during the acute phase and convalescence correlate with symptom severity, underscoring their role in mediating pain in CHIKV infections.",
      "retrieved_chunks": [
        "Passage: can explain pain associated with CHIKF . Title: Inflammatory Cytokine Expression Is Associated with Chikungunya Virus Resolution and Symptom Severity\nPassage: CHIKV infection is clinically characterized by the sudden appearance of high fever, rash, headache, nausea, vomiting, myalgia and arthalgia or severe joint pain. Severe joint pain is the defining symptom of CHIKV disease .",
        "A bent posture is often taken by those in severe joint pain after being infected with CHIKV. CHIKV symptoms start 4 to 7 days after exposure and most resolve within the acute phase of the disease. Although the acute phase lasts approximately 2 weeks, joint pain can persist for\n\nTitle: Inflammatory Cytokine Expression Is Associated with Chikungunya Virus Resolution and Symptom Severity\nPassage: Included patients were from the region of Emilia-Romagna in north-east Italy suspected to be infected with CHIKV since they showed symptoms such as myalgia, severe back and joint pain, headache, and skin rash. Collaboration with the regional microbiology reference laboratory of Bologna University and the Department of Infectious and Parasitic Diseases of the National Institute of Health in Rome was initiated and identified the patients as having CHIKV.",
        "CHIKV infection was confirmed by one or more of the acute phase tests:\n\nTitle: Inflammatory Cytokine Expression Is Associated with Chikungunya Virus Resolution and Symptom Severity\nPassage: following persistent joint pain and/or disease resolution. Blood samples were collected from 50 patients suffering from CHIKV infections during the 2007 Italian outbreak. Serum separated from whole blood was analyzed by cytokine bead analysis for 13 cytokines with the intention of determining a cytokine profile during CHIKV acute phase and disease convalescence.",
        "The clinical criteria was described as acute onset of fever and severe arthralgia not explained by other medical conditions.",
        "Title: Chikungunya: A Potentially Emerging Epidemic?"
      ],
      "computed_relevance": 0.3333333333333333,
      "computed_utilization": 0.3333333333333333,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.3157894736842105,
      "gt_utilization": 0.2631578947368421,
      "gt_completeness": 0.6666666666666666,
      "gt_adherence": 0.0,
      "binary_pred": 1,
      "binary_gt": 0,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 84,
      "dataset_id": "590",
      "question": "What was the hairpin morphology first described for?",
      "ground_truth_answer": "The hairpin morphology was first described for the design of b-hairpin mimetics based on motifs seen in protein crystal structures and their role in mediating protein-protein and protein-nucleic acid interactions.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What was the hairpin morphology first described for?\" I need to find the answer based on the provided context.\n\nFirst, I'll look through the passages to see where hairpins are mentioned. The first context talks about \u03b2-hairpin mimetics in proteins, mentioning their role in protein-protein and protein-nucleic acid interactions. It also discusses the structure of \u03b2-hairpins with loops of \u22645 residues and specific b-turns. \n\nThe second passage mentions a 12-residue \u03b2-hairpin mimetic derived from the Tat protein that binds to HIV-1 RNA. It says the mimetic adopts stable structures in solution and when bound to TAR RNA. \n\nAnother passage refers to hairpins and pseudoknots functioning as structural domains. The last one talks about DNA hairpins with mismatches affecting mechanical stability related to frameshifting.\n\nThe question is about the first description of hairpin morphology. The first context's passage starts by discussing \u03b2-hairpin motifs in proteins mediating interactions. The second passage mentions a specific example from the Tat protein. However, the first mention in the provided contexts is about \u03b2-hairpins in proteins. But the user is asking for the first description in the given texts. The first passage says \"Much of the work reviewed here has been focused upon the design of b-hairpin mimetics, based on motifs seen in protein crystal structures. b-Hairpin motifs are often found in proteins to mediate protein-protein and protein-nucleic acid interactions.\" So the initial description here is about their role in proteins. However, the answer might be more specific. The second passage mentions a 12-residue \u03b2-hairpin mimetic from the Tat protein binding to RNA. But the question is about the first description. The first context's first passage introduces \u03b2-hairpins in proteins. However, the answer might be in the second passage where it's applied to a specific example. Wait, the user is asking what the hairpin morphology was first described for. The earliest mention in the provided texts is their role in proteins mediating interactions. But maybe the answer refers to the Tat protein example. Let me check again. The first passage says \u03b2-hairpins are found in proteins to mediate interactions. The second passage gives an example of a mimetic from Tat protein binding to RNA. But the question is about the first description in",
      "retrieved_chunks": [
        "Title: Max Bergmann lecture Protein epitope mimetics in the age of structural vaccinology\u2021\nPassage: Much of the work reviewed here has been focused upon the design of b-hairpin mimetics, based on motifs seen in protein crystal structures. b-Hairpin motifs are often found in proteins to mediate protein-protein and protein-nucleic acid interactions. A b-hairpin is comprised of two consecutive hydrogenbonded antiparallel b-strands connected by a loop sequence. Many variations are observed in backbone conformation in b-hairpin loops in folded proteins, depending upon the hydrogen bonding pattern between the two antiparallel b-strands and the loop length ). This structural diversity can be captured, at least to some extent, in b-hairpin mimetics designed by transplanting the hairpin\n\nTitle: Max Bergmann lecture Protein epitope mimetics in the age of structural vaccinology\u2021\nPassage: Most b-hairpins in proteins of known 3D structure have loops of \u22645 residues .",
        "A type I 0 b-turn was observed at the tip of a 12-residue b-hairpin mimetic derived initially from the Tat protein, which binds to a nucleic acid target, the transactivation response element RNA of HIV-1 . The mimetic was found to adopt stable b-hairpin structures in free solution and when bound in the major groove of the TAR RNA hairpin .",
        "In two residue hairpin loops, type I 0 and II 0 b-turns are strongly favored over type I and type II b-turns.",
        "In the RNA-peptidomimetic\n\nTitle: Folding behavior of a T-shaped, ribosome-binding translation enhancer implicated in a wide-spread conformational switch\nPassage: hairpins and pseudoknots, function as a structural domain or subdomain . Title: Stem\u2013loop structures can effectively substitute for an RNA pseudoknot in \u22121 ribosomal frameshifting\nPassage: the overall destabilizing effect of mismatches in DNA hairpins. In a pioneer singlemolecule pulling study, it was shown that introducing a mismatch in a 20 bp DNA hairpin shifted its transition state close to the location of the mismatch .",
        "Our data also comply with this mechanical study and suggest that mechanical stability may be a better parameter than thermodynamic stability to describe the frameshift efficiency of hairpins."
      ],
      "computed_relevance": 0.16666666666666666,
      "computed_utilization": 0.16666666666666666,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.2777777777777778,
      "gt_utilization": 0.1111111111111111,
      "gt_completeness": 0.4,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 85,
      "dataset_id": "1070",
      "question": "hen did Asian genotype emerge?",
      "ground_truth_answer": "The Asian genotype emerged between 1998 and 2007.",
      "generated_response": "<think>\nOkay, let's try to figure out when the Asian genotype emerged based on the provided context. The user is asking specifically about the emergence of the Asian genotype, so I need to look through the passages to find any mentions of when this genotype first appeared or became dominant.\n\nFirst, looking at the first passage: It mentions that from 1998 to 2007, the dominant genotype in Asia was Cosmopolitan, except in India-Pakistan-Sri Lanka and Southeast-Oceania which had different lineages. Then it talks about Indochina countries having different major genotypes. In Thailand, Asian I was predominant, while Cambodia and Vietnam had Asian American. From 2001, Asian I increased in Cambodia and Vietnam, becoming predominant in Indochina by 2007. The Asian I genotype in Thailand spread into Vietnam via Cambodia but didn't reach Malaysia and Bangladesh. Also, Asian American was replaced by Asian I in Cambodia and Vietnam between 1998 and 2011.\n\nThe second passage mentions that from 2000 to 2014, there were three geographical borders for genotype distribution. The third passage refers to a timeline change in predominant genotypes and the query is about DENV-1 genotype I's Env region.\n\nThe question is about when the Asian genotype emerged. The term \"Asian genotype\" might refer to Asian I or other genotypes. The first mention of Asian I being predominant in Thailand is during the 1998-2007 period. However, the emergence would be before it became dominant. The passage says that Asian I increased in Cambodia and Vietnam starting from 2001, becoming predominant by 2007. Also, it's mentioned that Asian I viruses in Thailand were disseminated into Vietnam via Cambodia, implying that Asian I was present in Thailand before spreading. Since the dominant genotype in Asia was Cosmopolitan from 1998 to 2007, but Asian I was already predominant in Thailand, maybe Asian I emerged before 1998. However, the exact emergence date isn't specified. The answer might be inferred from when it started to increase. The passage says Asian I increased from 2001 in Cambodia and Vietnam, but it was already present in Thailand. If the emergence is when it started to become significant, maybe around 2001? But the user is asking",
      "retrieved_chunks": [
        "From 1998 to 2007, the dominant genotype in Asia was Cosmopolitan, although India-Pakistan-Sri Lanka and Southeast-Oceania belonged to different lineages . The major genotypes in the Indochina countries were different from those of the other Asian countries; genotype FIGURE 4 | A screenshot of the DENV sequence similarity search.",
        "Title: DGV: Dengue Genographic Viewer\nPassage: Asian I was predominant in Thailand, whereas genotype Asian American was predominant in Cambodia and Vietnam . From 2001, Asian I increased in Cambodia and Vietnam until finally in 2007 Asian I became the predominant genotype in Indochina. The genotype Asian I viruses in Thailand seemed to be widely disseminated into Vietnam via Cambodia but did not reach Malaysia and Bangladesh . Thus, the Asian American genotype was replaced by Asian I in Cambodia and Vietnam between 1998 and 2011.",
        "Title: DGV: Dengue Genographic Viewer\nPassage: Intriguingly, when focusing on the genotype instead of the serotype, the data from 2000 to 2014 showed at least three potential geographical genotype distribution border lines in Asia . The first border is between the American continents and other regions , the second is located between Bangladesh and Myanmar for the genotype distributions of DENV-1 and -2 and India and Myanmar for DENV-3, and the third is located between Indochina and the Malay Peninsula .",
        "This example also suggests the idea of genotype transition, which probably reflects the mosquito vector habitat and human activities in\n\nTitle: DGV: Dengue Genographic Viewer\nPassage: We also found a timeline change in the predominant genotypes.",
        "The query was assigned as the Env region of DENV-1 genotype I."
      ],
      "computed_relevance": 0.3,
      "computed_utilization": 0.2,
      "computed_completeness": 0.6666666666666666,
      "computed_adherence": 0.0,
      "gt_relevance": 0.2857142857142857,
      "gt_utilization": 0.14285714285714285,
      "gt_completeness": 0.5,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 86,
      "dataset_id": "88",
      "question": "What followed the reverse transcription step in the analysis?",
      "ground_truth_answer": "In the first and fourth passages, the next step after reverse transcription was real-time PCR analysis using Taqman RT-qPCR and TaqR mastermix, respectively. In the second passage, the next step after reverse transcription was RT-qPCR analysis with SYBR green. In the third passage, the next step after reverse transcription was real-time PCR analysis using the TaqMan Gene Expression Assays.",
      "generated_response": "<think>\nOkay, let's see. The question is asking what followed the reverse transcription step in the analysis. The context provided is about reverse transcription using AMV reverse transcriptase and some specific conditions. The passage mentions that after reverse transcription, the next step would be something else.\n\nLooking at the context, the reverse transcription was done with 400ng RNA, specific enzymes, and conditions. The passage also mentions that the RT mixture had various components like dNTPs, IAC RNA, primers, buffer, etc. Then it says all samples were run in duplicates and mentions human GAPDH. Wait, the title is about standardization of RNA quality assessment using microcapillary electrophoresis. The passage says \"An homogeneous quantity of the RNA samples was subjected to a reverse transcription step...\". The question is about what followed RT.\n\nIn the context, after RT, what's next? The context doesn't explicitly mention the next step. But the passage is part of a study on RNA quality assessment using microcapillary electrophoresis. Typically, after reverse transcription, you might do PCR or qPCR, especially since they mention TaqMan probes and GAPDH. But the passage doesn't state that. The passage only describes the RT step. The user is asking what followed RT in the analysis. The passage doesn't mention anything after RT. However, the title mentions microcapillary electrophoresis, which is a method for analyzing RNA integrity. Wait, but the passage says they did reverse transcription using the high-capacity cDNA archive kit. Maybe after RT, they did microcapillary electrophoresis to assess RNA quality? But the passage is part of a study aiming to standardize RNA quality assessment using that method. So perhaps after RT, they used microcapillary electrophoresis to analyze the RNA. But the passage doesn't explicitly say that. The passage only describes the RT step. Hmm. The answer might be that after RT, they proceeded with microcapillary electrophoresis. But I need to check the context again. The context is from the same study? The title is about microcapillary electrophoresis. The passage says they did RT, but the next step isn't mentioned. Wait, maybe the answer is that after RT, they used the cDNA for some analysis, like PCR. But the passage doesn't specify. Alternatively, since the title is about RNA quality assessment using microcapillary elect",
      "retrieved_chunks": [
        "The efficiency and reproducibility of the reverse transcription were tested using 18S rRNA TaqMan probes.",
        "Reverse transcription of 400ng total RNA was performed using AMV reverse transcriptase and random hexamers according to the manufacturer's protocol.",
        "The reaction was performed at 50 \u2022 C for 1 h followed by 75 \u2022 C for 15 min and a cooling step at 10 \u2022 C.",
        "The RT mixture contained 0.5 nmol of dNTP mix , 20,000 molecules of IAC RNA, 2 pmol of both reverse primers , 4 \u00b5l of PrimeScript reaction buffer, 5 U of reverse transcriptase, 1 U of RNase inhibitor and 5 \u00b5l of isolated RNA.",
        "All samples were run in duplicates and unless stated otherwise the human GAPDH\n\nTitle: Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces\nPassage: An homogeneous quantity of the RNA samples was subjected to a reverse transcription step using the highcapacity cDNA archive kit as described by the manufacturer."
      ],
      "computed_relevance": 0.2,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.19047619047619047,
      "gt_utilization": 0.14285714285714285,
      "gt_completeness": 0.75,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 87,
      "dataset_id": "1462",
      "question": "What analysis functions may be useful?",
      "ground_truth_answer": "The analysis functions that may be useful include hierarchical cluster analysis, response ratios, t-tests, ANOVA, dissimilarity tests, constrained ordination, distance-based redundancy analysis, variation partitioning analysis, Mantel test, random matrix theory-based neural network analysis, descriptive statistics, unconstrained ordination, correspondence analysis, qualitative risk-benefit analysis, and quantitative risk-benefit analysis.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What analysis functions may be useful?\" based on the provided context. Let me start by reading through the context and the passages carefully to identify relevant analysis methods mentioned.\n\nFirst, the context mentions several constrained ordination techniques: canonical correspondence analysis, distance-based redundancy analysis, variation partitioning analysis, and the Mantel test. These are all statistical methods used in ecological data analysis, particularly for understanding relationships between species and their environment. So these should be part of the answer.\n\nThen, looking at the other passages, there's a mention of a pipeline that performs common analyses. The title \"Use of functional gene arrays...\" has passages talking about data analysis challenges with GeoChip data. They mention maximizing variability with methods like hierarchical cluster analysis. Also, in the same title, they refer to unconstrained ordination and correspondence analysis for reducing dimensionality. Wait, the first context already listed constrained ordination, but here it's unconstrained. Both are types of ordination techniques. So maybe I should include both constrained and unconstrained ordination methods.\n\nAnother part mentions a random matrix theory-based neural network analysis as a new method. That's a more advanced technique, possibly for handling complex datasets. Also, the passage about hierarchical cluster analysis groups communities based on gene profiles. So clustering methods like hierarchical clustering are useful here.\n\nThe other title about Gain-of-Function Research doesn't seem directly related to data analysis methods but more about ethical analysis. However, the question is about analysis functions, so maybe those can be ignored unless there's a mention of specific methods. The passages there discuss risk-benefit analysis frameworks, both qualitative and quantitative. But since the question is about data analysis functions, perhaps those are not relevant here.\n\nPutting it all together, the useful analysis functions would include:\n\n- Constrained ordination methods (canonical correspondence analysis, distance-based redundancy analysis, variation partitioning analysis, Mantel test)\n- Unconstrained ordination and correspondence analysis\n- Hierarchical cluster analysis\n- Random matrix theory-based neural network analysis\n- Dimensionality reduction techniques (since correspondence analysis and ordination methods help reduce variables)\n- Variation partitioning analysis (already listed, but part of constrained ordination)\n- Data pipelines for common analyses (as mentioned in the context)\n\nI need to make sure I'm not missing any other methods. The GeoChip data analysis mentions maximizing variability, which could relate to principal component analysis (PCA) or similar,",
      "retrieved_chunks": [
        "These include constrained ordination, such as canonical correspondence analysis , distance-based redundancy analysis , variation partitioning analysis , and Mantel test.",
        "To assist users with data analysis steps, a pipeline is available which performs many of the common analyses 3 .",
        "To compare the overall community structure, unconstrained ordination and correspondence analysis ] to reduce the dimensionality of variables in order\n\nTitle: Gain-of-Function Research: Ethical Analysis\nPassage: While Kirsten Jacobson and colleagues suggest that, in light of measurement difficulties, '' qualitative risk-benefit analysis framework for assessing research\u2026would be the most decisive tool for asking the hardest and most important questions'' , Marc Lipsitch and Thomas Inglesby argue that risk-benefit analysis can and should be quantitative because ''xtensive qualitative arguments have not provided sufficient clarity or evidence to resolve concerns or identify a consensus path forward \u2026 this process should be quantitative, rather than relying on unquantified and unverifiable assurances that particular laboratories are safe'' . Though they admit measurement challenges associated with objective quantitative risk-benefit analysis, Arturo\n\nTitle: Gain-of-Function Research: Ethical Analysis\nPassage: There may be cases where the very same option promotes all three of these things at the very same time-and in cases like that it might be quite obvious what should be done.",
        "A relatively new analysis method is the random matrix theorybased neural network analysis used to\n\nTitle: Use of functional gene arrays for elucidating in situ biodegradation\nPassage: Due to the large volume of data obtained from GeoChip, data analysis can be very challenging.",
        "Title: Use of functional gene arrays for elucidating in situ biodegradation\nPassage: to maximize the visible variability of the data or hierarchical cluster analysis , which groups communities based on the similarity of their gene profiles, can be used."
      ],
      "computed_relevance": 0.3333333333333333,
      "computed_utilization": 0.3333333333333333,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.4,
      "gt_utilization": 0.3,
      "gt_completeness": 0.75,
      "gt_adherence": 0.0,
      "binary_pred": 0,
      "binary_gt": 0,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 88,
      "dataset_id": "1495",
      "question": "What is France's estimated mean percentage [95% credible interval] of total population infected as of 28th March?",
      "ground_truth_answer": "The estimated mean percentage of the total population infected in France as of 28th March is 3.0% with a 95% credible interval.",
      "generated_response": "<think>\nOkay, let's see. The user is asking for France's estimated mean percentage of the total population infected as of March 28th, along with the 95% credible interval. The context provided includes several passages from the Wikimedia Foundation, specifically related to estimating infections and the impact of non-... (maybe non-pharmaceutical interventions?).\n\nLooking at the passages, the first one mentions an attack rate of 9.8% of the population as of March 28th. Then there's a passage that just says \"France 3.0%\". Another passage mentions \"France measures Advice at the time of lockdown.32 16/03/2020\" and another with \"30. 2020 coronavirus pandemic in France. Spain Wikipedia.\"\n\nSo, the key pieces here are the 9.8% and the 3.0% mentioned. The 9.8% is from the first passage, which gives an attack rate as of March 28th. The second passage specifically states France at 3.0%. But which one is the correct answer?\n\nThe question is about the mean percentage with a 95% credible interval. The 9.8% is presented as an attack rate, which might be the mean. The 3.0% could be another estimate or perhaps a different measure. However, since the first passage directly mentions March 28th and gives 9.8%, that seems more relevant. The 3.0% might be a different study or a different date. Also, the mention of \"Spain\" in another passage might be a red herring unless it's part of a comparison.\n\nBut wait, the user is asking specifically about France. The passage with \"France 3.0%\" is likely referring to France's estimate. However, the first passage's 9.8% is also about France? Wait, the first passage's title is \"Estimating the number of infections and the impact of non-\" and the passage says \"infected as of March 28th, giving an attack rate of 9.8% of the population.\" The title might be cut off, but the passage mentions France in another part. Wait, the second passage is titled the same and says \"France 3.0%\". So maybe there are two different estimates here?\n\nBut the user is asking for the mean percentage with a",
      "retrieved_chunks": [
        "Wikimedia Foundation\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: infected as of March 28th, giving an attack rate of 9.8% of the population .",
        "Title: Estimating the number of infections and the impact of non-\nPassage: France 3.0%\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: France measures Advice at the time of lockdown.32 16/03/2020\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: 30.",
        "2020 coronavirus pandemic in France.",
        "Spain",
        "Wikipedia."
      ],
      "computed_relevance": 0.4,
      "computed_utilization": 0.4,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.25,
      "gt_utilization": 0.25,
      "gt_completeness": 1.0,
      "gt_adherence": 0.0,
      "binary_pred": 0,
      "binary_gt": 0,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 89,
      "dataset_id": "549",
      "question": "Why does the claim lack any scientific  basis?",
      "ground_truth_answer": "The claim lacks any scientific basis because there is no credible evidence supporting the claims of the laboratory engineering of SARS-CoV-2, as stated in the passages from the provided sources.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking why the claim about the laboratory engineering of SARS-CoV-2 lacks scientific basis. The context provided includes several sources, all titled \"No credible evidence supporting claims of the laboratory engineering of SARS-CoV-2\" and another about SARS transmission.\n\nFirst, I need to look at the authors and the sources. The first passage from NCBI and the DOI link both mention that there's no credible evidence for lab engineering. The authors listed are Liu, Shan-Lu; Saif, Linda J.; Weiss, Susan R.; Su, Lishan. These are likely experts in virology or related fields. Their work probably reviews existing research and finds no evidence supporting the lab-origin theory.\n\nThe other passage talks about SARS and mentions that attributing the end of SARS to lack of transmissibility instead of control measures isn't evidence-based. This might be a red herring, but maybe it's relevant if the user is conflating SARS and SARS-CoV-2. However, the main point here is about SARS-CoV-2's origin.\n\nThe key points from the context are that there's no credible evidence supporting lab engineering. The answer should explain that the claim isn't supported by scientific studies or data. The authors of the cited papers likely conducted a review or analysis and found no signs of genetic manipulation in the virus. They might have looked at the virus's genome and found it consistent with natural evolution, not lab modifications. Also, the lack of any published research or peer-reviewed studies that support the lab-engineered claim would be a factor. The answer should tie these elements together, emphasizing the absence of evidence and the reliance on natural origins as per the scientific consensus presented in the sources.\n</think>\n\nThe claim that SARS-CoV-2 was laboratory-engineered lacks scientific basis because multiple studies, including those cited in the provided context, have found **no credible evidence** to support such assertions. The authors of the referenced work (Liu et al.) explicitly state that there is no data or peer-reviewed research demonstrating that the virus was intentionally modified in a lab. Instead, the genetic and structural features of SARS-CoV-2 align with natural evolutionary patterns observed in related coronaviruses, and no signs of artificial manipulation (e.g., synthetic gene sequences or unnatural recombinant elements) have been identified. Additionally, the claim contradicts the scientific consensus",
      "retrieved_chunks": [
        "Title: No credible evidence supporting claims of the laboratory engineering of SARS-CoV-2\nPassage: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054935/\n\nTitle: No credible evidence supporting claims of the laboratory engineering of SARS-CoV-2\nPassage: DOI: 10.1080/22221751.2020.1733440\n\nTitle: Preparation for Possible Sustained Transmission of 2019 Novel Coronavirus\nPassage: To claim that it was the lack of transmissibility, rather than the control measures that ended SARS, is not based on any evidence.",
        "And it ignores the heroic efforts of affected countries.",
        "Title: No credible evidence supporting claims of the laboratory engineering of SARS-CoV-2\nPassage: Authors: Liu, Shan-Lu; Saif, Linda J.; Weiss, Susan R.; Su, Lishan"
      ],
      "computed_relevance": 0.6666666666666666,
      "computed_utilization": 0.6666666666666666,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.625,
      "gt_utilization": 0.625,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 90,
      "dataset_id": "350",
      "question": "What is the mean time from onset of symptoms to dyspnea in human adenovirus type 55 (HAdV-55)?",
      "ground_truth_answer": "The mean time from onset of symptoms to dyspnea in HAdV-55 is 5 days.",
      "generated_response": "<think>\nOkay, let's see. The user is asking for the mean time from the onset of symptoms to dyspnea in patients with HAdV-55. I need to look at the provided context to find the answer.\n\nLooking at the passage, it says, \"The mean time from onset to dyspnea was 5 days.\" That's mentioned twice, which probably emphasizes that this is a key finding. The study included five patients with severe ARDS caused by HAdV-55. All of them experienced dyspnea, and after that, they progressed to respiratory failure or hypoxemia. \n\nThe title mentions it's about adenovirus type 55 in immunocompetent adults from 2013. The other part about viral load might not be directly relevant here. The question specifically asks about the mean time to dyspnea, so the answer should be straightforward from the repeated statement of 5 days. I just need to confirm that there's no other number mentioned. The rest of the passage talks about flu-like symptoms at onset, like fever and cough, but that's the initial phase. The key part is the mean time being 5 days. So the answer is 5 days.\n</think>\n\nThe mean time from the onset of symptoms to dyspnea in patients with human adenovirus type 55 (HAdV-55) is **5 days**, as explicitly stated in the context. This was observed in a study of five immunocompetent adults with severe ARDS caused by HAdV-55, where all patients developed dyspnea after this interval.",
      "retrieved_chunks": [
        "The mean time from onset to dyspnea was 5 days.",
        "Title: Emergent severe acute respiratory distress syndrome caused by adenovirus type 55 in immunocompetent adults in 2013: a prospective observational study\nPassage: five consecutive patients with severe ARDS with confirmed HAdV-55 infection were included.",
        "All patients had dyspnea. The mean time from onset to dyspnea was 5 days . After the onset of dyspnea, patients usually progressed to respiratory failure or hypoxemia.",
        "All patients had dyspnea. The mean time from onset to dyspnea was 5 days . After the onset of dyspnea, patients usually progressed to respiratory failure or hypoxemia.",
        "The viral load was higher than 1 \u00d7 10 copies in three patients and was\n\nTitle: Emergent severe acute respiratory distress syndrome caused by adenovirus type 55 in immunocompetent adults in 2013: a prospective observational study\nPassage: Flulike symptoms, such as fever, cough and little sputum, were commonly observed at the onset of illness."
      ],
      "computed_relevance": 0.3333333333333333,
      "computed_utilization": 0.2222222222222222,
      "computed_completeness": 0.6666666666666666,
      "computed_adherence": 1.0,
      "gt_relevance": 0.05405405405405406,
      "gt_utilization": 0.05405405405405406,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 91,
      "dataset_id": "1223",
      "question": "What   has prevented worldwide spread of MERS-COV?",
      "ground_truth_answer": "The high severity and low transmissibility of MERS-CoV have prevented its worldwide spread. Additionally, control measures and vigilance have also contributed to containing the virus.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking what has prevented the worldwide spread of MERS-CoV. I need to look through the provided context to find the answer.\n\nFirst, looking at the first passage: it mentions that there's no vaccine and no specific treatment. But the question is about preventing spread, so maybe control measures? The first sentence says control measures relied on something, but the context is cut off. Hmm.\n\nNext, the second title talks about preparation for possible sustained transmission. The passage says MERS-CoV has high severity and low transmissibility. It also mentions that R0 estimates are less than 1, which means each infected person infects less than one other on average. That would naturally limit spread. Plus, it's been contained so far. The preparedness plan included surveillance, lab testing, and contact tracing. Those are public health measures that help contain outbreaks.\n\nAnother passage mentions vigilance and containment being important because the virus isn't stable genetically. Whole genome sequencing was used to track its variation. Maybe tracking mutations helps in containing it by understanding transmission routes.\n\nPutting this together: The low transmissibility (R0 <1) is a natural factor. Then, human interventions like surveillance, contact tracing, laboratory testing, and containment measures in hospitals (since outbreaks were mainly in hospitals) probably prevented wider spread. Also, the fact that it's been contained in specific regions without sustained transmission globally suggests that these measures worked. The answer should combine both the inherent low R0 and the public health responses.\n</think>\n\nThe worldwide spread of MERS-CoV has been prevented primarily due to its **low transmissibility** (with an estimated basic reproduction number $ R_0 $ less than 1) and effective **public health containment measures**. These measures include surveillance, laboratory testing, contact tracing, and hospital infection control protocols implemented in response to outbreaks, particularly in Saudi Arabia, Jordan, and South Korea. Additionally, the virus's genetic instability and ongoing monitoring through tools like whole genome sequencing have aided in tracking its spread and limiting sustained transmission. The combination of natural low transmissibility and proactive containment strategies has so far prevented global dissemination.",
      "retrieved_chunks": [
        "At present, no vaccine exists for preventing the infections of MERS-CoV.",
        "MERS-CoV was thought to be severe and control measures relied on\n\nTitle: Demographic Variations of MERS-CoV Infection among Suspected and Confirmed Cases: An Epidemiological Analysis of Laboratory-Based Data from Riyadh Regional Laboratory\nPassage: ere is no specific treatment for MERS-CoV.",
        "Title: Preparation for Possible Sustained Transmission of 2019 Novel Coronavirus\nPassage: Similarly, MERS-CoV appears to have high severity and low transmissibility. Since 2012, MERS-CoV has caused 2494 reported cases and 858 deaths in 27 countries. MERS-CoV has also caused some rapid outbreaks, mainly in hospitals in Saudi Arabia, Jordan, and South Korea, but estimates of MERS-CoV R0 are less than 1, and thus far it has been contained.5",
        "Title: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Vigilance remains important for containment since MERS-CoV is a virus with a genetic makeup that has been observed for only three years and is not stable.",
        "Whole genome sequencing has been used extensively to study MERS-CoV travel and variation and although it remains a tool for experts, it appears\n\nTitle: Preparation for Possible Sustained Transmission of 2019 Novel Coronavirus\nPassage: With the emergence of MERS-CoV in the Middle East, a preparedness plan was developed that included a surveillance plan, laboratory testing, and contact tracing guidance."
      ],
      "computed_relevance": 0.42857142857142855,
      "computed_utilization": 1.0,
      "computed_completeness": 0.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.3333333333333333,
      "gt_utilization": 0.3333333333333333,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 92,
      "dataset_id": "1000",
      "question": "What vaccinia vectors were created to address safety concerns?",
      "ground_truth_answer": "The modified vaccinia virus Ankara strain and the New York vaccinia virus were developed to address safety concerns with vaccinia virus vectors.",
      "generated_response": "<think>\nOkay, let's see. The user is asking which vaccinia vectors were created to address safety concerns. I need to look through the provided context to find the answer.\n\nFirst, the context mentions that early work with vaccinia virus vectors had safety issues, so two vectors were developed. The first one is the modified vaccinia virus Ankara strain, which was attenuated by passing it 530 times in chick embryo cultures. The second is the New York vaccinia virus, which is a plaque-purified clone of the Copenhagen strain, attenuated by deleting 18 open reading frames. The names given here are MVA (Modified Vaccinia Ankara) and NYVAC (New York Vaccinia Attenuated Clone). \n\nThe answer should list both of these vectors. Let me check the passages again to make sure. Yes, in the first passage, they talk about MVA and NYVAC as the two vectors developed to address safety concerns. The other parts mention their use in vaccines and pre-existing immunity, but the key part here is the creation of these two vectors for safety. So the answer should be MVA and NYVAC.\n</think>\n\nThe vaccinia vectors created to address safety concerns are the **modified vaccinia virus Ankara (MVA)** strain and the **New York attenuated vaccinia virus (NYVAC)** strain. These were developed to reduce reactogenicity and improve safety by attenuating the virus through extensive passage (MVA) or targeted deletion of open reading frames (NYVAC).",
      "retrieved_chunks": [
        "Poxviruses are also studied extensively as candidate vectors for human use, among which attenuated derivatives of vaccinia virus and New York attenuated vaccinia virus NYVAC strains] are the most promising vectors .",
        "Title: Virus-Vectored Influenza Virus Vaccines\nPassage: Early work with intact vaccinia virus vectors raised safety concerns, as there was substantial reactogenicity that hindered recombinant vaccine development . Two vaccinia vectors were developed to address these safety concerns.",
        "The modified vaccinia virus Ankara strain was attenuated by passage 530 times in chick embryo fibroblasts cultures. The second, New York vaccinia virus was a plaque-purified clone of the Copenhagen vaccine strain rationally attenuated by deletion of 18 open reading frames . Title: Virus-Vectored Influenza Virus Vaccines\nPassage: vectors with extensive animal safety and efficacy data may address the issues with preexisting immunity to the human vaccine strains, although the cross-reactivity originally described with cowpox could also limit use. Title: Pre-existing immunity against vaccine vectors \u2013 friend or foe?",
        "The NYVAC vector has been shown to induce CD4 + T cell-dominant responses, and MVA induces\n\nTitle: Virus-Vectored Influenza Virus Vaccines\nPassage: While there is strong safety and efficacy data for use of NYVAC or MVA-vectored influenza vaccines, preexisting immunity remains a concern. Although the smallpox vaccination campaign has resulted in a population of poxvirus-na\u00ef ve people, the initiation of an MVA or NYVAC vaccination program for HIV, influenza or other pathogens will rapidly reduce this susceptible population. While there is significant interest in development of pox-vectored influenza virus vaccines, current influenza vaccination strategies rely upon regular immunization with vaccines matched to circulating strains. This would likely limit the use and/or efficacy of poxvirus-vectored influenza virus vaccines for regular and seasonal use",
        "They are ideal candidate vectors due to their large DNA-packing capacity and their thermal and genetic stability ."
      ],
      "computed_relevance": 0.25,
      "computed_utilization": 0.25,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.35294117647058826,
      "gt_utilization": 0.23529411764705882,
      "gt_completeness": 0.6666666666666666,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 93,
      "dataset_id": "204",
      "question": "How many control samples were used in this study?",
      "ground_truth_answer": "There were a total of three control samples used in the study. The first control sample was a Haitian positive serum control pool created using country-wide DBS samples from RDT positive individuals. The second control sample was the WHO Pf 10/198 NIBSC standard 22, and the third control sample was created using country-wide DBS samples from individuals with confirmed malaria previously collected during healthcare visits.",
      "generated_response": "<think>\nOkay, let's see. The user is asking how many control samples were used in the study. The context provided has three passages from a paper about quality control in a malaria antibody detection study in Haiti.\n\nFirst, I need to look for mentions of control samples. The first passage mentions a \"Haitian hyperimmune sera\" that was used in each assay plate. But the question is about control samples. The second passage talks about an \"Assay standards\" section where a Haitian positive serum control pool was created using DBS samples from RDT positive individuals. The third passage also mentions the same thing, specifying that these were from individuals with confirmed malaria.\n\nNow, the key here is to determine if these control pools count as control samples. The passage says that a control pool was created and used. However, the exact number of control samples isn't directly stated. The numbers given are about the number of participant samples that passed QC: 5,898 in Survey 1, 21,234 in Survey 2, and 4,967 in Survey 3. But these are the participant samples, not the controls.\n\nThe control pool is mentioned as being created from country-wide DBS samples. However, the total number of participant samples processed is 32,758 over 18 weeks. The question is about control samples. The passage doesn't specify how many individual samples were in the control pool. It just says a pool was created. A pool typically means a mixture of multiple samples, but the exact number isn't given here. \n\nWait, the user is asking for the number of control samples. If the control pool is made from multiple samples, but the text doesn't state how many, then maybe the answer is that the number isn't specified. However, sometimes in such contexts, the control pool might be considered a single control sample per assay plate. The first passage mentions that the hyperimmune sera were used on each assay plate. If each plate uses one control sample (the pooled sera), then the number of control samples would depend on the number of plates. But the total number of participant samples is 32,758. If each plate can process, say, 96 samples, then the number of plates would be around 32,758 / 96 \u2248 341 plates. But the passage doesn't mention the number of plates used.",
      "retrieved_chunks": [
        "A 6-point titration\n\nTitle: Quality control of multiplex antibody detection in samples from large-scale surveys: the example of malaria in Haiti\nPassage: curve of the Haitian hyperimmune sera was created in bulk, stored at 4 \u00b0C and used on each assay plate.",
        "After removal of median fluorescence intensity data across all analytes for samples with missing or high responses to the generic glutathione-S-transferase , 5,898 samples passed QC in Survey 1 ; 21,234 samples in Survey 2 ; and 4,967 samples in Survey 3 .",
        "Following these QC checks, there\n\nTitle: Quality control of multiplex antibody detection in samples from large-scale surveys: the example of malaria in Haiti\nPassage: Assay standards. A Haitian positive serum control pool was created using country-wide DBS samples from RDT positive individuals collected during healthcare visits.",
        "Together these represent 32,758 participant samples processed over an eighteen-week period.",
        "As samples and controls were\n\nTitle: Quality control of multiplex antibody detection in samples from large-scale surveys: the example of malaria in Haiti\nPassage: was created using country-wide DBS samples from individuals with confirmed malaria previously collected during healthcare visits."
      ],
      "computed_relevance": 0.5,
      "computed_utilization": 0.8333333333333334,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.125,
      "gt_utilization": 0.125,
      "gt_completeness": 1.0,
      "gt_adherence": 0.0,
      "binary_pred": 0,
      "binary_gt": 0,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 94,
      "dataset_id": "831",
      "question": "What was the purpose of the search?",
      "ground_truth_answer": "The purpose of the search was to monitor diseases and track trends in the pilot study area, Guangdong Province, and to examine the predictive effects of the revised search volume.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What was the purpose of the search?\" based on the provided context and passages. \n\nFirst, I need to look at the context given. The context mentions ten criteria for assessing methodological quality, like having a clearly focused question, inclusion criteria, search strategy, etc. Then there are several titles and passages from different studies. \n\nThe first title is \"Towards Identifying and Reducing the Bias of Disease Information Extracted from Search Engine Data.\" The passages under this title talk about revised search volume for predictive effects, using search engine data to monitor diseases, and comparing with real cases. The second title is \"Missing and accounted for: gaps and areas of wealth in the public health review literature,\" with a passage mentioning evidence on health outcomes and search strategy description.\n\nThe specific question is about whether search engine data can track HFMD trends in Guangdong Province. The answer needs to be based on the context provided. \n\nLooking at the criteria, the purpose of the search would relate to the methodological quality assessment. The passages mention using search engine data for disease monitoring and evaluating bias. The answer should connect the purpose to assessing if search engine data is suitable for tracking HFMD, considering the methodological criteria like search strategy, evidence level, and validation against real cases. \n\nI need to make sure the answer addresses the evaluation of the methodological quality in the context of using search engine data for disease tracking, specifically HFMD in Guangdong. The answer should mention the criteria like comprehensive search strategy, evidence level, and validation against real cases as part of the purpose.\n</think>\n\nThe purpose of the search was to **evaluate the methodological quality of studies that use search engine data for disease monitoring**, specifically to assess whether such data can reliably track HFMD (Hand, Foot, and Mouth Disease) trends in Guangdong Province. This involved examining criteria such as the clarity of the research question, comprehensiveness of the search strategy, assessment of evidence levels, and validation of search engine data against real-world case data to identify biases or gaps. The goal was to determine the suitability and accuracy of search engine-derived information as a tool for public health surveillance in the region.",
      "retrieved_chunks": [
        "To assess the methodological quality, the following ten criteria are used: 1) a clearly focused question was stated; 2) inclusion criteria were explicitly stated; 3) a comprehensive search strategy was described; 4) an adequate number of years were covered in the search; 5) a description of the level of evidence was provided; 6) the methodological rigor of primary studies was conducted and results were described; 7) the methodological quality of primary studies was assessed by two reviewers and the level of agreement was provided; 8) tests\n\nTitle: Towards Identifying and Reducing the Bias of Disease Information Extracted from Search Engine Data\nPassage: revised search volume to examine the predictive effects of the revised search volume.",
        "Title: Towards Identifying and Reducing the Bias of Disease Information Extracted from Search Engine Data\nPassage: used to monitor diseases.",
        "Title: Towards Identifying and Reducing the Bias of Disease Information Extracted from Search Engine Data\nPassage: and real cases?",
        "Title: Missing and accounted for: gaps and areas of wealth in the public health review literature\nPassage: evidence on health outcomes is reported; and 5) the search strategy is described .",
        "Can search engine data serve as a suitable tool for tracking HFMD trends in our pilot study area, Guangdong Province?"
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.3,
      "gt_utilization": 0.3,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 95,
      "dataset_id": "1400",
      "question": "What is the result of increased eosinophilia?",
      "ground_truth_answer": "The increased eosinophilia results in a >40-fold increase in the ability to detect tissue infiltrating eosinophils, a >2-fold increase in the level of eosinophil degranulation compared to control subjects, and significantly higher levels of degranulation in ALI patients surviving their hospitalization compared to non-surviving patients.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What is the result of increased eosinophilia?\" based on the provided context. First, I need to understand what the context is saying.\n\nLooking at the passages, they all relate to a study about acute lung injury (ALI) patients and the detection of eosinophils in lung tissue biopsies. The key points mentioned are:\n\n1. ALI patients had a >2-fold increase in eosinophil degranulation compared to controls.\n2. Using EPX-mAb immunohistochemistry, they found a >40-fold increase in detecting eosinophils compared to H&E staining.\n3. Surviving ALI patients had significantly higher levels of degranulation than non-survivors.\n4. Degranulation levels are categorized into different levels based on the area affected (like Level 2a and 2b).\n\nThe question is about the result of increased eosinophilia. Eosinophilia refers to an increased number of eosinophils. But in the context, they're talking about degranulation of eosinophils, not just their presence. The study suggests that higher degranulation levels in ALI patients are associated with better survival rates. So, the result of increased eosinophil degranulation (which is a form of eosinophilia activity) is that it may help predict survival. Survivors had higher degranulation levels than non-survivors.\n\nWait, but the question is about \"increased eosinophilia,\" which could mean more eosinophils or their activity. The context mentions that immunodetection (which is more sensitive) shows higher degranulation in survivors. So the increased degranulation (a result of eosinophilia) is linked to better outcomes. Therefore, the answer should be that increased eosinophil degranulation is associated with higher survival rates in ALI patients. The study's title also mentions that detecting these eosinophils can help predict survival, reinforcing that the degranulation levels are a prognostic indicator.\n</think>\n\nThe result of increased eosinophilia (specifically, elevated eosinophil degranulation) in acute lung injury (ALI) patients is **associated with improved survival outcomes**. The study indicates that ALI patients who survived hospitalization exhibited **significantly higher levels of eosinophil degranulation** compared to non-survivors. This suggests that",
      "retrieved_chunks": [
        "Title: Immunodetection of occult eosinophils in lung tissue biopsies may help predict survival in acute lung injury\nPassage: disease progression in these subjects was such that nineteen of the twenty patients received corticosteroid therapy during their course of treatment. Title: Immunodetection of occult eosinophils in lung tissue biopsies may help predict survival in acute lung injury\nPassage: group of ALI patients, the collective group also evidenced a >2-fold increase in the level of eosinophil degranulation compared to control subjects .",
        "Title: Immunodetection of occult eosinophils in lung tissue biopsies may help predict survival in acute lung injury\nPassage: an enhanced sensitivity to detect eosinophils in these lung tissue sections. Specifically, evaluations of the lungs of control subjects using EPX-mAb immunohistochemistry revealed a >40-fold increase in the ability to detect tissue infiltrating eosinophils relative to H&E staining . Title: Immunodetection of occult eosinophils in lung tissue biopsies may help predict survival in acute lung injury\nPassage: elevated level of eosinophil degranulation representing \u22653 areas of granule protein release that again is <10% of the field of view. Level 2a: Significant level of eosinophil degranulation that includes 10-50% of the field of view. Level 2b: Significant level of eosinophil degranulation that includes extracellular release of EPX, enucleated eosinophils , and/or the presence of free granules .",
        "More importantly, quantitative assessments of degranulation based on EPX-mAb immunohistochemistry revealed that ALI patients surviving their hospitalization also displayed significantly higher levels of degranulation compared to non-surviving patients .",
        "The extent of degranulation represents >50% of the field's total area.",
        "Scale bar = 50 \u03bcm."
      ],
      "computed_relevance": 0.2,
      "computed_utilization": 0.2,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.35714285714285715,
      "gt_utilization": 0.21428571428571427,
      "gt_completeness": 0.6,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 96,
      "dataset_id": "1102",
      "question": "What is a conclusion of this report?",
      "ground_truth_answer": "The conclusion of the report is that strong conclusive statements are difficult to make.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking for a conclusion of the report based on the provided contexts. Let me look at each context carefully.\n\nFirst context: The title is \"Estimating the number of infections and the impact of non-\" and the passage mentions \"Conclusion and Limitations\" and \"the appendix, and general limitations presented below in the conclusions.\" This suggests that the report has a section on conclusions, but the passage here is a bit fragmented. Maybe the conclusion here is about the limitations of their estimation methods?\n\nSecond context: The title is \"Outcome of paediatric intensive care survivors\" with a passage that says \"and, therefore, strong conclusive statements difficult.\" This implies that the study might have found it hard to make strong conclusions, perhaps due to sample size or other factors.\n\nThird context: The title is \"Globalization and emerging governance modalities\" and the passage says \"me two conclusions.\" That seems like a typo or error, maybe \"make two conclusions\"? If so, the report might present two main conclusions about how globalization affects governance.\n\nThe question is asking for a conclusion of \"this report,\" but there are multiple contexts here. However, the first context's title is repeated, which might be the main report in question. The passage mentions \"Conclusion and Limitations\" and refers to the appendix and general limitations. So the conclusion here could be that while they estimated infections, there are limitations in their approach. The answer might be that the report concludes with certain limitations affecting the accuracy of infection estimates.\n\nBut the user wants a specific answer. Let me check again. The first passage says \"strong conclusive statements difficult,\" which is from the second context. Maybe the answer is that the report's conclusion is that making strong conclusions is difficult due to limitations. However, the third context's mention of \"two conclusions\" is unclear. Since the first context's title is about estimating infections and mentions conclusions and limitations, the answer likely relates to that. So the conclusion is that the study's estimates have limitations, making strong statements difficult. Therefore, the answer would be that the report concludes that there are limitations in estimating the number of infections, leading to challenges in making strong conclusions.\n</think>\n\nThe report concludes that there are significant limitations in estimating the number of infections and the impact of non-pharmaceutical interventions, which makes it challenging to draw strong, definitive statements about the outcomes or effectiveness of these measures.",
      "retrieved_chunks": [
        "Title: Estimating the number of infections and the impact of non-\nPassage: 4 Conclusion and Limitations\n\nTitle: Outcome of paediatric intensive care survivors\nPassage: and, therefore, strong conclusive statements difficult.",
        "Title: Globalization and emerging governance modalities\nPassage: me two conclusions.",
        "Title: Estimating the number of infections and the impact of non-\nPassage: the appendix, and general limitations presented below in the conclusions."
      ],
      "computed_relevance": 0.6666666666666666,
      "computed_utilization": 0.6666666666666666,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.125,
      "gt_utilization": 0.125,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 97,
      "dataset_id": "300",
      "question": "What was used to measure the performance of the NINA heaters?",
      "ground_truth_answer": "The performance of the NINA heaters was measured by comparing replicate temperature profiles, demonstrating the ability to support isothermal nucleic acid amplification assays, and showing minimal variation in temperature from run to run within the reaction tubes.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking what was used to measure the performance of the NINA heaters. I need to look through the provided context to find the answer.\n\nFirst, I'll scan through the passages. The first context mentions that the NINA heater is part of a stand-alone assay kit without needing external power or readers. But that's more about the application, not the measurement method.\n\nLooking at the second passage: \"Ten replicate runs of the optimized prototype displayed minimal variation in temperature from run to run within the reaction tubes.\" So they did ten runs and checked temperature variation. That's a measurement of performance. Also, \"Replicate temperature profiles display minimal variation between runs and far less variation\" \u2013 so temperature profiles over time were measured.\n\nThird passage: They compared the NINA heater to two reference heaters, GeneAmpH 9600 and ESE-Quant Tube Scanner. They mention using LAMP assays and comparing results. So they used these commercial instruments as benchmarks. Also, they mention equivalence to PCR instruments, which implies they tested the heater's ability to perform the same as existing devices.\n\nAnother part says the heater reached optimal temperature in 15 minutes and maintained it for 60 minutes. That's about time and temperature maintenance, which are performance metrics. So temperature measurements over time, comparison to reference heaters, and testing with LAMP assays to see if results are comparable.\n\nSo putting it all together, the performance was measured by temperature profiles (checking consistency and stability), comparison to commercial heaters (GeneAmp and ESE-Quant), and using LAMP assays to validate functionality. The answer should include these elements.\n</think>\n\nThe performance of the NINA heaters was measured using **temperature profiles** (assessing consistency across replicate runs and over time), **comparison to commercial reference heaters** (GeneAmpH 9600 and ESE-Quant Tube Scanner) for equivalence in supporting isothermal nucleic acid amplification, and **LAMP assays** to validate functionality. Additionally, the heater's ability to reach and maintain optimal incubation temperatures (within 15 minutes and sustained for 60 minutes) was evaluated. These methods confirmed its reliability and equivalence to existing PCR instruments without requiring electricity or closed-loop control.",
      "retrieved_chunks": [
        "More compelling is the potential of the NINA heater as the core component of a stand-alone assay kit, capable of providing a result without external electrical power, a reader instrument, or any complex ancillaries. Such a device might include the NINA heater, reaction chambers containing lyophilized reagents, sample metering devices, a readout chamber or lateral flow strip for visible interrogation,",
        "Although we did not intend to rigorously\n\nTitle: A Simple, Inexpensive Device for Nucleic Acid Amplification without Electricity\u2014Toward Instrument-Free Molecular Diagnostics in Low-Resource Settings\nPassage: Heat Production and Temperature in the NINA Heater Ten replicate runs of the optimized prototype displayed minimal variation in temperature from run to run within the reaction tubes .",
        "When combined with other innovations in development that eliminate power requirements for sample preparation, cold reagent storage, and readout, the NINA heater will comprise part of a kit that enables electricity-free NA testing for many important analytes. Replicate temperature profiles display minimal variation between runs and far less variation\n\nTitle: A Simple, Inexpensive Device for Nucleic Acid Amplification without Electricity\u2014Toward Instrument-Free Molecular Diagnostics in Low-Resource Settings\nPassage: These results clearly show that the NINA heater can incubate isothermal reactions predictably and precisely with no electricity and without any form of closed-loop control. We also demonstrate that it can be used for LAMP assays, with no discernable difference when compared to two reference heaters, the GeneAmpH 9600 and the ESE-Quant Tube Scanner. There is a bias between the NINA heater and the ESE-Quant , but this is not a significant finding considering we are comparing FIU without any assay calibration.",
        "Title: A Simple, Inexpensive Device for Nucleic Acid Amplification without Electricity\u2014Toward Instrument-Free Molecular Diagnostics in Low-Resource Settings\nPassage: We have demonstrated the ability of an optimized NINA heater prototype, based on exothermic chemical reactions and EPCM, to support isothermal NA amplification assays and established its equivalence to commercially available PCR instruments. The disposable heater described is a component of an instrument-free point of care molecular diagnostics system under development.",
        "The heater reached the optimal incubation temperature in 15 minutes, and maintained the target temperature with minimal drift over 60 minutes."
      ],
      "computed_relevance": 0.7,
      "computed_utilization": 0.8,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2857142857142857,
      "gt_utilization": 0.09523809523809523,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 98,
      "dataset_id": "450",
      "question": "What did the comparison of  the FPASSA-ANFIS model with several existing models, show?",
      "ground_truth_answer": "The comparison of the FPASSA-ANFIS model with several existing models showed that it had better performance in terms of Mean Absolute Percentage Error, Root Mean Squared Relative Error, and Root Mean Squared.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking what the comparison of the FPASSA-ANFIS model with existing models showed. I need to look through the provided context to find the relevant information.\n\nFirst, the context mentions that the FPASSA-ANFIS model was evaluated using WHO data on COVID-19 cases to forecast the next ten days. Then it says the model was compared to several existing models and showed better performance in terms of Mean Absolute Percentage Error (MAPE), Root Mean Squared Relative Error (RMSRE), and Root Mean Squared Error (RMSE). \n\nThe key part here is \"it showed better performance in terms of...\" So the answer should state that the FPASSA-ANFIS outperformed other models in those specific error metrics. Also, the title mentions it's an optimization method for forecasting, which aligns with the results. I should make sure to mention the metrics and that it's better than models like ANFIS trained with PSO, GA, ABC, FPA, etc., as listed in the passage. The answer should be concise but include all the metrics mentioned.\n</think>\n\nThe comparison of the FPASSA-ANFIS model with several existing models demonstrated that it outperformed them in terms of **Mean Absolute Percentage Error (MAPE)**, **Root Mean Squared Relative Error (RMSRE)**, and **Root Mean Squared Error (RMSE)**. This improved performance is attributed to the integration of the modified Flower Pollination Algorithm (FPA) for optimizing the ANFIS parameters, which addresses limitations of traditional ANFIS and other trained ANFIS models (e.g., those using PSO, GA, ABC, or FPA).",
      "retrieved_chunks": [
        "The FPASSA-ANFIS utilizes the improved FPA to train the ANFIS model by optimizing its parameters. The FPASSA-ANFIS contains five layers as the classic ANFIS model.",
        "The main idea of the proposed model, called FPASSA-ANFIS, is to improve the performance of ANFIS by determining the parameters of ANFIS using FPASSA. The FPASSA-ANFIS model is evaluated using the World Health Organization official data of the outbreak of the COVID-19 to forecast the confirmed cases of the upcoming ten days. More so, the FPASSA-ANFIS model is compared to several existing models, and it showed better performance in terms of Mean Absolute Percentage Error , Root Mean Squared Relative Error , Root Mean Squared\n\nTitle: Optimization Method for Forecasting Confirmed Cases of COVID-19 in China\nPassage: This section explains the proposed FPASSA-ANFIS method.",
        "These results avoid the limitations of traditional ANFIS because of the combination with the modified FPA method.",
        "Title: Optimization Method for Forecasting Confirmed Cases of COVID-19 in China\nPassage: This paper aims to assess the ability of the FPASSA to forecast the COVID-19 by comparing its performance with other methods, namely the ANFIS and the trained ANFIS models using PSO, GA, ABC, FPA, and FPASSA.",
        "However, the time computational of the proposed FPASSA method still requires more improvements."
      ],
      "computed_relevance": 0.25,
      "computed_utilization": 0.25,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.17391304347826086,
      "gt_utilization": 0.043478260869565216,
      "gt_completeness": 0.25,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 99,
      "dataset_id": "363",
      "question": "When did WHO declare a pandemic of pH1N1/2009v influenza?",
      "ground_truth_answer": "The World Health Organization declared a pandemic of pH1N1/2009v influenza on June 11, 2009.",
      "generated_response": "<think>\nOkay, let's see. The user is asking when the WHO declared a pandemic of pH1N1/2009v influenza. I need to look through the provided contexts to find the correct date.\n\nFirst, looking at the first context: The title mentions the declaration by WHO. The passage says, \"The World Health Organization declared that spread... satisfied the criteria for a pandemic on June 11, 2009, although technically conditions... had been met some weeks earlier.\" So the official declaration date is June 11, 2009.\n\nThe second context also talks about the same event. It states, \"The rapid spread... led the World Health Organization to declare on 11 June 2009 that a pandemic... was under way.\" That confirms the same date.\n\nThird context doesn't mention the declaration date, it's more about transmissibility and data from Taiwan. The fourth context from Hong Kong mentions the timeline but doesn't specify the declaration date. \n\nSo the answer is June 11, 2009. Both the first and second contexts confirm this. The user might be testing if I can cross-reference the information from different sources provided. I need to make sure there's no conflicting info. Since both sources agree, the answer is solid.\n</think>\n\nThe World Health Organization declared a pandemic of pH1N1/2009v influenza on **June 11, 2009**. This is explicitly stated in both the first and second contexts, which note that the WHO determined the virus's spread met pandemic criteria on this date.",
      "retrieved_chunks": [
        "Title: We should not be complacent about our population-based public health response to the first influenza pandemic of the 21(st )century\nPassage: The World Health Organization declared that spread of the newly recognised quadruple reassortant influenza A H1N1 virus satisfied the criteria for a pandemic on June 11, 2009 , although technically conditions for declaring a pandemic had been met some weeks earlier. The virus, generally referred to as pandemic influenza H1N1 2009 , had first been recognised in Mexico and the United States in late April 2009.",
        "Title: Pandemic Influenza Due to pH1N1/2009 Virus: Estimation of Infection Burden in Reunion Island through a Prospective Serosurvey, Austral Winter 2009\nPassage: Text: In April 2009, the first cases of acute respiratory infections caused by a novel triple-reassortant influenza virus, pH1N1/ 2009v, occurred in Mexico and the United States . The rapid spread of infection to other continents led the World Health Organization to declare on 11 June 2009 that a pandemic of pH1N1/2009v influenza was under way, which raised major international concern about the risk of high morbidity and lethality and the potential for severe socio-economic impact. Actually, the potential impact of this first third-millenium influenza pandemic has been revisited downwards as morbidity and case-fatality rates were less severe than initially\n\nTitle: Transmissibility and temporal changes of 2009 pH1N1 pandemic during summer and fall/winter waves\nPassage: The data was accessed from the Central Epidemic Command Center website of the Taiwan Centers for Disease Control . Samples were collected from hospitals and clinics participating in the Taiwan Influenza surveillance system under the Taiwan National Influenza Center , which was established in 2006 to integrate all existing efforts of influenza surveillance and notification with laboratory analysis systems throughout Taiwan in order to enhance the epidemic data collection capacity in Taiwan . The weekly laboratory confirmed pH1N1 case data and the weekly hospitalization data from June 28, 2009 to March 27, 2010 was accessed from the weekly Influenza Express\n\nTitle: The epidemiological and public health research response to 2009 pandemic influenza A(H1N1): experiences from Hong Kong\nPassage: identified.",
        "More than a year later, WHO has declared the pandemic to be over and early assessments of the global response have commenced .",
        "Confirmed pH1N1 infection was a notifiable disease throughout the first wave. Figure 1 summarizes a timeline of the first wave of pH1N1 in Hong Kong.",
        "Incidence peaked in September, and the first wave petered out by early November."
      ],
      "computed_relevance": 0.18181818181818182,
      "computed_utilization": 0.18181818181818182,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.125,
      "gt_utilization": 0.125,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_skipped": false,
      "error": ""
    }
  ],
  "skipped_samples": []
}